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CHAPTER 1
GENERAL INTRODUCTION
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Gliomas are a heterogeneous group of primary brain tumors originating from transformed 
brain cell progenitors which abnormally reproduce brain development programs1–3. 
Dependent on the cell of origin and genetical background gliomas can be divided in 
astrocytomas, oligodendrogliomas and epindenomas with different cancer progression 
stages4. The stage IV of astrocytomas, primary glioblastoma, is the most aggressive 
form of gliomas and one of the deadliest cancer in humans. The median survival time 
of glioblastoma patients is between 14.5 and 16.6 months, despite radio- and chemo- 
therapy treatments5,6. The high lethality of glioblastoma patients results from diffuse 
glioma cell dissemination in the brain7. After surgical resection of the primary lesion, 
glioma cells which have invaded into surrounding tissue give rise to recurrence of the tumor 
within months. Glioma cells disseminate into the brain stroma along the intertwining cell 
networks formed by astrocytes, neurons, myelinated axons and blood vessels7,8. However, 
due to anatomic and molecular complexity, the mechanisms of glioma cell invasion in 
the brain parenchyma is neither resolved mechanistically nor therapeutically exploited. 
The aims of this thesis are: (1) to design three-dimensional (3D) invasion assays 
recapitulating glioma cell dissemination in different anatomical environments of 
the brain – along blood vessels and in neuronal/astrocytic networks; (2) to perform 
three-dimensional (3D) reconstruction of glioma lesions and characterize glioma invasion 
patterns in patient brain samples; (3) to identify cell-cell and cell-matrix adhesion 
molecules driving glioma cell invasion in the brain.   
In Chapter 2 we describe the brain tissue architecture at cellular and molecular levels 
and recapitulates the main anatomical structures which guide glioma cell invasion in 
the brain. Myelinated axons, astrocyte processes and blood vessels create a complex system 
of microchannels utilized by glioma cells for their disseminations. The extracellular space 
in the brain parenchyma is filled primarily with a soft matrix composed by hyaluronan-
lectican-tenascin molecular complexes, unlike connective tissue where collagen bundles 
are predominant in extracellular matrix. 
2D and 3D assays developed to study glioma cell invasion in vitro neither reproduce 
a complex anatomical and molecular structure of the brain tissue, nor a major mechanism 
of glioma cell dissemination in the brain - multicellular network expansion8–10. The majority 
of the assays devoid brain cellular components like astrocytes and myelinated axons, 
which are utilized by glioma cells for their invasion. We developed a set of 3D assays 
recapitulating different anatomical and molecular routes of glioma cell invasion in the brain 
tissue (Chapter 3). To mimic cohesive perivascular invasion of glioma cells, a hyaluronan-
reconstituted basement membrane interface and organotypic brain slice assays were 
designed. As model for diffuse migration into the astrocyte-rich brain parenchyma, a 3D 
astrocyte scaffold assay was developed which supports both individual-cell and glioma 
multicellular network invasion. Each assay serves for both, high-resolution functional 
analysis of molecular mechanisms underlying glioma invasion, as well as high-throughput 
screening of clinically relevant treatments to inhibit glioma cell invasion and proliferation 
in distinct brain compartments (Chapter 3).  
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Cancer cells can invade peritumoral tissue either individually without cell-cell 
interaction to neighboring cells or collectively, as cohesive groups maintaining cell-cell 
junctions to their neighbor cells and moving as a coordinated group11,12. The concept 
that glioma cells infiltrate brain parenchyma exclusively as single cells has dominated 
the glioma field for decades, however is currently challenged based on recent data10. By 
3D reconstruction of glioma lesions from patient samples and glioma models in mouse 
brain, we described the identification of moving multicellular networks with dendrite-like 
protrusions connecting glioma cells as an important yet unappreciated invasion strategy10 
(Chapter 4). Multicellular glioma networks thus adopt a specialized mode of collective 
invasion, which enables cell-cell interaction between glioma cells while moving through 
complex-shaped brain stroma. As central mechanism of glioma network formation and 
maintenance, we show that filament connections between glioma cells are stabilized by 
adherens junctions with p120 catenin as indispensable for glioma network migration and 
tumor growth in the mouse brain (Chapter 4).   
Perivascular glioma cell invasion is driven mainly by basement membranes ensheathing 
capillaries and bigger blood vessels in the brain7,8,13. Therefore basement membrane 
proteins are potential candidates and mediators for glioma cell invasion and growth 
signalling in the brain8,14. Using the 3D astrocyte scaffold invasion assay we identified 
laminin 511 as a major extracellular matrix component driving glioma cell invasion 
(Chapter 5). Interference with different integrin subunits showed that β1 integrins are 
the predominant receptors mediating glioma cell migration along laminin 511. However, 
since interference with adhesion systems using antibody targeting and RNA interference, 
alone or in combination, was incomplete in inhibiting glioma invasion, the data further 
suggest the presence of integrin-independent, additional cell-matrix interaction 
strategies15. This further indicates potential limitations of anti-integrin therapies to 
combat perivascular glioma cell dissemination and growth (Chapter 5).
In conclusion, using novel 3D culture approaches and 3D reconstruction of glioma 
lesions in mouse brain and patient samples, we suggest new concepts of glioma 
cell dissemination in the brain parenchyma: diffuse multicellular network invasion 
ensured by p120 catenin and perivascular glioma cell invasion driven by β1 integrin - 
laminin 511 interactions.    
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ABSTRACT
Cancer cell invasion into healthy tissues develops preferentially along pre-existing tracks 
of least resistance, followed by secondary tissue remodelling and destruction. The tissue 
scaffolds supporting or preventing guidance of invasion vary in structure and molecular 
composition between organs. In the brain, the guidance is provided by myelinated axons, 
astrocyte processes, and blood vessels which are used as invasion routes by glioma cells. 
In the human breast, containing interstitial collagen-rich connective tissue, disseminating 
breast cancer cells preferentially invade along bundled collagen fibrils and the surface of 
adipocytes. In both invasion types, physical guidance prompted by interfaces and space 
is complemented by molecular guidance. Generic mechanisms shared by most, if not 
all, tissues include (i) guidance by integrins towards fibrillar interstitial collagen and/or 
laminins and type IV collagen in basement membranes decorating vessels and adipocytes, 
and, likely, CD44 engaging with hyaluronan; (ii) haptotactic guidance by chemokines 
and growth factors; and likely (iii) physical pushing mechanisms. Tissue-specific, resticted 
guidance cues include ECM proteins with restricted expression (tenascins, lecticans), 
cell–cell interfaces, and newly secreted matrix molecules decorating ECM fibres (laminin-
332, thrombospondin-1, osteopontin, periostin). We here review physical and molecular 
guidance mechanisms in interstitial tissue and brain parenchyma and explore shared 
principles and organ-specific differences, and their implications for experimental model 
design and therapeutic targeting of tumour cell invasion.
INTRODUCTION
Cancer cell invasion results from actomyosin dependent movement of the cellular body 
through or along tissue structures. After metastasis to secondary organs, local invasion 
by cancer cells may lead to secondary organ infiltration, thereby engaging with a tissue 
environment that differs from the primary organ 1. At any invasion stage, cancer cells are 
confronted with non-neoplastic tissue composed of cells and cell-derived extracellular 
matrix (ECM). Cancer cells constitutively express adhesion receptors that bind to ECM 
as well as to resident stromal cells which not only activate the actomyosin machinery to 
generate traction forces needed to migrate, but also deliver important signals for their 
growth and survival 2. Initially cancer invasion is largely non-destructive, but over time 
leads to substantial tissue remodelling, local destruction with ulceration, vessel disruption, 
and, ultimately, loss of function of invaded organs 3.
Two principal types of interstitial tissues are transmigrated by tumour cells: (i) collagen-
rich interstitial connective tissue present in most parenchymatous organs of the body 
and (ii) the interstitium of the brain. Both share significant similarities but also show 
important anatomic and molecular differences that impact upon the invasion process. 
The understanding of how physical and molecular guidance mechanisms converge, 
and how these principles apply to different tissues and organ systems, is important for 
developing experimental in vitro models of cancer invasion; it is further important for 
addressing and interpreting cell invasion patterns and routes in vivo by histopathological 
analysis. Using brain parenchyma and breast stroma as prototypic models for nervous and 
peripheral connective tissue invasion, respectively, we here review key tissue structures 
and their molecular properties that enable and guide cancer invasion and discuss 
the implications for designing experimental models and molecular anti-invasion therapy.
CELL–CELL AND CELL–MATRIX RECEPTORS
During cell–tissue interaction and migration in most tumours, integrin and non-integrin 
cell surface receptors simultaneously engage with locally available ECM and cell surface 
ligands (Table 1).
INTEGRINS
Integrins are heterodimeric transmembrane glycoproteins consisting of non-covalently 
linked α and β chains, which both determine ligand binding strength and specificity. 
Eight distinct α and 18 β chains combine to form 24 different heterodimers with distinct 
ligand specificity for ECM proteins (eg collagens, laminins, fibronectin, vitronectin, 
tenascins, thrombospondin, and fibrin) and cell surface receptors (eg ICAM-1, VCAM-1, 
and L1-CAM) 4,5. By these means, each cell type maintains a selective and activation-
dependent integrin repertoire and thus ligand preference. The cytoplasmic integrin 
domains connect, via cytosolic adaptor and signalling proteins, to the actin cytoskeleton 
and mediate intracellular mechanocoupling and signal transduction 6. Consequently, 
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integrins are important mediators for cell adhesion and migration. They further contribute 
to cell–cell contacts via direct interactions with counterpart cell receptors or indirectly, by 
bridging intercellular ECM molecules, including fibronectin or vitronectin 7.
SYNDECANS
Syndecans are a family of transmembrane heparan sulphate proteoglycans with four 
members, syndecans 1 to 4. Syndecans function mainly as co-receptors by binding to 
their ECM ligands in conjunction with other receptors, notably integrins 8. Through their 
heparan sulphate side chains, syndecans may further engage directly in ligand binding 9.
DYSTROGLYCANS
Dystroglycans are heterodimeric complexes consisting of non-covalently associated α and 
β subunits with extracellular ligand-binding and transmembrane functions, respectively 10. 
Dystroglycans are a part of the larger dystrophin-associated protein (DAP) complex 
that connects basement membranes to the cytoskeleton, particularly via α2 laminins 
and perlecan 10.
IMMUNOGLOBULIN (Ig) SUPERFAMILY CELL ADHESION PROTEINS
Ig superfamily members consist of immunoglobulin-like and fibronectin type III domains 
involved in homophilic and heterophilic cell–cell adhesion 11. The superfamily includes 
a variety of cell adhesion molecules (CAMs) with distinct ligand-binding specificities, 
including ICAM (intercellular), NCAM (neural), Ep-CAM (epithelial), L1-CAM, VCAM 
(vascular), ALCAM (activated leukocyte), and JAM (junctional adhesion molecule), 
among others 11.
CADHERINS
Cadherins are transmembrane proteins consisting of several tandemly repeated cadherin 
domains that mediate calcium-dependent homophilic cell–cell contacts 12,13. The cadherin 
superfamily comprises a total of more than 100 different members 14, with E- (epithelial) 
and N-cadherin (neural) most widely expressed in epithelial and neural tissues, respectively.
LINK MODULE SUPERFAMILY OF HA-BINDING PROTEINS 
(HYALADHERINS)
CD44 is the main HA receptor expressed by all nucleated cells in vertebrates 15. Besides 
the standard form (CD44s), multiple splice variants encoded by variable exons v1–10 
(CD44v1–10) can be expressed depending on the cell differentiation and activation state 16. 
Interactions of CD44 with multiple other molecules, including collagens, laminins, and 
fibronectin, have been shown in vitro; however, the relevance of these interactions to 
processes in vivo is not clear.
Table 1. Cell–matrix and cell–cell adhesion molecules expressed in glioma and carcinoma cells 
compared with normal brain and breast tissue
Cell receptor ECM/cell ligand
Glioma 
cells*
Carcinoma 
cells* Ref
Integrin
α1 β1 
α2 β1 
α3 β1
Type I and IV collagens, laminin
Type I and IV collagens
Laminins including laminin-332, 
type IV collagen
–
↔
↑
↓
↓
↓
[43,152]
[43,152,153] 
[42,43,136,152]
α6 β1
α6 β4 
α9 β1 
α5 β1 
αV β3
Laminins
Laminins
Tenascins, fibronectin
Fibronectin
Vitronectin, laminin, 
thrombospondin, tenascins, 
type IV collagen, osteopontin, 
periostin, tropoelastin
↔
↑
↑
↔/– 
↑
↓
↓
↔
↓
↑
[42,43,152,158]
[153–158] 
[53,159] 
[42,43,152,153,160] 
[42,43,141,161]
αV β5 Vitronectin, laminin, 
thrombospondin, tenascins, 
type IV collagen, osteopontin, 
periostin
↑ – [161]
Syndecans (1 – 4) Laminin, type I collagen, 
tenascins, fibronectin, 
thrombospondin, vitronectin
↔ ↔ [44,162]
α- and β-dystroglycans
CD44
ICAM-1
NCAM 
L1-CAM
N-cadherin
E-cadherin
Laminin, perlecan
Hyaluronan, type IV collagen
Hyaluronan, LFA-1
NCAM, L1-CAM, neurocan
L1-CAM, NCAM 
N-cadherin
E-cadherin
↓
↑
↑
↓
↑
↓
–
↓
↑
↔
–
↑
↑
↓↔(D)/–(L)
[45,163,164]
[42,52,165,166] 
[42,167,168] 
[169–171] 
[172–175] 
[176–178] 
[91,177,179]
*Expression in histopathological samples compared with normal human tissue: ↔, not altered; 
–, not expressed; ↑, up-regulation; ↓, down-regulation. D = ductal breast carcinoma; L = lobular 
breast carcinoma. References often show trends, with divergent expression regulation in  
patient subgroups.
These receptors mediate tissue recognition and mechanical coupling and, with their 
expression levels and tissue context, whether cells remain immobile, migrate slowly or 
rapidly; and they further determine whether migration occurs individually with cell–cell 
junctions absent or collectively, as multicellular groups with cell–cell junctions present 2,17.
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GUIDANCE STRUCTURES OF BRAIN TISSUE
Brain tissue harbours both primary tumours of neural origin and secondary metastases 
originating from other tissues. The structures that guide invasion into brain tissue are cell 
processes of neuronal and astrocytic origin, blood vessels, and tissue gaps present along 
vessels and brain surfaces.
BRAIN CELLS AND VESSELS
The grey matter of the brain cortex consists of a dense network of neurons, including 
their dendrites and myelinated axons, together with astrocytes (Figure 1A). The top layer 
Figure 1. Three-dimensional reconstruction of human brain structures. Images represent 3D 
projections from 200-µm-thick sections of formalin-fixed post-mortem human brain, including 
cortex (A, D), white matter (B), and corpus callosum (C). Staining was performed using the following 
primary antibodies: rabbit anti-type I collagen (Col I) polyclonal Ab (pAb; Abcam); chicken anti-
glial fibrillary acidic protein (GFAP) pAb (Abcam); rat anti-myelin basic protein (MBP) mAb (clone 
12, Abcam); mouse anti-collagen IV mAb (clone Col-94, Sigma); and DAPI. Astrocyte processes 
and myelinated axons form interconnected networks in the cortex and aligned tracks in the white 
matter. (D) Blood vessel surrounded by glia limitans (filled arrowhead) bordering perivascular space 
(open arrowhead). Scale bars = 100 µm.
of the cortex, termed glia limitans superficialis, is formed by astrocyte processes which 
interact tightly with the pia mater, consisting of a basement membrane and an outward 
monolayer of mesothelial cells (Figure 2A). Besides contributing to the outer meninges, 
both pia mater and glia limitans also extend into the brain parenchyma, where they 
cover and ensheath arteries, arterioles, and larger veins 18. Glia limitans with its basement 
membrane, but without pia mater, further surrounds small venules and capillaries 18. 
Thus, all larger blood vessels in the brain differ from vessels in other organs by their 
dual-layer microanatomy with a continuous perivascular space bordered by pia mater 
and glia limitans (Figure 1D) 19. Through this connection, the perivascular space conducts 
interstitial fluid and passenger leukocytes towards the subarachnoid space and ventricular 
cavities, thus fulfilling a draining function, which is similar to that of lymphatic vessels 
that are absent in the brain (Figure 2A) 20. As an exception, in capillaries, the basement 
membranes of glia limitans and endothelial cells are fused to a singular layer and obliterate 
the perivascular space 20.
Adjacent to the cortex, the white matter consists of myelinated axon tracks with 
adjacent oligodendrocytes providing axonal myelin sheaths and astrocytes providing 
an interstitial stroma by their interconnected processes, but lacks neuronal cell bodies 
(Figures 1B and 1C). Myelinated fibres thus form elongated tracks with interspersed 
astrocyte processes and a gap-like interstitium filled with ECM (Figures 1B and 1C). 
The brain anatomy thus consists of cell-fibre and perivascular space-track systems, which 
both provide constitutive trails of least resistance to moving cells.
MOLECULAR COMPOSITION OF BRAIN ECM AND BASEMENT 
MEMBRANES
The brain ECM is mainly deposited by astrocytes and oligodendrocytes and comprises 
an estimated 20% of the brain volume in adults 21. The main ECM components are 
hyaluronic acid (HA), tenascin R, and lecticans, which interconnect with each other non-
covalently and form molecular networks filling the intercellular space 22.
HA is a non-sulphated, linear, high-molecular-weight glycosaminoglycan which, due 
to its water-binding capacity, controls the high water content of the brain interstitium 23. 
Besides tenascins and lecticans, HA binds to cell surface receptors including CD44 and 
ICAM-1, which together contribute to both ECM organization and cell–matrix interaction. 
Tenascin R, a brain-specific member of the tenascin family comprising also tenascins C, X, 
and W, is a homotrimer with both lectican and integrin binding sites forming an adhesion 
bridge between the ECM and cells 24. Lecticans comprise a family of chondroitin sulphate 
proteoglycans with four members (brevican, versican, neurocan, and aggrecan), whereby 
brevican and neurocan are brain-specific 25. Lecticans contain HA and tenascin R binding 
sites and thus act as link molecules in protein–proteoglycan–glycosaminoglycan networks 26. 
Compared with peripheral interstitial tissues, a distinctive feature of the brain ECM is 
the absence of fibrillar collagen networks, which results in a low stiffness of the brain 
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parenchyma 18. In a restricted expression pattern, fibrillar collagens I and III are, however, 
deposited by leptomeningeal cells, pericytes, and smooth muscle cells in blood vessels 
and the brain meninges, including the pia mater 18, 27, 28 (Figure 1).
Basement membranes are dense sheet-like meshworks of 50–100 nm thickness, which 
are particularly permissive for guiding cell migration 29. Basement membranes consist 
of interconnected collagen IV, laminins, heparan sulphate proteoglycans (perlecan), and 
nidogen/entactin 29. Collagen IV is a heterotrimer composed of three α-polypeptide 
chains 30, which interconnect with laminins, also heterotrimeric molecules, consisting of 
α, β, and γ chains 31.
GUIDANCE OF GLIOMA CELLS
Gliomas are the most common primary brain tumours in adults. Gliomas presumably 
originate from transformed glial progenitors and, depending on their differentiation state, 
several subtypes exist, including astrocytomas, oligodendrogliomas, and ependymomas 
32,33. Glioma cells can form tumours in any brain region and infiltrate adjacent parenchyma 
diffusely, thereby, arguably, recapitulating the migration of glial progenitor cells during 
brain development 32,34,35. Glioma cell invasion into brain tissue occurs along pre-
existing brain structures, with notable preference for myelinated fibres and blood vessels 
(Figure 2) 36, 37. Ultimately, through the perivascular space, glioma cells can reach and 
populate the subarachnoid space 37, 38. As a consequence of such extended tissue 
invasion, surgical resection of gliomas is usually non-curative and followed by cell survival 
and regrowth from invasion zones beyond the resection margins 35. For as yet unknown 
reasons, glioma cells usually do not invade vessel lumens; thus, unlike most other 
malignancies, systemic dissemination and metastasis in non-neuronal organs are a rarity 
in brain neoplasia 39.
GUIDANCE BY BLOOD VESSELS
Glioma cells migrate along blood vessels using two biomechanically distinct routes: (i) 
the glia limitans along the outward vessel–parenchyma interface (Figure 2B) and (ii) inside 
the lumen of the perivascular space (Figures 2C). For the interstitial-type migration along 
the glia limitans, glioma cells may displace astrocytes bordering the blood vessels and 
employ the basement membrane as a substrate 40,41, whereas the role of simultaneous 
glioma cell–astrocyte interactions is unclear. Glioma cells further penetrate through the glia 
limitans and its basement membrane to reach the barrier-free lumen of the perivascular 
space and migrate along the inner basement membranes of vessels 40,41 (Figure 2C).
In vivo, glioma cells express and/or up-regulate a range of receptors binding to 
laminins and collagen IV, including integrins (α2β1, α3β1, α6β1, α6β4, αvβ3, αvβ5), 
dystroglycans, and syndecans 42–45 (Table 1). Consequently, laminins and collagen IV are 
the main ligands supporting glioma cell invasion along basement membranes, with 
α3β1 integrin as the major laminin receptor and laminins 332 and 511 as the matching 
ligands 43,46. Candidate cell–cell adhesions for the invasion route along the glia limitans 
comprise integrins connecting to cell surface-associated fibronectin and vitronectin, 
together with homophilic engagement of N-cadherin, L1-CAM, and NCAM (Figure 2B). 
Thus, whereas molecular guidance by the basement membrane appears to predominate 
in perivascular invasion, the role of glioma–astrocyte interactions remains to be clarified. 
GUIDANCE BY NERVE TRACKS
The mechanisms of glioma cell invasion along myelinated fibres are likely multifactorial, 
whereby each relative contribution remains to be elucidated (Figure 2D).
Figure 2. Anatomic and molecular guidance of glioma cell invasion. (A) Guidance along the glia 
limitans and perivascular space, as well as by neuronal and astrocyte tracks. (B) Extravascular 
guidance along the vessel–stroma interface. (C) Guidance by the perivascular space. (D) Glioma 
cell migration along white matter tracks. HA = hyaluronan; Vn = vitronectin; Fn = fibronectin; 
Ln = laminin
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Myelin sheaths formed by oligodendrocyte processes are considered as non-permissive 
substrates for cell migration, because they lack commonly known pro-migratory 
ECM proteins (eg laminins, collagens) and cell surface receptors that can bind these 
molecules 47. In addition, myelin sheaths express repelling receptors, including Nogo-A, 
myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein, which together 
inhibit axonal growth and cell migration 48, 49. Glioma cells, due to their altered protease 
expression profile, including increased MMP-14/MT1-MMP and MMP-2 levels 50, are, 
however, able to proteolytically cleave inhibitory molecules from the myelin surface using 
MMP-14 and thereby remove otherwise dominant anti-migration signals 51. Thus, an anti-
migratory brain scaffold is conditioned by ECM remodelling and processing of cell surface 
receptors towards a migration-enhancing tissue environment.
Due to their high water content and non-covalent intermolecular linkages, the ECM 
networks between myelinated fibres formed by HA, tenascin R, and lecticans are likely 
soft and deformable, compared with collagen-rich peripheral tissues. It is not known 
whether and how glioma cells use this HA-based matrix as a migration substrate; 
however, the consistent up-regulation of the HA receptors CD44 and ICAM-1, and of 
the tenascin R receptor α9β1 integrin in glioma cells, is suggestive of a pro-invasive 
cell–ECM interaction 42,52,53. Glioma cells further up-regulate ADAMTS-5 (a disintegrin 
and metalloproteinase with thrombospondin motifs), which is secreted, cleaves brevican, 
and thereby likely disrupts ECM networks and lowers the physical interfibre resistance 
26,54,55. The distance between myelinated fibres in white matter tracks is less than 1 µm; 
thus, glioma cells have to expand the inter-fibre space and deform their nuclei, which 
are the largest and most rigid organelle in cells 56. Consequently, glioma cell invasion 
along myelinated fibres in a rat brain model also depends on cell squeezing in a myosin 
II-dependent manner 57.
Simultaneously with myelinated fibres themselves, astrocyte processes localizing 
ubiquitously in all brain regions may contribute to glioma cell guidance (Figure 1). 
The border of gliomas shows an increased number of reactive astrocytes, which together 
with glioma cells secrete various pro-migratory molecules, including laminins, vitronectin, 
fibronectin, and thrombospondin 46, 58–61. Because of their polyvalency (ie one molecule 
comprises more than one receptor-binding site), they adsorb to and decorate cell surfaces 
and provide a multimeric ECM meshwork available for counterpart cell surface receptor 
engagement (Figures 2B and 2D) 7. Thus, glioma cells employing myelinated fibres and 
astrocyte processes as a substrate for migration engage multiple receptor–ligand systems 
for polarization and generating actomyosin-mediated traction forces, together with 
pericellular proteolysis.
GUIDANCE OF METASTATIC TUMOUR CELLS IN BRAIN TISSUE
Besides glioma cells, circulating tumour cells of other organs (mainly carcinoma and 
melanoma cells) may penetrate through blood vessels, establish metastatic brain lesions, 
and invade the brain. Similar to glioma cell invasion, metastatic brain invasion occurs 
preferentially along the blood vessels but spares white matter tracks and thus commonly 
lacks diffuse infiltration 62, 63. The vascular basement membranes are considered the most 
important structures for initial growth and migration of carcinoma and melanoma cells 
metastasizing in the brain 64, 65. It is likely that the lack of glioma cell-specific capabilities to 
remove anti-migratory activity of white matter tracks confines metastatic cell movement 
to the perivascular space, reminiscent of retained structural and molecular cues present 
in the connective tissue environment that they originate from.
CELL AND TISSUE STRUCTURES OF THE MAMMARY GLAND
The mammary gland is a prototypic peripheral organ consisting of the epithelium with an 
underlying basement membrane that forms the milk-producing alveoli and connecting 
ducts, and surrounding collagen-rich connective tissue including blood and lymph vessels 
and nerve tracks, as well as an adjacent layer of fat tissue (Figure 3A). In contrast to 
most other peripheral tissues, the postnatal mammary gland is structurally dynamic and 
undergoes glandular growth and sprouting during puberty and pregnancy, a process that 
is recapitulated in a pathological manner during breast cancer.
MAMMARY EPITHELIUM
The basic structural units of the mammary gland are alveoli joined together to form 
a lobule. Each lobule has its own lactiferous duct converging with other ducts to form 
a tree-like branching network towards the nipple. Both alveoli and ducts consist of 
Figure  3. Three-dimensional reconstruction of human mammary gland tissue. Images represent 
3D projections from 200-µm-thick sections of formalin-fixed breast carcinoma samples and show 
normal, non-invaded tissue regions. (A) Ducts surrounded by non-desmoplastic fibrous tissue. (B) 
Adipose tissue. Samples were labelled by mouse anti-collagen IV mAb (clone Col-94; Sigma), mouse 
anti-E-cadherin mAb (clone SHE78-7; Calbiochem), and DAPI. Fibrillar collagen was detected by 
second harmonic generation (SHG), revealing structural discontinuities and clefts (arrowheads). 
Dashed line in B, inter-adipocyte track part of which is highlighted in inset. Scale bars = 100 µm.
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a bilayered epithelium, inner luminal cells surrounding the cavities, and outer myoepithelial 
cells engaging with the surrounding epithelial basement membrane 66. Mammary ducts 
remain quiescent until puberty, when hormone-induced elongation and secondary 
branching occur by sprouting-type movement of the terminal end bud (TEB), a specialized 
region at the end of each primary duct. During pregnancy, through a similar sprouting 
mechanism, additional lateral branching occurs and luminal epithelial cells differentiate 
in the secretory alveoli 67.
ECM OF THE MAMMARY GLAND
The interstitial tissue of the mammary gland contains fibrillar type I collagen as 
a main structural component and interconnected glycoproteins 67, 68. After extracellular 
deposition by fibroblasts, the propeptides of the triple-helical type I procollagen molecule 
are proteolytically cleaved by the endopeptidases ADAMTS-2, 3, and BMP-1 (bone 
morphogenetic protein-1), resulting in monomeric tropocollagen, which spontaneously 
polymerizes to multimeric fibrils 69–72. The fibrous connective tissue of the normal 
breast stroma is heterogeneous in physical organization and density, with collagen 
fibrils measuring approximately 70 nm in diameter organized laterally into wavy fibre 
bundles (Figure 3) 73. Thereby, regions of dense collagen bundles intersperse with loosely 
organized networks and inter-fibre clefts of variable widths, ranging from 3 to 30 µm 74 
(O Ilina, unpublished data). This spatial structure of interstitial collagen, including physical 
and molecular signalling properties, are strongly modulated by collagen cross-linking and 
the presence of regulatory proteins. Collagen fibrils are cross-linked covalently by lysyl 
oxidases released by fibroblasts, stably bridging neighbouring collagen monomers and 
increasing fibril stiffness 75, 76. The kinetics of fibril formation, their physical properties, and 
function towards cells are further modulated by type I collagen-binding ECM constituents, 
including fibrillar type III 77 and V collagens 78, fibronectin 79, decorin 80, and biglycan 81. 
Fibronectin is an abundant fibrillar constituent of the ECM, with multi-adaptor functions, 
coupling cells and matrix via α5β1 integrin and providing binding sites for collagen type 
I and heparan sulphate proteoglycans 82. Collagen-interacting molecules that modify 
its function further include proteoglycans (heparan sulphate, chondroitin sulphate) and 
hyaluronan, which together form a viscous, gel-like filling of inter-fibrillar spaces and 
provide binding sites for growth factors and cytokines. Heparan-sulphate proteoglycans 
bind growth factors, such as FGF1, FGF2, and HGF; chemokines incuding SDF-1α; and 
collagen-associated glycoproteins, including periostin 83. HA non-covalently binds to 
proteoglycans and ECM proteins, including osteopontin, tenascin C, and versican 84, 85.
The adipose tissue of the mammary gland comprises groups of adipocytes with a cell 
surface-associated basement membrane composed of collagen type IV, laminins, and 
perlecan 86. The interstitial ECM supporting adipocytes is composed of type I collagen 
fibres 87, interconnected with collagen types III, V, and VI, fibronectin, and proteoglycans 88, 
which form a loose reticular network with interstitial clefts 89 and interspersed cell- and 
vessel-rich fibrous septa (Figure 3B).
In human quiescent breast epithelium, α1β1, α2β1, α3β1, and α6β4 integrins are 
expressed by myoepithelial cells and are involved in the stable adhesion to ECM and 
thus cell anchoring to the matrix 90. The quiescent state of normal breast epithelium 
is further maintained by desmocollin-2 (Dsc-2) and desmoglein-2 (Dsg-2), which form 
hemidesmosomal junctions between luminal epithelial and myoepithelial cells and 
E-cadherin connecting luminal epithelial cells laterally 91. Thus, in the quiescent mammary 
gland, the structure of the ECM is mainly anti-migratory, stabilized by integrin- and 
cadherin-based cell–matrix and cell–cell adhesion.
GUIDANCE OF BREAST CARCINOMA INVASION
The majority of breast carcinomas originate from dedifferentiated luminal epithelial cells, 
histopathologically classified as ductal or lobular lesions depending on their original 
location 92. Thereby, invading breast cancer cells appear to recapitulate the process 
of duct elongation occurring during development, although in a spatially and timely 
deregulated form. During gland formation, the terminal end buds invade the mammary 
stroma collectively as multicellular ducts with cell–cell junctions intact 93. Similarly, ductal 
carcinomas form multicellular invasion strands consisting of cancer cells with cell–cell 
junctions retained, which with decreasing differentiation lose apicobasal polarity 
and the lumen 92. During collective invasion, ductal carcinoma cells remain physically 
and functionally connected, with expressed cadherins (E-cadherin and P-cadherin), 
tight (JAM-A, claudin-3, and -4), and immunoglobulin-based junctions (ALCAM and 
L1-CAM) 2, 94–96. Unlike ductal carcinoma, most of these cell–cell junction proteins are 
down-regulated in invading lobular carcinoma cells, with the loss of E-cadherin as 
a parameter for the diagnostic differentiation between ductal and lobular carcinoma 92. 
Nonetheless, most invasive lobular carcinomas invade collectively as thin multicellular 
sheets and strands (Indian file pattern) parallel to collagen bundles, histologically with 
notable cell–cell contact retained or as detached individual cells with cell–cell junctions 
lost 97. Candidate adhesion mechanisms for multicellular cohesion within Indian files 
that lack E-cadherin include N-cadherin and other cadherins, yet their mechanical and 
signalling contribution remains to be defined. Irrespective of the type of invasion, and 
in contrast to TEB sprouting which occurs with a basement membrane largely intact, 
the transition to invasive carcinoma is initiated by the disappearance of the basement 
membrane which allows for initial tumour cell contact to and migration along 
fibrillar collagen 98.
In response to the direct tumour cell–stroma interaction, both tumour cell- and stromal 
cell-derived changes in intracellular signalling and reactive cytokine and growth factor 
release induce substantial molecular and physical reorganization of the ECM molecular and 
physical reorganization, enhancing pro-migratory cancer cell activation and guidance 99. 
The main structural and molecular guiding principles within the mammary gland are 
the ducts themselves, the surrounding bundled type I collagen fibres, their secondary 
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decoration with pro-migratory ECM molecules, and intercellular spaces between 
the basement membranes of adipocytes. 
INTRADUCTAL GUIDANCE
As a not yet invasive precursor, carcinoma in situ is an intraluminal ductal or lobular 
accumulation of epithelial cells with disordered, multilayered epithelial organization, 
partially or completely obliterated lumen, but intact cell–cell junctions and basement 
membrane (Figures 4A and 4B). As a first in situ invasion route with basement membranes 
and stromal tissues intact, neoplastic epithelial cells proliferate within and likely move 
along the lumen of the duct, which leads to the expansive growth of tumour foci and 
outward pushing of the surrounding ECM but not interstitial invasion or metastatic 
dissemination 100.
Figure 4. Anatomic and molecular guidance of breast cancer invasion. (A) Overview of guidance 
structures in the mammary gland. (B) Intraductal guidance in breast carcinoma in situ. (C) Guidance 
by fibrous tissue. (D) Carcinoma cell invasion in adipose tissue. HA = hyaluronan; Vn = vitronectin; 
Fn = fibronectin; Ln = laminin
HAPTOTATIC GUIDANCE
The ECM surrounding invading breast tumours undergoes substantial changes in density, 
composition, and structural organization, termed a desmoplastic reaction 101,102, including 
the accumulation of fibrillar collagen and other matrix components, which enhance 
neoplastic invasion and disease progression. With increased collagen I deposition, the fibres 
become aligned and bundled, and cross-linking is increased, resulting in elevated stiffness 
of peritumoural ECM 103. As mechanisms, elevated activity of lysyl oxidases and tissue 
transglutaminases in stromal cells mediate covalent collagen cross-linking 104 and thereby 
enhance carcinoma cell invasion 105. Adhesion-promoting additional ECM constituents, 
including laminin-332 106, non-basement membrane collagen IV 107, fibronectin 108, 
and elastin 102, are jointly synthesized by carcinoma cells themselves and stroma cells, 
and reinforce migration-promoting activities, as suggested by their chemotaxis- and 
haptotaxis-enhancing effects in vitro 109. Likewise, the composition of core proteins 
and glycosaminoglycan chains is altered in the ECM surrounding breast carcinoma. 
Versican, the major chondroitin sulphate proteoglycan present in the peritumoural 
stroma 110, forms non-covalent cross-links to different matrix molecules, including HA, 
tenascins, and fibronectin, and is recognized by the cell surface molecules β1 integrin and 
CD44 111. Similarly, the expression of HA is strongly up-regulated in the peritumoural 
stroma and carcinoma cells themselves 112,113, together with its receptor CD44 114, thus 
creating additional options for cell–ECM interactions.
Besides structural ECM components, numerous matricellular proteins are de novo 
deposited nearby the front of invading tumours, including thrombospondin-1 115, 
tenascin C 116, SPARC (osteonectin) 117, osteopontin 118, and periostin 119, all of which 
exert structural, growth factor binding and signalling functions towards tumour and 
stromal cells. Matricellular proteins, including osteopontin and thrombospondin-1, favour 
cell invasion in vitro in haptokinetic and 3D migration assays 120–122, and further support 
the growth and spontaneous metastasis of breast carcinoma cells in mouse models 
in vivo 123.
As mechanisms, matricellular proteins likely support motility and metastasis by 
complexing with and interconnecting between ECM structures, including fibrillar collagen 
type I, fibronectin, and heparin, thus modulating tissue porosity and stiffness, and 
providing additional functional ligands for cell surface receptors. As examples, periostin 
and osteopontin display binding sites towards cell surface αvβ1, αvβ5 and αvβ5 integrins 
and CD44 120, 123, 124. Tenascins C and X bind to collagen type I and fibronectin fibres via 
periostin 125 and/or the leucine-rich proteoglycan decorin 126, which provides bridging and 
possibly bundling of ECM, and additional ligand sites for cell guidance. Thus, interactions 
of various de novo deposited ECM proteins and proteoglycans with the collagen-based 
scaffold lead to its decoration and ‘functionalization’, which adds a migration-promoting 
layer, often together with signals for growth and survival.
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PHYSICAL GUIDANCE BY COLLAGEN SCAFFOLDS
The molecular modifications of the peritumoural ECM microanatomy further lead to 
marked physical alterations, resulting in lateral association and bundling of collagen 
fibrils, and increased overall ECM stiffness. The curly normal structure of collagen fibres 
oriented parallel to ducts becomes straightened and realigned perpendicular to the tumour 
boundary, and fibre bundles are thickened with marked inter-bundle gaps and spaces 127. 
Despite the elevated collagen density, inter-fibre clefts present in desmoplastic regions of 
invading tumours likely represent a network of microchannels suited to provide contact 
guidance to invading cells (O Ilina, unpublished data).
As part of the underlying process of anatomic restructuring, carcinoma-associated 
fibroblasts mechanically remodel the collagen network by adhesion, compaction and 
contraction 128, and/or proteolytic cleavage and re-alignment in parallel order 129. Aligned 
collagen bundles are a strong pro-migratory stimulus for cell invasion and further correlated 
with enhanced metastasis in vivo 128, arguably by providing unhindered tracks of least 
resistance 130 and contact guidance 131. Similar guidance is recapitulated by experimental 
microtracks in 3D collagen lattices enhancing breast cancer cell invasion in vitro 132. As 
a consequence of entering narrow tracks, carcinoma cells adjust their calibre by first 
deforming themselves followed by lateral pushing, thereby accommodating the ECM 
geometry to the space required for invasion by a physical mechanism 132.
GUIDANCE BY ADIPOSE TISSUE
Following penetration of the stromal layer, breast carcinoma cells reach the adipose 
tissue, as an indication of particularly aggressive forms of invasive carcinomas 133. Ductal 
breast cancer cells invade as solid strands between adipocytes, followed by adipocyte 
inclusion and destruction by the tumour mass 133. Lobular carcinoma cells invade adipose 
tissue preferentially along collagen fibres between adipocytes as multicellular Indian files 
or as individual cells 134. These different routes likely depend on adhesion or chemokine 
receptors differentially expressed by breast cancer cells and available counterpart 
ligands in the adipose tissue. Molecular guidance mechanisms of differential adipose 
tissue invasion are unknown, yet candidate pathways include integrins interacting with 
basement membrane components (ie α3β1, α6β4, and αvβ3, fibronectin (α5β1), and 
collagen type I (α2β1) 134,135 (Figure 4D). Carcinoma cells may further utilize barrier-free 
clefts formed by loosely organized ECM between adipocytes for unhindered invasion 
and expansive growth, thus adjusting the space by outward pushing of the fibrillar ECM 
network. Thus, peritumoural ECM provides a complex environment with distinct invasion-
promoting molecular zones together with spaces of least resistance.
ADHESION RECEPTORS IN BREAST CARCINOMA INVASION
Together with migration-promoting ECM modifications, expression modulation of 
the adhesion receptor repertoire in breast carcinoma cells coincides with the acquisition 
of a mobile state. Numerous in vitro models implicate β1, β3, and β4 integrins as 
the major receptors for cell–matrix coupling and mechanotransduction in breast cancer 
cells, the blocking of which attenuates migration and invasion in 2D and 3D models 136, 137 
(O Ilina, unpublished data). Histopathological data from human breast cancer lesions 
show marked down-regulation of most integrin subunits in tumour cells at the invasion 
front (Table 1 and references cited therein). Conversely, αvβ3 integrin, which is not 
expressed by normal breast epithelium, becomes up-regulated, which coincides with 
the increased stromal deposition of ECM ligands for αvβ3 integrin, including periostin, 
osteopontin, and tenascin C 138, 139. Because of their pro-adhesive functions, the down-
regulation of many integrins at the tumour invasive edge might allow cancer cells to turn 
over stable contacts to basement membrane or other ECM components, and transit to 
a mobile state through alternative integrins engaging with neo-ligands of the reactive 
stroma. In vitro, tenascin C, thrombospondin-1, and osteonectin modulate otherwise 
stable integrin-dependent attachment, which favours the turn-over of adhesion sites 
and enhances cell migration 140; thus, lowering strong adhesion to ECM ligands may 
support invasiveness in a context-dependent manner. Consistently, β3 integrin supports 
the haptotactic migration of breast carcinoma cells towards osteopontin in vitro and 
enhances bone-specific spontaneous metastasis in vivo 141. Likewise, integrins α6β4 and 
α3β1 mediate migration along or invasion into model basement membrane in vitro and 
furthermore are associated with enhanced systemic metastasis 135, 142, suggesting a role 
in promoting both cell migration and metastatic dissemination. In summary, the integrin 
profile in invading breast cancer cells likely matches and engages with an altered ligand 
repertoire in the reactive tumour stroma, which results in dynamic interactions with ECM 
and enhanced invasion.
In morphogenesis, the multicellular sprouting of breast epithelium during mammary 
gland development is not affected by the knockout of individual integrin subunits, 
including α2, α3, α4, and β4 143–145, with reduced epithelial branching caused by α2 
integrin deficiency 144 and mild defects of gland polarity and anchoring to the basement 
membrane after the loss of β1 integrin 145. This mild phenotype suggests the function of 
as yet unknown compensatory adhesion systems to mediate normal duct elongation and 
sprouting morphogenesis, with unclear implications for the redundancy of pro-invasive 
adhesion systems in breast cancer.
Besides their contribution to cell migration and metastasis, integrins mediate stroma-
derived growth and survival signals in tumour cells 137. Consequently, the cellular 
mechanisms by which certain integrin subsets control poor outcome in breast carcinoma 
in vivo, ie their role in promoting invasion versus metastasis versus growth and survival, 
remain unclear.
INTRAVASATION AND METASTASIS OF CARCINOMA CELLS
Whereas in other tumour types blood and lymph vessels serve as pro-invasive 
structures 37, 130 perivascular invasion is not a prominent feature of invading breast 
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carcinoma in human lesions (O Ilina, unpublished data). However, similar to most 
metastasizing tumour types, breast cancer cells eventually reach the lumen of blood 
and lymph vessels. Tumour-associated blood vessels are less organized, with incomplete 
basement membrane, only loosely associated pericytes, and leaky cell–cell junctions 146, 
and thereby likely facilitate the vessel wall penetration and intravasation by tumour cells. 
In lymph vessels, carcinoma cells were shown to form tissue-like multicellular cords, 
‘emboli’, and intravascular growing tumour foci, which eventually spread further and 
reach distant organs 147, 148. A range of invasion-promoting factors locally up-regulated 
in the tumour stroma, including periostin 123, osteopontin 149, and tenascin C 116, strongly 
support distant breast cancer metastasis in mouse models in vivo, whereby their local and 
systemic effects 150 likely converge to enhance both local invasion and metastatic seeding 
at a distant site (eg by generating a ‘pre-metastatic niche’).
TUMOUR CELL INVASION IN BRAIN AND MAMMARY  
GLAND – SIMILARITIES AND DIFFERENCES
Despite their distinct invasion routes and molecular mechanisms, the invasion of 
glioma and carcinoma cells into the brain and mammary gland, respectively, shares 
the principle of guidance by the tissue scaffold, likely by a combination of molecular and 
physical mechanisms guiding cells along interfaces through pre-existing trails of least 
resistance. In the brain interstitium, which lacks fibrillar collagen, major invasion routes 
are basement membranes and intercellular tracks provided by myelinated axons and 
astrocyte processes. Basement membranes guide via laminin- and collagen-IV-mediated 
integrin engagement, whereas white matter tracks guide by cell–cell contacts and as yet 
unknown adhesion and force generation mechanisms. In the mammary gland, guided 
invasion follows gaps between bundled collagen fibres and interstitial spaces bordered 
by adipocyte-associated basement membrane, and likely depends on restricted integrin-
mediated mechanocoupling. However, in both cases, it remains unclear how physical and 
molecular guidance principles are coordinated, how both principles synergize, and where 
they negatively impact each other.
Mechanically, migration through a porous interstitial space, along a viscoelastic protein 
polymer such as collagen bundles or basement membranes or along cell surfaces such as 
myelinated axons, represents a near barrier-free migration type with little or no enzymatic 
tissue modification required. Interface-mediated guidance is recapitulated in vitro by 2D 
culture in which cells move along a functionalized surface or by engineered 3D ECM-based 
models guiding cell invasion along tissue gaps and trails 17, 132. In diffuse brain infiltration, 
the inter-scaffold substrate is soft ECM dominated by HA non-covalently linked to scaffold 
proteins; thus, the mechanical resistance is likely low and allows glioma cells to squeeze 
through the gaps and push the gel-like interstitial matrix aside. In the reactive stroma 
of breast tumours, the ECM content between collagen bundles is poorly contrasted by 
immunohistochemistry or non-linear (multi-photon) microscopy; thus, their composition 
and mechanical properties in native state are unknown. Whereas the dimensions and 
function of the inter-fibre gaps in vivo likely provide space for invasion by cell squeezing, 
pulling, and pushing in collagen-based in vitro models 132, their guidance function in 
desmoplastic stroma remains to be shown. Histologically, invading cancer cells seem to 
‘respect’ cell and ECM boundaries, resulting in proteolytic tissue destruction as a late 
consequence rather than as a prerequisite of invasion.
As a further shared event between brain and connective tissue invasion, tumour cells 
themselves, or the reactive tumour stroma, provide pro-migratory tissue conditioning. In 
breast carcinoma, the invasion-promoting properties of fibrillar collagen are increased 
by pro-migratory proteins deposited into the existing scaffold. In glioma, the proteolytic 
removal of otherwise anti-migratory activity is required for white matter infiltration, and 
it is not known whether similar mechanisms are involved in the invasion of peripheral 
connective tissue.
IMPLICATIONS
Despite extensive in vitro and in vivo investigations, for most invasion routes the combined 
molecular and physical mechanisms are not clear, and likely several complementary 
mechanisms converge to influence invasion outcome. Whereas molecular pathways 
have been studied extensively, the physical guidance mechanisms, including mandatory 
surface receptors and proteases required for contact guidance, remain poorly addressed. 
Thus, a mechanistic understanding of guidance, including its central signalling or 
mechanocoupling nodes that could be targeted, is required to design effective inhibition 
approaches, besides the targeting of integrins and other adhesion systems. It is likely 
that, even with integrins inhibited, major invasion pathways are still active in cancer cells, 
similar to leukocytes 151; therefore, models are needed to identify additive effects and 
compensation in order to establish rational targeting of tissue invasion.
Structural and molecular insight into tissue invasion by cancer cells is further 
mandatory for the development of experimental in vitro and in vivo models exploring 
the mechanisms of cancer invasion. Whereas for breast cancer invasion, protein-scaffold-
based collagen, basement membrane, and interconnecting accessory protein-containing 
ECM models appear sufficient as they reflect the natural main routes and ligands, glioma 
invasion is likely more complex and requires the simultaneous presence of cell and ECM 
scaffolds in an interconnected manner. The design of an appropriate cell environment 
comprising the main tissue components critical for each cancer cell invasion route in vivo 
will improve the clinically relevant identification of key molecules that guide cancer cell 
invasion, and dissect the relative contribution of physical versus molecular guidance.
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ABSTRACT
Diffuse invasion of glioma cells into the brain parenchyma leads to nonresectable brain 
tumors and poor prognosis of glioma disease. In vivo, glioma cells can adopt a range of 
invasion strategies and routes, by moving as single cells, collective strands and multicellular 
networks along perivascular, perineuronal and interstitial guidance cues. Current in vitro 
assays to probe glioma cell invasion, however, are limited in recapitulating the modes 
and adaptability of glioma invasion observed in brain parenchyma, including collective 
behaviours. To mimic in vivo-like glioma cell invasion in vitro, we here applied three tissue-
inspired 3D environments combining multicellular glioma spheroids and reconstituted 
microanatomic features of vascular and interstitial brain structures. Radial migration 
from multicellular glioma spheroids of human cell lines and patient-derived xenograft 
cells was monitored using (i) reconstituted basement membrane/hyaluronan interfaces 
representing the space along brain vessels; (ii) 3D scaffolds generated by multi-layered 
mouse astrocytes to reflect brain interstitium; and (iii) freshly isolated mouse brain slice 
culture ex vivo. The invasion patterns in vitro were validated using histological analysis of 
brain sections from glioblastoma patients and glioma xenografts infiltrating the mouse 
brain. Each 3D assay recapitulated distinct aspects of major glioma invasion patterns 
identified in mouse xenograft and patient brain samples, including individually migrating 
cells, collective strands extending along blood vessels, and multicellular networks of 
interconnected glioma cells infiltrating the neuropil. In conjunction, these organotypic 
assays enable a range of invasion modes used by glioma cells and will be applicable for 
mechanistic analysis and targeting of glioma cell dissemination.  
INTRODUCTION
Gliomas represent the most common primary brain tumor type in adults, with glioblastoma 
as one of the most detrimental cancers in humans1. The high lethality of glioma patients 
is mainly caused by diffuse invasion of glioma cells into the brain parenchyma, the extent 
of which typically precludes curative surgical resection and radiotherapy2. This diffuse 
invasive character is a relatively unique characteristic of gliomas and rarely seen in other 
brain cancers3. The structures of the brain tissue along which glioma cells migrate are 
complex and their microanatomic and molecular organization varies. Guiding structures 
include myelinated axons and astrocyte processes (white matter tracks) as well as 
basement membranes of blood vessels and the meninges (perivascular tracks)2,4. Both 
brain regions contain hyaluronan as main component of the brain extracellular matrix 
(ECM)5. Disseminating glioma cells orient preferentially along aligned myelinated fibers 
and astrocyte processes throughout the white matter2,4. In parallel, glioma cell invasion 
occurs along the interface between blood vessels and brain parenchyma2,4,6. Glioma 
cells invade the brain tissue either individually, after detaching from neighboring glioma 
cells, or as cohesive groups preferentially moving along blood vessels6–12. In addition, 
glioma cells may form multicellular networks with long filaments connecting glioma 
cells in vivo, and these networks were recently implicated in glioma cell invasion and 
resistance signaling13. 
In recent years, different assays were developed to model glioma microenvironments 
of the brain tissue and test the extent and mechanisms of glioma cell invasion14,15. Widely 
used 2D assays are based on coating of the culture dish with ECM molecules, including 
laminin, fibronectin or collagen16,17. However, these models lack crucial parameters of 3D 
brain environments which modulate migration mechanisms, including (i) low substrate 
stiffness, (ii) anatomically complex 3D organization, (iii) 3D space confinements which 
enable adhesion-dependent and adhesion-independent migration, and (iv) molecularly 
rich ECM composition maintained by brain cells and containing chemotactic factors14. 
Reconstituted 3D migration assays are based on natural or synthetic hydrogels with 
various molecular components, including fibrillar collagen, reconstituted basement 
membrane (rBM) rich in laminin and type IV collagen, and composite hydrogels containing 
polyacrylamide, fibronectin and/or cross-linked hyaluronan18–21. In unperturbed brain 
fibrillar collagens are expressed mainly along blood vessels but not in the parenchyma4,22, 
and upregulated in a subset of clinical gliomas in the tumor mass and perivascular 
regions23–25. Type I collagen scaffolds are effectively invaded by glioma cells18,26,27, however 
the relevance of collagen as substrate for diffuse glioma cell infiltration beyond the tumor 
core remains unclear14. rBM and cross-linked hyaluronan both represent key components 
of the brain stroma and, like synthetic hydrogels, provide soft environments similar to 
brain tissue; however they lack other adhesion ligands and cell-derived brain structures, 
such as astrocyte networks and myelinated axons4. 
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Migration assays comprising brain-derived cells in monolayer culture, including 
primary astrocytes, provide 2D interaction scaffolds for glioma cells28–30. Astrocyte 
monolayers support glioma cell invasiveness via gap-junction communications and by 
secretion of promigratory molecules28–30. As 3D modification, primary rat astrocytes 
were combined with electrospun nanofiber scaffolds, and this approach revealed 
a contribution of astrocytes to single cell migration of glioma cells by secreting migration-
enhancing factors15. However, both astrocyte monolayers and electrospun  scaffolds lack 
the complexity and, likely, softness of 3D brain stroma14. 
Consequently, live brain slice assays are considered as “gold standard” recapitulating 
the complexity of brain tissue, however they support mainly perivascular but not 
parenchymatous routes of glioma cell invasion31–33. To this end, we hypothesize 
that the complexity of glioma invasion requires the combined application of a set of 
complementary in vitro models to enable an adaptive range of glioma invasion types, 
including collective perivascular invasion and network-like interstitial invasion patterns13,34. 
We here developed a set of 3D assays mimicking brain-like structures to analyse glioma 
cell invasion patterns from 3D multicellular spheroids. When compared to in vivo invasion 
of the same cell types in the mouse brain and to histopathology of human lesions, each 
assay delivers dedicated in vivo-like invasion programs, including single cell migration, 
collective sheets and strands, and/or multicellular glioma networks.
MATERIALS AND METHODS
Antibodies and reagents
The following antibodies were used: anti-mouse β-catenin (mouse clone 14/beta-catenin, 
1:100, BD Biosciences); anti-human β-catenin (rabbit polyclonal, 1:1000, Abcam); anti-
mouse N-cadherin (mouse, clone GC-4, 1:200, Sigma); anti-mouse laminin (rabbit 
polyclonal, 1:100, Sigma); anti-human collagen-IV (mouse, clone Col-94, 1:300, Sigma); 
anti-human vimentin (rabbit, SP20 clone, human specific,1:300, Thermo Scientific), anti-
bovine glial fibrillary acidic protein (GFAP) (chicken polyclonal, 1:1000, Abcam); anti-
human nestin (rabbit polyclonal, human specific,1:100, Millipore). Primary antibodies 
were visualized with secondary AlexaFluor-conjugated goat-anti-mouse, goat-anti-rabbit 
or goat-anti-chicken polyclonal antibodies (Invitrogen; 5 µg/ml). For background controls, 
isotype-matched unspecific mouse IgG (BD Biosciences) was used for monoclonal 
antibody stainings, and for polyclonal antibody stainings samples were incubated 
only with secondary AlexaFluor-conjugated antibodies. Cell nuclei were stained with 
4’,6-diamidino-2-phenylindole (DAPI; 2.5 µg/ml). F-actin was labelled with AlexaFluor-
conjugated phalloidin (Invitrogen). Growth factor-reduced reconstituted basement 
membrane (rBM) (Matrigel, BD Biosciences; 9.8 mg/ml) was used for rBM interface culture. 
Cell lines and culture
Human glioblastoma E-98 and E-468 cells were maintained as patient-derived xenografts 
by serial subcutaneous (E-98) and intracerebral (E-468) inoculation without in vitro 
culture35. E-468 cells were freshly isolated from mouse brain 7-8 days prior to each 
spheroid preparation for migration assays to minimize adaptation to in vitro culture. E-468 
cells were maintained in neurobasal medium (Invitrogen) supplemented with human EGF 
(20 ng/ml), human bFGF (20 ng/ml), B27 Supplement (1:50), L-glutamine (2 mM) (all 
from Invitrogen), heparin (2 mg/ml, Sigma), penicillin (100 U/ml) and streptomycin (100 
μg/ml; both PAA). Cells were maintained for up to 2 passages (E-468) in 2D culture on 
flasks coated with growth factor-reduced reconstituted basement membrane (rBM) (BD 
Biosciences; 30 µg/ml in PBS). Accutase digestion (10 min, 400-600 units/ml; Sigma) 
was used for cell detachment and dissociation of multicellular spheroids. A subline of 
E-98 cells was propagated in vitro in flasks for up to passage 35. Human glioblastoma 
U-251MG cells (kind gift from Dr. J. Schalkwijk, Nijmegen) were maintained permanently 
in in vitro culture. Primary mouse astrocytes immortalized with SV40 large T-antigen and 
additionally transformed with retrovirus pBabe puro H-Ras V12 (kindly provided by Amparo 
Acker-Palmer, Institute of Cell Biology and Neuroscience and BMLS, Goethe University 
Frankfurt, Germany), were maintained as described36,37. H2B/eGFP-expressing U-251 and 
E-98 cells were generated by lentiviral transduction with pLenti6.2/V5-DEST™ Gateway 
(Invitrogen) containing histone2B/eGFP. For in vitro invasion assays murine astrocytes and 
human E-98 and U-251 cells were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Invitrogen) supplemented with 10% fetal bovine serum (Sigma-Aldrich), penicillin 
(100 U/ml) and streptomycin (100 μg/ml; both PAA), L-glutamine (2 mM, Invitrogen) and 
sodium pyruvate (1 mM, Invitrogen). 
Generation of glioma cell spheroids
Glioma cell spheroids were generated using the hanging drop method38. Cells were 
cultured in DMEM until subconfluency, detached with 1 mM EDTA/0.075% trypsin or 
with Accutase (400-600 units/ml; Sigma), washed with PBS, and maintained for 24h in 
complete DMEM/methylcellulose (2.4%; Sigma) as hanging droplets (25 μL) containing 
1000 (U-251, E-468) or 2000 (E-98) cells. 
Reconstituted basement membrane interface migration assays
3D rBM/hyaluronan interface cultures were generated by polymerizing growth factor-
reduced rBM on a culture dish (30 min, 37°C), followed by addition of glioma spheroids 
over polymerized rBM in complete DMEM with further incubation (2h, 37°C, 10% CO2), 
replacement of media by complete DMEM supplemented with sodium hyaluronate (Sigma, 
Cat: 53747, from Streptococcus equi, Mr ~ 1.5 – 1.8 ´106 Da, 10 mg/ml) or methyl-
cellulose (Sigma, Cat: M6385, viscosity 25 cP, 15 mg/ml) and incubation for 24–48 h. For 
rBM-plastic interface cultures, glioma spheroids were placed on 96-well plates (Greiner 
Bio One, PS, F-bottom, mClear, Black, CELLSTAR) coated with growth factor reduced rBM 
(30 µg/ml, diluted in PBS, preadsorbed overnight at 4oC). After spheroid addition, cultures 
were incubated in complete DMEM or neurobasal media (2h, 37°C, 10% CO2), overlaid 
with growth factor reduced rBM (5 mg/ml, diluted in PBS) and incubated to allow rBM 
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polymerization (30 min, 37°C). After 24 or 48h of migration culture in complete DMEM 
or neurobasal media, samples were fixed (4% PFA, 30 min, RT) and analysed by bright-
field or confocal microscopy. 
3D astrocyte scaffold invasion assay
3D astrocyte-derived scaffolds were generated by immortalized murine astrocytes 
maintained at high cell density in 96-well plates (Greiner Bio One, PS, F-bottom, mClear, 
Black, CELLSTAR; 20,000 cells/well, coated with growth factor-reduced rBM) for 2-3 days 
resulting in consolidated 3D scaffolds of up to 3 - 4 cell layers in height. Glioma cell 
spheroids expressing H2B/eGFP were cultured on top of astrocyte scaffolds (4-5 spheroids/
well) for 2 days, fixed (4% PFA, 30 min, RT), and stained to visualize glioma cells (human 
specific anti-vimentin antibody), astrocytes and ECM proteins. 
Organotypic mouse brain slice invasion assay
To probe glioma cell invasion into 3D brain slices, the assay from39 was modified for 
multicellular spheroid culture. Brains from female mice (5-6 weeks old; Charles River 
or Jackson Laboratories) were dissected, using the strain C57BL/6-Tg(TcraTcrb)1100Mjb/
Crl  (OT1) which was crossed with B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J (dsRed) in our 
laboratory. Brains were freshly sectioned as 400 µm-thick tissue slices using a vibratome 
(Leica, VT1000s). Slices were maintained on transwell insert membranes (Costar, 12-well 
plate; 8 µm pore diameter) in complete DMEM (37°C, 5% CO2) for 1h. Glioma cell 
spheroids expressing H2B/eGFP were added on top of brain slices (8-10 spheroids per 
slice), cultured in complete DMEM for 48h, fixed (4% PFA, 1h, 20°C), washed and stained 
with human-specific anti-vimentin antibody to discriminate glioma cells from DsRed-
expressing blood vessels. 
Confocal microscopy and quantification of glioma cell migration
Confocal microscopy (Olympus FV1000) was performed using long working distance 20× 
NA 0.50 and 40× NA 0.80 objectives at a vertical step size of 2-3 µm. 3D reconstruction 
of Z-stacks was performed using Imaris V.6.1.5 (Bitplane).
For quantitative image analysis, operator-assisted image segmentation of bright-field 
or confocal 3D stacks was performed (Fiji software, V.1.49g 40). The average cell migration 
distance representing radial migration of glioma cells from spheroids was calculated 
according to the following formula:
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Glioblastoma xenografts in mouse brain. Female athymic Balb/C nu/nu mice (6–
8 weeks old), were obtained from Charles River Laboratories and maintained under 
specific pathogen-free conditions at the central animal facility of Radboudumc, 
Nijmegen. The animal experiments were approved by the Ethical Committee on 
Animal Experiments of the Radboud University, Nijmegen, The Netherlands (RU-
DEC-2013-251) and performed in accordance with the Dutch Animal 
Experimentation Acts and the European FELASA protocol 
(www.felasa.eu/guidelines.php). U-251-Fluc-mCherry and E-98-Fluc-mCherry 
parental cells41,42 were cultured as spheroids in neurobasal media for 1 month, 
enzymatically dissociated by Accutase digestion, and intracranially implanted (5  
105 cells in 20 µL PBS) by guided injection into the right parieto-occipital 
hemisphere of isofluorane-anesthetized mice 2 mm from the midline.  
 
3D reconstruction of glioma lesions. Paraffinized clinical samples from four 
anonymized glioma patients (primary glioblastoma) were obtained from the 
archives of the Department of Pathology, Radboudumc, Nijmegen. Informed patient 
consent and ethical committee approval for the use of (archival) brain tissue was 
obtained and the material was used in a manner compliant with the Declaration of 
Helsinki. Slices of 100 µm thickness were obtained by microtome slicing (HM 340E, 
Thermo Scientific Microm), deparaffinized (100% xylene), gradually rehydratated 
(sequential 100, 96, 70, 50% v/v ethanol/water), heated for antigen retrieval (98oC, 
15 min in Tris-EDTA, pH 9.0), incubated with blocking solution (0.1% Tween-20 
and 1% bovine serum albumin in PBS) and stained with antibodies. To reach 
Glioblastoma xenografts in mouse brain
Female athymic Balb/C nu/nu mice (6–8 weeks old), were obtained from Charles River 
Laboratories and maintained under specific pathogen-free conditions at the central 
animal facility of Radboudumc, Nijmegen. The animal experiments were approved by 
the Ethical Committee on Animal Experiments of the Radboud University, Nijmegen, 
The Netherlands (RU-DEC-2013-251) and performed in accordance with the Dutch Animal 
Experimentation Acts and the European FELASA protocol (www.felasa.eu/guidelines.php). 
U-251-Fluc-mCherry and E-98-Fluc-mCherry parental cells41,42 were cultured as spheroids 
in neurobasal media for 1 month, enzymatically dissociated by Accutase digestion, and 
intracranially implanted (5 ´ 105 cells in 20 µL PBS) by guided injection into the right 
parieto-occipital hemisphere of isofluorane-anesthetized mice 2 mm from the midline. 
3D reconstruction of glioma lesions
Paraffinized clinical samples from four anonymized glioma patients (primary glioblastoma) 
were obtained from the archives of the Department of Pathology, Radboudumc, Nijmegen. 
Informed patient consent and ethical committee approval for the use of (archival) brain 
tissue was obtained and the material was used in a manner compliant with the Declaration 
of Helsinki. Slices of 100 µm thickness were obtained by microtome slicing (HM 340E, 
Thermo Scientific Microm), deparaffinized (100% xylene), gradually rehydratated 
(sequential 100, 96, 70, 50% v/v ethanol/water), heated for antigen retrieval (98oC, 15 
min in Tris-EDTA, pH 9.0), incubated with blocking solution (0.1% Tween-20 and 1% 
bovine serum albumin in PBS) and stained with antibodies. To reach saturated antibody 
conditions and efficient washing in the 3D sample, prolonged incubation periods with 
primary and secondary antibodies and each washing step (0.1% tween-20/PBS; 0.05% 
NaN3) were 8-24h at room temperature to ascertain antigen saturation and complete 
removal of unbound antibody. The presence of nestin in the absence of astrocytic and 
neuronal markers GFAP and myelin basic protein (MBP), respectively, was used to identify 
glioma cells43. 200 µm thick sections from glioblastoma xenografts (U-251, E-98 and 
E-468 cells) in mouse brains were obtained after fixation (4% PFA, 20h) by vibratome 
slicing (Leica, VT1000s) followed by counterstaining to detect murine astrocytes by 
anti-GFAP pAbs, basement membranes by anti-laminin pAb and glioma cells by human-
specific anti-vimentin or anti-nestin pAbs.
RESULTS AND DISCUSSION
Glioma cell migration along reconstituted basement membrane 
interfaces 
To recapitulate perivascular glioma cell invasion along interfaces formed by brain 
parenchyma and basement membranes, we used polymerized rBM, which comprises 
structural glycoproteins constituting basement membrane44,45, overlaid with hyaluronan, 
the most abundant component of interstitial brain ECM5 (Fig. 1a). When overlaid on 3D 
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rBM without hyaluronan in the supernatant, U-251 glioma cells invaded into, but not 
along the rBM, and E-98 cells failed to establish radial migration but grew as compact 
spheroids (Fig. 1b). When hyaluronan was overlaid, both U-251 and E-98 cells developed 
sheet-like migration (Fig. 1b) with the speed increasing in dependence of the hyaluronan 
concentration reaching up to 10 mg/ml, a supra-physiological concentration at which 
hyaluronan formed a viscous, semi-solid solution (Fig. 1c, d). In gliomas, extracellular 
hyaluronan concentrations may range from 0.2 up to 5 mg/ml46,47. In control experiments 
using methylcellulose as non-physiological, inert polysaccharide in combination with 
rBM, migration of U-251 and E-98 cells was equally well supported (Fig. 1b, c). This 
indicates a generic pro-migratory function of a protein interface adjacent to viscous 
polysaccharide. In previous work, glioma cell migration was primarily assessed in single-
cell migration assays, using cell suspensions after enzymatic dispersion16,17. However, 
when tested as tumor-like multicellular spheroids, which allow cells to establish cell-cell 
junctions, both U-251 and E-98 cells migrated collectively, as a cohesive sheet of 
cells, along the rBM-hyaluronan interface (Fig. 1d, e). Similarly, when spheroids were 
positioned at the interface between rBM overlaying the plastic substrate of the culture 
plate (Fig. 2a), U-251 glioma cells migrated as epithelial-like sheets and collective strands, 
whereas E-98 cells formed thinner strands and complex-shaped multicellular networks 
with cells retaining both linear junctions and connecting filaments between cell bodies 
(Fig. 2b, c). Glioma invasion modes observed in hyaluronan-rBM vs rBM-plastic interfaces 
may result from the different molecular and mechanical characteristics of the interface 
along which they migrated, including coverage of rBM proteins by hyaluronan which 
may provide confinement and further modulate ligand availability for cell adhesion 
systems and the stiffness of migration substrate. These parameters may cooperatively 
influence the retention of cell-cell junctions, migration mode and speed48–51. Accordingly, 
both glioma cell lines moving collectively under rBM established linear or focal adherens 
junctions at cell-cell contacts which were positive for N-cadherin and β-catenin, whereas 
glioma cells migrating on a 2D surface lacked junctional β-catenin and showed its 
redistribution to the cytoplasm (Fig. 2d, e). The average distance of glioma cell migration 
under rBM was decreased by 60-80%, compared to migration along rBM-hyaluronan 
interfaces (compare Fig. 2c with Fig. 1c), indicating speed regulation in dependence of 
variations of confinement and/or substrate stiffness. 
Invasion into 3D astrocyte scaffolds
To reproduce diffuse glioma cell invasion in astrocyte-rich brain stroma we generated 3D 
scaffolds formed by immortalized murine astrocytes in hyperconfluent culture (Fig. 3a). 
Astrocytes proliferated and formed dense multicellular networks with up to 3 cell layers 
in thickness (~35 µm) during 3 days of culture (Fig. 3b). Astrocytes of the bottom layer 
typically aligned in parallel, whereas the top layer developed more varied and randomly 
orientated network-like organization (Fig. 3b). Hyperconfluent astrocyte cultures produced 
Figure 1. Reconstituted basement membrane/hyaluronan interface migration assay. a Assay design. 
b Radial migration of U-251 and E-98 cells from spheroids along the rBM - hyaluronan (HA) or 
methylcellulose (MC) interface after 1 day of culture, detected by bright-field microscopy. c Average 
distance migrated by U-251 and E-98 cells along the rBM/HA or rBM/MC interface at different 
concentration of HA or MC; values display medians (black line), 25/75 percentiles (boxes) and 
maximum/minimum (whiskers) from 3 independent experiments. P values, Mann Whitney test. d 
3D projection from confocal z-stack of U-251 and E-98 cell migration from multicellular spheroids 
(S) along rBM/HA interface (10 mg/ml HA concentration). Arrowheads indicate the invasion front. 
e Scanning electron microscopy of U-251 cells after 1 day of radial migration from spheroids (S) on 
rBM in media without or with HA (10 mg/ml). Arrowheads, invasion front with signs of degradation 
of rBM (HA, 0 mg/ml) or without rBM degradation (HA, 10 mg/ml). Scale bars, 200 μm (b), 50 μm 
(d, e).
R
EC
A
PITU
LA
TIN
G
 IN
 V
IV
O
-LIK
E PLA
STIC
ITY
 O
F G
LIO
M
A
 C
ELL IN
V
A
SIO
N
R
EC
A
PITU
LA
TIN
G
 IN
 V
IV
O
-LIK
E PLA
STIC
ITY
 O
F G
LIO
M
A
 C
ELL IN
V
A
SIO
N
56 57
33
A
A
B
B
C
C
D
D
E
extracellular matrix molecules along their cell boundaries, including laminin and collagen 
IV (Fig. 3b), resulting in a dense cell- and ECM-rich 3D scaffold. 
Glioma cells readily invaded astrocyte scaffolds, by aligning along and intercalating 
between astrocytes and penetrating all scaffold layers (Fig. 3c). The speed of glioma cell 
invasion correlated inversely with the duration of astrocyte scaffold conditioning, with 
average distances covered decreasing from ~100 µm/d in 2-day old scaffolds to less than 
10 µm/day in 10-day old scaffolds (Fig. 3d). Notably, and in contrast to rBM based culture, 
U-251 and E-98 cells invaded astrocyte scaffolds as both, single cells (Fig. 3c, asterisk) and 
Figure 2. rBM-plastic interface migration assay. a Assay design. b Overviews of U-251 and E-98 
cells after 2 days of radial migration from spheroids under rBM in neurobasal media. Arrowheads, 
focal cell-cell interactions. c Average migration distance of U-251 and E-98 cells under rBM. Values 
display median (black line), 25/75 percentiles (boxes) and maximum/minimum (whiskers) from 3 
independent experiments. d Molecular topology of adherens junction proteins in U-251 and E-98 
cells migrating under rBM. Images were obtained by epifluorescence (b) and confocal microscopy 
(d). e Maximum z-projection of U-251 and E-98 cells after 2 days of emigration from multicellular 
spheroids maintained on polystyrene surface coated with rBM. Scale bars, 100 μm (b), 20 μm 
(zoomed insert b), 50 μm (d,e).
Figure 3. 3D astrocyte scaffold invasion assay. a Assay design. b Confocal xy-sections of astrocyte 
culture (3 days) stained for F-actin, laminin and collagen type IV (Col IV). c  3D reconstruction 
(confocal z-stack, 90 μm, horizontal and orthogonal projections) of E-98 and U-251 cell invasion 
from spheroids (S) into 3-day old mouse astrocyte scaffolds. Glioma cells were identified by vimentin 
staining with human-specific antibody and constitutive expression of H2BeGFP in the nucleus, and 
murine astrocytes using phalloidin (F-actin). Arrowheads point to contacts between glioma cells 
via dendrite-like filaments. Asterisk, detached single cell. d Average migration distance of U-251 
and E-98 cells invading astrocyte scaffolds matured for 2, 3 or 10 days before addition of glioma 
spheroids. Values display median (black line), 25/75 percentiles (boxes) and maximum/minimum 
(whiskers) from 3 independent experiments. Scale bars, 50 μm.
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multicellular networks of individual cells connecting with neighbor cells via long dendrite-
like filaments (Fig. 3c, arrowheads). 
Invasion into mouse brain slices
The brain blood vessels have a complex anatomical and molecular organization52,53, 
and in vitro assays fail to reconstitute these microanatomic features. To recapitulate 
the perivascular niche for U-251 and E-98 cell invasion and validate the results obtained 
in rBM culture, we used organotypic brain slice culture (Fig. 4a). U-251 and E-98 cells 
both invaded the brain slice tissue effectively and preferentially associated with blood 
vessels (Fig. 4b, c). Using end-point analysis of the position of individual cells relative 
to the spheroid boundary, the invasion speed was ~10 to 50 µm/day (median ~25 µm/
day) for both cell lines (Fig. 4d), similar to the invasion speed in 3-day matured astrocyte 
scaffolds (Fig. 3d). The invasion pattern of U-251 and E-98 glioma cells in brain slice 
culture was adaptive and was dominated by collective cell strands while extending 
along blood vessels (Fig. 4b, arrowheads) and occasional detached single cells (Fig. 4b, 
asterisks). Thus, glioma cell invasion from spheroid culture on brain slices displays plastic 
adaptation in dependence of the tissue subregion.
Validation of in vitro assays by glioma invasion in vivo  
To benchmark each in vitro invasion model, we compared the respective invasion patterns 
obtained in rBM, 3D astrocyte scaffolds and brain slice cultures with brain invasion in vivo, 
using 3D reconstructions of patient-derived xenografts in mouse brain and glioblastoma 
patient samples (Fig. 5a, b). Orthotopically injected in mouse brain, perivascular invasion 
of U-251 and E-98 glioma cells progressed as collective, finger-like strands along capillaries 
and larger blood vessels (Fig. 5a), and this pattern was reminiscent to their cohesive 
strand migration along rBM interfaces (Fig. 5a). Among other invasion patterns, similar 
cohesive, strand-like glioma cell invasion along blood vessels were previously observed 
by intravital two-photon microscopy in the mouse brain11,12. The number of connections 
per cell in perivascular invasion strands was similar for in vitro rBM and in vivo mouse 
models, with 70% of the cells in direct contact with 3 to 7 neighbor cells (Fig. 5c). rBM 
is often used for coating transwell filters to model cell invasion through, rather than 
along, basement membrane54. However, the data from the perivascular invasion in vivo 
confirm that glioma cells preferentially migrate along basement membranes and follow 
the perivascular space, but typically do not intravasate6,12. 
Likewise, the in vitro/in vivo correlation was high for multicellular glioma network 
organization. Glioma cells connected with long filaments were found both in peritumoral 
regions of E-468 patient derived xenografts (PDX) in the mouse brain and glioblastoma 
lesions from patient samples (Fig. 5b, arrowheads), which was consistent with the filament-
based network-like pattern of E-468 cells (Fig. 5b) during infiltration of 3D astrocyte 
scaffolds. The number of filament-based connections between E-468 cells in 3D astrocyte 
Figure 4. Organotypic mouse brain slice invasion assay. a Assay design. b 3D reconstruction 
(confocal z-stack, 90 μm, horizontal and orthogonal projections) of U-251 and E-98 cell migration 
from spheroids in mouse brain slices after 2 days of culture. Arrowheads indicate multicellular 
strands. Asterisks, detached single cells. Red signal originates from the DsRed mouse background, 
as contrast of vessels (bright signals) and stromal cells (dim signal). c Fractions of glioma cells 
associated with blood vessels, identified by vimentin staining with human-specific antibody. d 
Average distance of U-251 and E-98 cell migration in mouse brain slices. Values display median 
(black line), 25/75 percentiles (boxes) and maximum/minimum (whiskers) from 3 independent 
experiments. Scale bars, 100 μm.
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Figure 5. Validation of in vitro assays by glioma invasion in murine and human brain in vivo. a 3D 
reconstruction of U-251 cell invasion along rBM-plastic interface in vitro compared to invasion 
pattern in the mouse brain 1 month after orthotopic implantation of U-251 cells. Glioma cells 
were identified using human-specific anti-vimentin, basement membranes with anti-laminin, and 
astrocytes and glia limitans perivascularis with anti-GFAP antibody. Arrowhead indicates glioma cells 
invading along basement membrane of a linear brain vessel under glia limitans. V - vessel lumen. 
In vivo images are projections from 100 μm-thick z-stacks. b E-468 patient-derived glioblastoma 
cells invading (2 days) 3D astrocyte scaffolds in vitro, or mouse brain 2 months after orthotopic 
implantation, compared with the peritumoral region of a primary glioblastoma (PGB) patient 
sample. Images represent 100 μm-thick z-stacks. Arrowheads denote contacts between glioma 
cells via dendrite-like filaments. Glioma cells were positive for vimentin (E-468) or nestin (E-468 and 
human sample), detected with human specific antibodies. Astrocytes were detected by anti-GFAP 
antibody. c Number of cell-cell junctions between U-251 and E-98 glioma cells in different assays, 
including collective strands under rBM compared to perivascular invasion in mouse brain. Values 
represent the number of cell contact per glioma cell (colour code of stacked boxes) and their relative 
frequency in the population. The number of connected neighbour cells is indicated as median (red 
square), 25/75 percentiles (whiskers), representing 3 independent in vitro experiments and 2 mice 
per cell line in mouse brain. d Number of filaments connecting glioblastoma cells during astrocyte 
scaffold invasion compared with mouse brain tissue and primary glioblastoma lesion. Values display 
median (black line), 25/75 percentiles (boxes) and maximum/minimum (whiskers). Data represent 3 
independent in vitro experiments; 2 E-468 xenografts in mouse brain, and 4 glioblastoma patients. 
Scale bars, 50 μm.
scaffolds (median 4 connections/cell) matched the number of filamentous connections 
between E-468 cells in the mouse brain (median 4 connections/cell) as well as in human 
glioblastoma samples (median 5 connections/cell) (Fig. 5d). The plasticity of glioma cell 
invasion modes, including cohesive strand- and sheet-like structures along rBM interfaces 
and in perivascular space, and diffuse multicellular networks in astrocyte scaffolds likely 
reflect the geometry of the environment, including microtracks of least resistance and 
confinement effects55. 
Thus, the rBM interface and 3D astrocyte scaffold assays reliably represent two major 
routes of glioma dissemination in brain tissue in vivo: strand-like collective perivascular 
invasion along basement membranes and multicellular networks in astrocyte-rich stroma. 
Because rBM interface and astrocyte scaffold invasion assays are performed in 96-well 
plate format, both assays may be amenable for pharmacological compound screens and 
other experimental treatments.
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ABSTRACT
Diffuse brain infiltration represents a detrimental progression step of glioma disease, 
the cellular and mechanochemical basis of which is poorly understood. Using quantitative 
3D tissue segmentation of human lesions and patient-derived xenografts in mouse brain, 
we here identify moving multicellular glioma cell networks as a collective organization 
principle for diffuse brain infiltration. Contacts between moving glioma cells were adaptive 
epithelial-like or filamentous junctions stabilized by N-cadherin, b-catenin and p120-
catenin, which underwent kinetic turn-over to secure intercellular synchronization and 
directional persistence. Downregulation of p120-catenin destabilized collective networks 
and severely compromised diffuse brain infiltration with marginalized microlesions as 
outcome. Differential transcriptomics by next-generation sequencing identified p120-
cateninas upstream regulator of axonal guidance and neurogenesis pathways and 
as strong predictor of poor clinical outcome in human glioma. The data suggest that 
neoplastic brain infiltration recapitulates mechanisms of brain morphogenesis with 
kinetically adaptive adherens junctions and intercellular communication driving glioma 
cell migration as multicellular network. Targeting adherens junctions thus may offer an 
unanticipated strategy to halt glioma progression.
INTRODUCTION
Malignant gliomas represent a molecularly defined group of consistently invasive and 
fatal primary brain tumors with astrocytic and oligodendroglial subtypes and glioblastoma 
(GBM) as the most malignant astrocytic variant. Gliomas are maintained by a limited set 
of driver mutations affecting isocitrate dehydrogenase (IDH), RTK/RAS/PI3K, p53 and RB 
pathways as well as δ2-catenin, all implicated in reprogramming cell differentiation and 
stemness by deranging cell cycle, metabolic programs, cell-cell interaction and migration1–4. 
Irrespective of their divergent cell origin and level of dedifferentiation, all diffuse glioma 
types share the dual capability of devastating brain infiltration and therapy resistance, 
with progressing disease even during high-dose chemo- and radiation therapy5,6. Through 
signaling cross-talk, glioma invasion, growth and resistance signaling cooperate7, and 
additional protection arises from the intact blood-brain barrier which shields diffusely 
infiltrated brain stroma from systemic therapy. Thus, understanding the organization of 
glioma invasion and identifying glioma cell-intrinsic or microenvironmental regulators 
of invasion and survival programs are critical for developing effective targeted 
intervention strategies7.
Glioma cells infiltrate brain tissue by at least two topographic and likely interconvertible 
programs, including perivascular and diffuse perineural invasion. Perivascular invasion, by 
chemotactic and/or tissue-guided motion, occurs along vascular basement membranes 
bordering perivascular spaces and eventually disrupts the neurovascular niche8–10. 
Diffuse infiltration of the neuropil depends upon glioma cell guidance along extracellular 
matrix, nerve and astrocytic tracts which consumes and ultimately destroys brain tissue9. 
Progressing gliomas retain an epithelial-to-mesenchymal transition (EMT)-like state of 
single cell growth, migration and survival programs, as suggested by molecular profiling 
and in vitro functional analyses10,11. Therefore, glioma invasion and survival programs 
are typically understood as cell-autonomous processes, with unclear cross-talk between 
glioma cells themselves and with non-neoplastic glial or neuronal cells8,12,13.
In potential conflict with single-cell dissemination concepts, three-dimensional (3D) 
reconstruction of glioma lesions recently identified multicellular networks with dendrite-
like microtubules connecting glioma cells in developing and established glioma lesions in 
human brain and mouse models14. By ensuring multicellular communication the glioma 
cell network depends upon connexin 43 for gap junctional intercellular communication 
and survival during experimental radiation therapy, indicating multicellular connectivity as 
important contributor to glioma progression and therapy resistance14.
To reconcile the organization principle of glioma networks with mechanisms of 
glioma cell migration and brain infiltration, we here address whether cell-cell junctions 
are a property moving glioma cells and required for tissue infiltration. We identify a novel 
type of collective invasion deployed by cells with particular plasticity and interconversion 
between epithelial-like and filamentous intercellular junctions and further reveal p120-
catenin dependent adherens junctions (AJs) as central hub stabilizing cell-cell interactions 
and network infiltration into brain parenchyma.
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RESULTS
Network organization of glioma lesions in vivo
To revisit the cellular and molecular basis of brain infiltration by glioma cells, we first 
mapped the three-dimensional (3D) microanatomy of clinical glioma samples of different 
histological subtypes. In conventional single-slice pathology staining, infiltrating gliomas 
consist of spatially dispersed cell bodies with small filamentous protrusions and little 
sign of intercellular connectivity. However, when assessed by 3D image reconstruction 
using immunohistochemical staining for IDH1R132H and nestin to discriminate glioma from 
non-neoplastic glial and other brain cells15 both tumor center and diffusely infiltrating 
margins revealed extensive multicellular glioma cell networks (Supplementary Fig. 1a-f 
and Supplementary Video 1). 
These data confirm network-like organization of glioma lesions14. The network pattern 
was present in different glioma subtypes, including low-grade astrocytomas, secondary 
Figure 1. Perivascular invasion and multicellular glioma cell networks in vivo. Morphological pattern 
and quantitative cell-cell junction analysis of perivascular invasion (a-d) and interstitial networks 
(e-h) in human glioblastoma xenografts. E-98 and E-468 cell lines were implanted into mouse brain 
and after 28d peritumor regions were assessed by confocal microscopy (in 200 mm-thick brain 
slices). Identification of glioma cells by human nestin staining, brain stroma was detected by GFAP 
(astrocytes) and MBP staining (myelinated axons). Values display the median (black line), 25/75 
percentiles (boxes) and maximum/minimum values (whiskers) or relative fractions of connected 
glioma cells interacting with 0 up to 10 connected cells (boxes), median (red square), 25/75 
percentiles (whiskers). Data were obtained from two random mice (from 19 independent tumors) 
with 42 to 84 cells analyzed per mouse. Bars, 50 µm. 
glioblastoma (originating from low-grade astrocytoma) and primary GBM, indicating 
general relevance. Two morphological types of cell-cell junctions were identified, (i) 
filamentous networks between glioma cells reaching deeply into the brain parenchyma 
(Supplementary Fig. 1a,f) and (ii) compact linear junctions present in cell-dense regions 
of the tumor core and collective invasion strands extending along the perivascular niche 
(Supplementary Fig. 1g, h). 
Both, compact perivascular and network-like diffuse invasion types were present in 
two different human glioma models diffusely infiltrating both grey and white matter 
of the mouse brain, including patient-derived pro-neuronal E-98 and mesenchymal/
classical patient-derived xenograft (PDX) E-468 cells16,17 (Fig. 1a and Supplementary 
Fig. 2a). Consistent with the topology of clinical lesions, the organization of networks 
consisted of dispersed cell bodies connected by branched filaments to an average number 
of 4 to 8 (Fig. 1b-d, Supplementary Fig. 1b-d; Supplementary Videos 2, 3). Through 
filaments, glioma cell bodies separated by distances between 10 and up to 200 mm (Fig. 
1b, Supplementary Fig. 1b) retained anatomical contacts to an average of 4 to 6 (total 
range 1 to >10) neighboring glioma cells in 3D space, with a trend for higher connectivity 
to neighbors in low-grade astrocytoma compared with GBM (Fig. 1c, d, Supplementary 
Fig. 1c, d and Supplementary Table 1). Filamentous, dendrite-like branched protrusions 
between glioma cells contained microtubules and the intermediate filament proteins 
vimentin and nestin (Supplementary Fig. 1i; Supplementary Video 4), in morphological 
reminiscence of filamentous junctions between astrocytes or neuronal networks during 
morphogenesis18,19. Alternatively, perivascular invasion zones comprised either directly 
adjacent cells bordered by epithelial-like AJs with linear junctional b-catenin or, when 
aligned along glia limitans, sparsely distributed cells connected with filamentous junctions 
(Fig. 1e-h, Supplementary Fig.1 g, h)20,21. Thus, during both diffuse and vessel-associated 
invasion, glioma cells retain cell-cell junctions.
Collective invasion of glioma cell networks
This abundance of either filamentous or epithelial-like junctions between glioma cells 
during brain infiltration is a morphological indication of collective invasion22. Collective 
invasion is defined as the movement of cells retaining adhesive cell-cell junctions and 
mechanochemical cooperativity while moving across surfaces or through 3D tissue22,23,24. 
Using complementary 3D in vitro models mimicking brain invasion, we next addressed 
whether cell-cell junctions hinder or support tissue infiltration by glioma cells. Glioma 
cells invaded as compact capillary-like strands at the interphase between two layers of 
reconstituted basement membrane (rBM) (Fig. 2a), similar to collective patterns formed 
by glioma cells in rBM culture25. Moving glioma cells retained connections with 3 to 5 
neighboring cells (Supplementary Fig. 3c) while generating speeds of 300-350 mm/day, 
consistent with sheet-like collective invasion in monolayer culture23,26.
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To model diffuse infiltration into brain parenchyma in an organotypic model which 
provides structural complexity but retains high transparency for 3D microscopy, we 
monitored glioma cell invasion along 40-50 mm-thick 3D scaffolds consisting of 
transformed mouse astrocytes and astrocyte-derived interstitial matrix (Supplementary 
Fig. 3a). Similar to neuropil infiltration, glioma cells formed invading networks by aligning 
along astrocyte processes with tip-like cell junctions to an average of 3 to 4 adjacent 
glioma cells, while complete detachment of individual cells occurred rarely (Fig. 2b, e; 
Supplementary Fig. 3b, c). 
Thus, E-98 and E-468 cells developed very similar cell-to-cell distance, number of 
connecting filaments and the number of connected glioma cells across interstitial in vitro 
and in vivo models (Fig. 1f-h; Fig. 2c-e), indicating multicellular connectivity between 
moving cells as default strategy across tissue subtype and experimental model.
The filamentous interactions between glioma cells are reminiscent of dendritic 
protrusions and interactions between neuronal cells and astrocytes27,28. The connectivity 
between neuronal cells is compromised by high actomyosin contractility under the control 
of RhoA/ROCK signaling29,30; we therefore tested whether limiting Rho/ROCK further 
supports glioma cell interactions and network dynamics. ROCK inhibition significantly 
enhanced filamentous intercellular connectivity and invasion efficiency of E-468 cells 
into astrocyte scaffolds (Fig. 2g, h). This indicates that the invasion activity of glioma 
cell networks is enhanced when actomyosin contractility is limited, similar to developing 
neuronal networks27, but unlike epithelial tumors where limiting  RhoA/ROCK signaling 
reduces invasive and metastatic competence31,32.
Epithelial collective invasion results from relatively long-lived AJs between cells22, 
however the organization and stability of AJs in moving glioma networks is unclear. 
Collectively moving glioma cells comprised high junction plasticity with interconversion 
between epithelial-like and filamentous junctions, dependent on cell density. Linear 
junctions were a continuous feature of cohesive emigration from the spheroid where 
cell density was high (Fig. 2a), while filamentous junctions formed and resolved over 
distance between moving cells towards the invasion front where cell density was low, 
revealed by 3D time-lapse microscopy (Fig. 3a,b; Supplementary Video 5). We therefore 
analyzed how cell movement and junction stability are balanced. Anterior, lateral and rear 
filaments formed, persisted for several (up to 10) hours and resolved while interacting 
cells translocated (Fig. 3c). Because multiple junctions were engaged in parallel at any 
time point, with a steady-state number of 2 to 6 connections/cell (Fig. 3d), cell movement 
allowed the network to expand (Supplementary Video 5). While maintaining junctional 
plasticity, cells leading the network maintained an oscillatory stop-go pattern with an 
average speed of 10 to 12 μm/h (Fig. 3c), similar to the speed of moving glioma cells in 
the mouse brain (5-15 μm/h)33.
This variability of junction organization was consistent between in vitro models, glioma 
cells in the mouse brain and in patient glioblastoma samples (Fig. 3e, f), with epithelial-like 
linear or filament-based focal AJs between neighbor cells containing F-actin, b-catenin 
Figure 2. Collective glioma cell invasion in 3D assays representing different anatomical structures of 
brain tissue. Glioma cell invasion from 3D spheroids in mechanically distinct environments in vitro 
including (a) the interface between two layers of reconstituted basement membranes (rBM) and (b) 
3D astrocyte scaffolds. Arrowheads, cell-cell junctions. Quantification of next-neighbor proximity (c), 
cell-cell connecting filaments (d), number of connected cells (e), and invasion speed (f) in astrocyte 
scaffolds. Quantitative analysis of glioma cell invasion in rBM assays is shown in Supplementary Fig. 
3c. g, h. Enhanced glioma cell network formation and invasion in response to ROCK inhibition. 
Overviews and quantification of E-468 glioma cell invasion in 3D astrocyte scaffolds with or without 
ROCK inhibitor Y-27632 (10 µM). Values display the median (black line), 25/75 percentiles (boxes) 
and maximum/minimum values (whiskers) or relative fractions of connected glioma cells interacting 
with 0 up to 10 connected cells (boxes), median (red square), 25/75 percentiles (whiskers). Data 
represent 12 to 15 spheroids per condition from three independent experiments.  P values, Mann 
Whitney test (h). Bars, 50 µm (a-c) and 200 µm (g).
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and p120 catenin (Fig. 3e, f; Supplementary Fig. 4c). Thus, dependent on cell density and 
environmental context, glioma cells maintain cohesive or network-based junctions and 
anatomically adaptive collective invasion, not unlike astrocyte precursors that migrate 
collectively during retina development34 and reactive astrocytes after wounding18,19.
Cell-cell signaling between invading glioma cells
In morphogenesis and mature brain parenchyma, astrocyte networks share coordinated 
multicellular calcium oscillations, which are implicated in glial cell growth and neuronal 
signaling35. Moving individual glioma cells exhibit non-coordinated calcium transients10 
but depend upon calcium channel activity for invasion36, whereas stable glioma networks 
constitutively and during radiation therapy exhibit calcium transients across multiple cells14. 
To test whether collectively moving glioma cells retain intercellular signaling, intracellular 
calcium ([Ca2++]i) levels were recorded by the calcium indicator Fura-2AM in the spheroid 
migration assay. Connected E-98 and E-468 cells produced [Ca2++]i oscillations originating 
in individual or multiple cells that have emigrated from the spheroid (Fig. 4a,b) followed 
by signal spreading across fields of up to 20 cells (Fig. 4c; Supplementary Videos 6, 7). As 
in neuronal or astrocyte networks37, calcium transients and field size were compromised 
by the connexin channel inhibitor carbenoxolone (CBX) (Supplementary Fig. 3d,e; 
Supplementary Video 8), confirming that invading glioma cells maintain gap junctional 
cell-cell signaling, similar to stable glioma cells networks14. Thus, collectively migrating 
glioma cells retain adhesive cell-cell junctions and intercellular signaling.
Mechanical glioma-cell coupling by AJs
To test whether glioma-cell connections are critical for tissue invasion and disease outcome, 
or rather represent functionally irrelevant morphological variants, we mapped and 
disrupted mechanisms of cell-cell cooperation. In epithelial, mesenchymal and neuronal 
cells during morphogenesis and homeostasis, AJs depend upon partially overlapping E- 
and N-cadherin-mediated mechanical and functional coupling20,21. E-98 and E-468 cells 
expressed multiple classical cadherins (Supplementary Fig. 2c) and additional adhesion 
molecules implicated in homophilic cell-cell adhesion, including ALCAM and NCAM 
(Supplementary Fig. 4a). Deregulation of N-cadherin, b-catenin and p120-catenin by 
transient RNA interference (RNAi) consistently disrupted cell-cell junctions and facilitated 
cell individualization, with negligible impact by additional downregulation of ALCAM 
and NCAM (Supplementary Fig. 5a). This identifies classical cadherins in maintaining AJ 
between glioma cells.
p120-catenin as gatekeeper of glioma cell cooperation
As non-redundant intracellular regulator of AJs formed by a range of classical 
cadherins, p120-catenin (p120) is essential in enabling mechanical and signaling cell-cell 
interaction38,39. In neuronal cells p120 stabilizes dendritic intercellular junctions40 and 
Figure 3. Topology, kinetics and molecular organization of cell-cell junctions during glioma network 
invasion. a, Actin dynamics. Sequence analysis of E-468 cell network migration from spheroid culture 
on 3D astrocyte scaffolds. Formation (arrowheads) and resolution of cell-cell junctions (asterisk) 
was monitored in LifeAct/GFP expressing E-468 cells. b, LifeAct/GFP intensity at filamentous 
cell-cell junctions over time (3 different junctions; Roi defined by filamentous cell-cell-junctions). 
c, Steady-state speed (blue line) and accompanying formation and turn-over of cell-cell junctions 
in representative single cell. d, Steady-state number of intercellular connections in three moving 
cells (depicted by paths in Video 6), represented as time-dependent heat-map. Sph, spheroid. e, 
Heterogeneity of junction organization, including linear, focal and filamentous cell-cell interactions 
between glioma cells. Subcellular distribution of β-catenin and p120 catenin in E-98 cells (rBM 
assay), E-468 cells (xenograft in mouse brain) and glioblastoma cells in patient sample (GBM) (top 
panels). Arrowheads, β- and p120 catenin accumulation along the cell-cell interface. β-catenin 
and p120 catenin accumulation quantified as relative fluorescence intensity (rFI) along (linear) or 
perpendicular (focal, filamentous) to the cell-cell junction (bottom panels). Bars, 50 μm.
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(E-468 PDX cells) (Supplementary Fig. 5b-e). Downregulation of p120 further caused 
a severe junction defect with loss of cell-cell interactions followed by cell individualization 
(Fig. 5a) and the inability to participate in multicellular calcium wave propagation 
(Fig. 5b,c; Supplementary Video 9). 
To address how perturbed cell-cell junctions affect the coordination of moving glioma 
networks, we recorded their migration on 3D astrocyte scaffolds. After downregulation 
of p120 catenin, the loss of filament-like cell-cell junctions resulted in poorly polarized 
and uncoordinated migration with compromised ability to migrate outward (Fig. 5d-g 
and Supplementary Video 10). Importantly, whereas migration speed was moderately 
decreased after p120 silencing (Supplementary Fig. 5f), migration persistence and outward 
propagation away from the spheroid were impaired (Fig. 5e; “running on the spot”). This 
reveals a critical role of p120 in securing collective polarity and migration persistence in 
glioma cells, similar to normal astrocytes23.
We next tested whether the promotion of de novo formation of filamentous junctions 
or rather mechanical junction stabilization by p120 was critical for maintaining glioma 
cell coordination. P120 catenin limits the RhoA/ROCK pathway and down-stream 
actomyosin contractility including the light chain of myosin II (MLC)41,42. Downregulation 
of p120 caused an elevation of pMLC, and ROCK inhibitor Y27632 reverted pMLC levels 
in p120 knock-down cells to near-control level (Supplementary Fig. 5g,h) and further 
increased the number of filamentous connections (Fig. 5h,i); however ROCK inhibition 
failed to restore network propagation and invasion into astrocyte scaffolds (Fig. 5i). Thus, 
filamentous junctions require stabilization by AJs to support cell-cell coupling, cell polarity 
and network migration. Taken together, moving networks reflect a novel, neuronal type 
of collective migration in complex environments which depends upon morphologically 
plastic intercellular connections via AJs of variable duration. These particular cell and 
junction topologies and kinetics between glioma cells are distinct from stable junctions 
connecting moving epithelia or co-attraction engaged in collectively moving mesenchymal 
cells43,44.
P120-catenin dependent networks mediate diffuse brain infiltration 
We next aimed to delineate whether glioma cell networks maintained by AJs are indeed 
required for diffuse brain infiltration. Luciferase-expressing E-98 cells as well as non-
luminescent E-468 cells were implanted into the mouse brain and the effect of p120 
downregulation on tumor growth and brain infiltration was monitored by bioluminescence 
in live mice after up to 4 weeks (Fig. 6a) and/or whole-brain reconstruction and volumetric 
analysis post mortem after 4 weeks (Fig. 6b and Supplementary Video 11). Whereas 
multifocal control tumors developed reliably over weeks, all p120-deficient models lacked 
large or multifocal lesions and further failed to diffusely infiltrate the brain parenchyma 
(Fig. 6c; Supplementary Fig. 6a1). Overall, the reduction of diseased brain parenchyma 
after p120 targeting was profound, amounting to minus 90-98% (Fig. 6c). To detect 
Figure 4. Functional coupling of glioma cellsin networks. a, Functional cell-cell coupling in E-98 and 
E-468 cells measured as intracellular calcium transients. Cell identification for ratiometric time-series 
(left panels) and derived calcium transients in neighboring cells (right panel). b, Near-instantaneous 
and sequential calcium transients in E-98 and E-468 cell clusters and networks. Example micrograph 
highlighting neighboring cells participating in calcium wave (left panel) and fields of connected cells 
recorded over 2 min (right image). c, Calcium waves and propagation speed (left panels, speed in 
brackets) and number of connected cells (right panel) in E-98 and E-468 cells. The propagation speed 
in E-98 is consistent with the velocity of calcium waves between astrocytes (approx. 6 mm/s)35. Sph, 
spheroid. Values display the median (black line) and individual values from individual cells (dots). 
Data represent 22 (E-98) and 17 (E-468) cell clusters from three independent experiments. P value, 
Mann Whitney test. Bars, 50 μm.
network stability39. In astrocytes p120 supports collective migration in vitro23. P120 is 
upregulated in glioma lesions1 (Supplementary Fig. 4b) and detectable in both bulky 
and diffusely infiltrating regions of clinical glioma samples (Supplementary Fig. 4b,c). 
In addition, cadherin-associated protein/δ2-catenin, an endogenous p120 antagonist 
primarily expressed in cells with neuronal differentiation, is target of inactivating driver 
mutations in glioblastomas2. These correlative data point towards a role for AJs and 
particularly p120 in glioma progression, yet with unclear mechanism. We thus stably 
downregulated p120 by shRNA to test its role in glioma network organization and function. 
In both cell lines, p120 downregulation using 4 independent RNA sequences (70-80% 
efficacy verified by qPCR and Western blot analysis) impaired cell-cell interactions followed 
by cell individualization, compromised cell cycle progression with diminished mitosis rate 
and geminin expression, and either de-novo (E-98) or persisting severe growth deficit 
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whether networks were disrupted by p120 downregulation in vivo, we performed 3D 
high-resolution morphometry of large-field sections capturing both tumor center and 
invasion front of E-468 PDX tumors (Fig. 6d). In control lesions, both tumor center and 
invasion front were composed of glioma cell networks with filamentous cell-cell junctions 
and an average of 3 cell-cell contacts (Fig. 6e) with gradual decrease of connection 
density towards the outward edge (Fig. 6f). Likewise, the network organization was lost 
and replaced by individualized less polarized or rounded cells in E-98 lesions after p120 
downregulation with abolished interstitial invasion (Supplementary Fig. 6a). Residual 
microlesions contained few clustered cells lacking p120-positive intercellular junctions 
(Supplementary Fig. 6c) or individualized cells with shortened filaments positioned along 
interstitial tracks (Fig. 6d, Supplementary Fig. 6a2; Video 12), together with compromised 
cell cycle progression detected by diminished geminin-positive cell subsets (Supplementary 
Fig. 6b). In line with defective brain infiltration, colonization of the spinal cord was 
lacking in E-98 cells upon follow-up for up to 4 weeks (Fig. 6a). Thus, diffuse glioma cell 
invasion in brain tissue depend on cell-cell junctions and p120 availability, resulting in 
poorly invasive, marginalized microlesions.
Glioma cell networks recapitulate a neuronal morphogenesis program
To map the putative signaling mechanisms by which AJs may support glioma progression, 
we performed next-generation RNA sequencing and gene ontology (GO) analysis. 
Differential response patterns in glioma cells expressing non-targeting or p120 shRNA 
were largely cell-type specific with unique sets of down- or up-regulated genes, however 
with a significant cluster common to both E-98 and E-468 cells (Supplementary Fig. 2b 
and Supplementary Fig. 7a). GO-term analysis of downregulated gene sets identified 
perturbation of neuron development, differentiation and axonogenesis in both cell lines 
(Fig. 7a, Supplementary Fig. 7b). Deregulated ephrins, netrins, neurofascin and contactin-
2, among other targets (Fig. 7a) are critically involved in cell-cell interactions, neuronal 
development and synaptic transmission45 as well as GAP43 which was identified in 
the radiation resistance response of glioma networks14 (Fig. 7a, Supplementary Table 3). 
Thus, p120 is a critical upstream regulator of protein networks required for neuronal-like 
features in glioma cells.
High p120-catenin expression correlates with poor clinical outcome
To validate the role of p120 in glioma progression for human disease, we generated 
a p120 downstream gene signature using two independent datasets from human 
gliomas17,46. Genes that were up- and down-regulated after knock-down of p120 in 
E-98 cells were directionally weighed-matched with gene expression data of the clinical 
samples. The p120 signature significantly matched with signatures of genes involved in 
cell migration and extracellular matrix remodeling (Supplementary Fig. 7c; Supplementary 
Table 4), using the list of scanned 3875 Broad curated gene signatures. When stratified 
Figure 5. p120-dependent cell-cell cooperation and persistence of collective invasion of glioma 
cells. a, Morphology (1), number of cell-contacts between neighboring cells (2) and cell growth 
(3) in response to stable expression of non-targeting (NT) and p120 shRNA in E-98 and E-468 
cells. Data represent 196 to 208 cells from duplicate wells from three independent shRNA lentiviral 
transductions. Efficiency, stability of downregulation and validation using independent shRNA probes 
are shown in Supplementary Fig. 5c. b-f, Impact of p120 downregulation on glioma cell network 
functions. b,c, Morphology and quantitative impact of p120 downregulation on calcium wave 
propagation between neighbor cells in E-98 and E-468 cells. Data represent 10 - 19 spheroids per 
condition from two independent shRNA lentiviral transductions. d, Time-lapse sequence of E-468 
cells from spheroid on 3D astrocyte scaffold expressing NT or p120 shRNA. Arrowheads, non-polar 
cells deficient of protrusions and intercellular connections. e, Decreased migration persistence, 
measured as confinement ratio (distance start-end point / total length of path) over a period of 
10-13 h. f,g, Image-sequence based quantification of the median number (f) and time-dependent 
cell-cell interactions (g) in moving cells during 13h of migration. Data represent 6 to 8 representative 
movies with each 3 spheroids from 3 independent experiments. h,i, Marginal rescue of filamentous 
connectivity and invasion efficiency of E-468 cells after p120 catenin downregulation by ROCK 
inhibitor Y-27632 (10 µM) in 3D astrocyte scaffolds. Overview images (h) and quantitative analysis 
(i). Data represent 25 to 30 spheroids from three independent shRNA lentiviral transductions. Values 
display the median (black line), 25/75 percentiles (boxes) and maximum/minimum values (whiskers). 
P values, Mann Whitney test. Bars, 100 μm (a), 50 μm (b, d), 200 μm (h).
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for p120 expression, overall survival of glioma patients was significantly prolonged in 
the subgroup with low p120 level (Fig.7b). Thus, in PDX models and clinical glioma 
samples, p120 regulated genes are associated with neuronal network and migration 
functions and strongly associated with glioma progression.
DISCUSSION
These findings implicate multicellular networks as a novel pathomechanistic principle 
of glioma disease and identify p120-catenin as integrator of neuronal-like functions 
in glioma cells required for diffuse brain infiltration. As a consequence, multicellular 
networks rather than individualized cells secure mechanocoupling, signaling and large-
scale brain infiltration, similar to astrocytic or neuronal networks27,47,48. Although glioma 
networks may contain functional subunits and intratumoral heterogeneity3 and occasional 
cell individualization, the extensive intercellular connections imply that diffuse gliomas 
should be considered as a single functional operon, rather than a collection of individual 
cells, which as a whole sustain particularly aggressive growth, invasion and survival ability, 
as proposed14. 
As basis for network function, AJs provide cell-cell adhesion and signaling for both 
neuronal-like network function in collective migration programs and growth, in potential 
reminiscence of certain epithelial tumors which rely upon p120 signaling for anchorage-
independent growth, anoikis resistance and metastasis49–52. Our data establish p120 as 
a central gatekeeper of AJs38,39 in glioma tumors and suggest oncogene-like functions of 
p120 in glioma and disrupting p120-dependent signaling disables glioma aggressiveness. 
The emerging roles for cell-cell cooperation in tumor progression, including in glioma, 
indicate that targeting of AJs may suffice to revert detrimental neoplastic growth and 
tissue infiltration programs congruently. 
Plasticity of collective invasion programs
In glioma, collective migration strategies are remarkably adaptive, in a tissue-context 
dependent manner. Perivascular cohesive strands move through aligned confined space 
form epithelial-like AJs whereas multicellular networks with dynamic and relatively short-
lived neuronal-like filaments support intercellular connections during interstitial invasion 
of brain stroma (Fig. 7c). While cohesive cell migration with linear cell-cell junctions is 
a well-established collective invasion mode utilized by epithelial embryonic and cancer 
cells22,53, glioma multicellular network migration combines neuronal network plasticity 
present with transient cell-cell interactions in dynamic crest cell and neuronal networks in 
Figure 6. p120 is indispensable for glioma growth, network formation and diffuse brain infiltration. 
a, Bioluminescence distribution and intensity after implantation into the mouse brain. Data represent 
the means and SEM from 5 mice/group. b, Ex vivo technique to quantify the mouse brain volume 
infiltrated with glioma cells. c1, Impaired tumor growth and diffuse brain infiltration of E-468 cells 
after p120 downregulation. Overviews and detail (insets) from 200 μm thick brain slices. Bar, 2 mm. 
c2, Extent of brain volume consumption by three glioma lines, expressed as cumulative percent 
of brain section area containing vimentin-positive cells 4 weeks post-implantation. Data represent 
the mean values ± SEM 19 mice (E-98) and 16 mice (E-468) from two independent implantation series. 
P values, Mann Whitney test. d, Diffuse brain infiltration of E-468 cells as multicellular networks 
and perturbation after p120 downregulation 30d post-implantation (3D confocal microscopy from 
200 mm thick brain slices). Arrowheads, filaments in multicellular networks of vimentin-positive 
E-468 cells. Bars, 100 μm (overview) and 25 μm (detail). e, Perturbation of cell-cell interactions in 
two glioma models in 4 weeks post-implantation. Data represent 49 to 108 cells from two mice per 
condition. Relative fractions of connected glioma cells interacting with 0 up to 10 connected cells 
(boxes), median (red square), 25/75 percentiles (whiskers). f, Frequency of cell-cell junctions from 
the region of maximum cell density (“0”) to the front of the diffuse infiltration zone covering >1200 
mm in cells expressing NT or p120 shRNA. Bar, 25 μm.
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embryogenesis54–56, and with ongoing mechanical and chemical coupling between cells, 
thus fulfilling key criteria of collective invasion22. 
Molecular profiling after p120 downregulation indicates defects in the expression of 
neurofascin, contactin 2, ankyrin G, MAP1B, doublecortin, GAP43 and other molecules 
(Fig. 7a and Supplementary Table 3), which regulate neuronal polarization and cytoskeleton 
dynamic in neuronal network formation27,57,58. Beyond intercellular signaling, relevance 
for AJs was shown for collective durotaxis of epithelial monolayers, when compared to 
individually-moving cells, as they provide mechanical coupling across multiple cell bodies 
required for collective persistence towards stiffer substrate24. Likely, AJs thus deliver 
combined mechanical and molecular signals to sustain front-rear polarity and create 
a morphogenesis-like program in glioma cell networks. P120 catenin is an established 
modulator of Rho GTPases which control the polarity of collective invasion and axonal 
growth29,30,41,59,60. Accordingly, by diminishing RhoA and engaging Rac1 activities p120 
catenin promotes extension of processes in neuronal cells40,61. However, the marginal 
effects of ROCK inhibition in reverting the loss of network function and invasion after 
p120 downregulation indicates that increasing filament formation is insufficient to 
secure collective behaviors when AJs are dysfunctional. Besides mechanical cell-cell 
cohesion and  junctional signaling, additional functions of p120 reside in translocation to 
the nucleus and transcription regulation of genes implicated in neuronal differentiation 
via the transcriptional repressors REST and GLIS262 as well as Kaiso; these effectors, 
which antagonize β-catenin/TCF/LEF transcriptional activity and modulate Wnt signaling 
pathways in axonal guidance and cell proliferation41,62–64, may be engaged and support 
glioma networks.
In conclusion, mechanical and signaling functions of p120 catenin are indispensable 
for structural and signaling integrity of axonal guidance and neurogenesis programs in 
glioma cell networks, implicating classical AJs as central hub maintaining collective brain 
infiltration and ultimately brain consumption. Future targeting of AJs or their downstream 
effectors will offer yet unappreciated strategies to overcome diffuse brain infiltration and 
fatal outcome.
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Materials and Methods
Antibodies and reagents
The following antibodies were used for immunolabeling: anti-human IDH1 R132H 
(mouse, clone H09, 1:20, Dianova);  anti-bovine GFAP (chicken polyclonal, 1:1000, 
Abcam); anti-human myelin basic protein (rabbit polyclonal, 1:200, Sigma); anti-human 
nestin (mouse, clone 10C2, human specific, 1:200, Millipore); anti-human nestin (rabbit 
polyclonal, human specific,1:100, Millipore); anti-human vimentin (chicken polyclonal, 
1:400, Abcam); anti-human vimentin (rabbit, SP20 clone, human specific,1:300, Thermo 
Scientific); anti-human tubulin (rabbit polyclonal, 1:200, Abcam); anti-mouse laminin 
β1 (rat, clone LT3, 1:100, Thermo Scientific); anti-mouse laminin (rabbit polyclonal, 1: 
100, Sigma); anti-mouse p120 catenin (mouse, clone 98/pp120, 1:200, BD Biosciences); 
anti-human p120 catenin (rabbit, clone YE372, human specific, 1:200, Millipore);  anti 
mouse β-catenin (mouse clone 14/beta-catenin, 1:100, BD Biosciences); anti-human 
β-catenin (rabbit polyclonal, 1:1000, Abcam); anti-mouse N-cadherin (mouse, clone 
GC-4, 1:200, Sigma); anti-human β1 integrin (mouse, clone 4B4, human specific, 1:100, 
BD Biosciences); anti-human ALCAM (mouse, clone 3A6, 1:50, BD Biosciences); anti-
human NCAM (mouse, clone NCAM16.2, 1:100, BD Biosciences); anti-human collagen-IV 
(mouse, clone Col-94, 1:300, Sigma); anti-human collagen-I (rabbit polyclonal, 1:100, 
Rockland); anti-human geminin (rabbit polyclonal, 1 : 500, Thermo Scientific).
3D reconstruction of glioma lesions
Paraffinized clinical samples from glioma patients were obtained from the archives of 
the Department of Pathology, Radboudumc, Nijmegen. Samples included lower grade 
astrocytomas, anaplastic oligodendroglioma (with the characteristic complete deletion 
of chromosome arms 1p and 19q), secondary GBM (originating from low-grade 
astrocytoma) and primary GBM (Supplementary Table 1). Informed patient consent 
and ethical committee approval for the use of (archival) brain tissue was obtained and 
the material was used in a manner compliant with the Declaration of Helsinki. Slices 
of 100 µm thickness were obtained by microtome slicing (HM 340E, Thermo Scientific 
Microm), deparaffinized (100% xylene), gradually rehydratated (sequential 100, 96, 
70, 50% v/v ethanol/water), heated for antigen retrieval (98oC, 15 min in Tris-EDTA, 
pH 9.0 ), incubated with blocking solution (0.05% Tween-20 and 1% bovine serum 
albumin in PBS) and stained with antibodies. Likewise, 200 µm thick sections from 
glioblastoma xenografts in mouse brain were obtained after fixation (4 % PFA, 20h) using 
vibratome slicing (Leica, VT100s). To reach saturated antibody conditions and efficient 
washing in the 3D sample, incubation periods with primary and secondary antibodies and 
each washing step (0.05% tween-20/PBS; 0.05% NaN3) were 8-24h at room temperature. 
Glioma cell populations in LGA and in secondary glioblastoma were identified by positivity 
for the IDH1 R132H mutation colocalized with nestin in the majority of cells. In primary 
glioblastoma, due to the absence of IDH1 R132H, the presence of nestin in the absence 
of astrocytic and neuronal markers GFAP and MBP, respectively, was used to identify 
glioma cells65.
Cell lines and culture
Human glioblastoma E-98 and E-468 cells were maintained as patient-derived xenografts 
by serial intradermal (E-98) and intracerebral (E-468) inoculation without in vitro culture16. 
E-468 cells were freshly isolated from mouse brain 8-10 days prior each transduction to 
minimize adaptation to in vitro culture, underwent showed very low baseline proliferation. 
A subline of E-98 cells was propagated in vitro in flasks for up to passage 35. For in 
vivo monitoring, E-98-Fluc-mCherry was generated by lentiviral transduction using firefly 
luciferase (Fluc) and mCherry construct (CSCW-Fluc-mCherry), as described66,67. 
Glioma cells were maintained in neurobasal medium (Invitrogen) supplemented with 
human EGF (20 ng/ml), human bFGF (20 ng/ml), B27 Supplement (1:50), L-glutamine (2 
mM) (all from Invitrogen), heparin (2 mg/ml, Sigma), penicillin (100 U/ml) and streptomycin 
(100 μg/ml; both PAA). Cells were cultured either as 2D culture on flasks coated with 
growth factor-reduced reconstituted basement membrane (rBM) (BD Biosciences; 30 µg/
ml in PBS, overnight at 4oC) or as neurobasal spheroids. Accutase digestion (10 min, 
400-600 units/ml; Sigma) was used for cell detachment and dissociation of the spheroids. 
Cells were cultured at a minimum for 1 month with regular change of media before their 
use for migration assays, lentiviral transduction or brain implantation. Murine astrocytes 
and, for selected experiments, glioma cells were maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (Sigma-
Aldrich), penicillin (100 U/ml) and streptomycin (100 μg/ml; both PAA), L-glutamine (2 
mM, Invitrogen) and sodium pyruvate (1mM, Invitrogen).
Generation of glioma cell spheroids
Spheroids from E-98 and E-468 cells used in short-term migration assays were 
generated using the hanging drop method68. Cells were cultured in neurobasal media 
to subconfluency, detached with accutase (400-600 units/ml; Sigma) washed with PBS, 
suspended in medium/methylcellulose (2.4 - 4.8 %; Sigma) and maintained as hanging 
droplets (25 μL) containing 2000 (E-98) or 1000 (E-468) cells for 24 or 48 h. 
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Reconstituted basement membrane interface invasion assay
Glioma cell spheroids were placed on 96-well-plates coated with growth factor-reduced 
rBM and, after initial attachment (2h), overlaid with 3D rBM (5 mg/ml). After matrix 
polymerization, cultures were overlaid with neural basal media, incubated for radial 
emigration (1d), fixed and stained for 3D confocal reconstruction and quantitative 
image analysis.
Murine astrocyte invasion assay
Primary mouse astrocytes were immortalized with SV40 large T-antigen and additionally 
transformed with retrovirus pBabe puro H-Ras V12, as described69. To generate 3D 
scaffolds, immortalized astrocytes were detached from subconfluent culture (1 mM 
EDTA /0.075% trypsin), transferred to 96-well plates (20,000 cells/well) coated with 
growth factor-reduced rBM). For invasion culture, 3-4 glioma cell spheroids/well were 
placed on top of consolidated astrocyte scaffolds (2d), incubated for 1-2 additional 
days, fixed (4%PFA), stained and quantified for invasion efficacy and pattern by 3D 
confocal microscopy. 3D organotypic tissue organization and matrix proteins deposited 
in glioma-cell free 3D astrocyte-derived scaffolds after 4d of culture were analyzed by 3D 
confocal microscopy. 
Confocal microscopy and quantitative image analysis
Confocal imaging was performed on an Olympus FV1000 microscope, using long 
working distance 20× NA 0.50 and 40× NA 0.80 objectives at step size of 2-3 µm. 
Large-field microscopy of tissue sections from murine glioma lesions as well as multi-
well in vitro culture of E-98 cells on rBM was performed by automated high-content 
microscopy and image stitching (Leica DMI6000B). Imaris V.6.1.5 software (Bitplane) 
was used for 3D reconstruction of Z-stacks. For quantitative image analysis, operator-
assisted image segmentation of 3D stacks and analysis were performed using Fiji analysis 
software (V.1.49g) for the following parameters: number of nestin-, vimentin- or IDH1 
R132H-positive filaments extending per cell with connections to neighboring glioma cells; 
number of connected cells, as the number of neighboring glioma cells engaged with each 
glioma cell by nestin- or vimentin-positive connecting filaments; number of neighbors by 
epithelial-like junctions; distance between connecting glioma cell bodies as the direct line 
between 4’,6-diamidino-2-phenylindole-(DAPI) or H2B/eGFP-positive nuclei; organization 
of cell-cell junctions as the fluorescence intensity of cell-cell junction and filament markers 
along the intercellular junction line; migration speed, as the distance of either leading 
invasion edge or all cells from the spheroid margin.
Time-lapse confocal microscopy of LifeAct/GFP expressing E-98 and E-468 cells was 
performed on a Leica-SP8 SMD confocal scanner equipped with high-sensitivity HyD 
detectors using 0.05 mW for excitation (488nm). Multicellular glioma cell spheroids 
were overlaid on non-fluorescent astrocyte scaffolds (day 2) and 3D stacks comprising 
the entire volume of the invasion zone were recorded every 20 - 25 min. The position 
of the cell body (centroid) for each cell was recorded manually for every frame using 
the maximum intensity projection to calculate speed for each step and confinement ratio 
(distance from start to end-point divided by total length of the path for an observation 
period of 10 to 13 hours). The number of cell-cell connections/cell during migration was 
obtained from individual slices to exclude false-positive projections. 
Live-cell calcium imaging
Glioma cell spheroids after growth in neurobasal media for 1 month were placed on high-
grade 96-well imaging plates (BD Biosciences) coated with growth factor- reduced rBM. 
After 3 -5 days of emigration from spheroids, cells were loaded with Fura-2AM (2.5 μM, 
40 min; Invitrogen), washed once with neurobasal medium (20 min) followed by washing 
twice with Krebs solution (5.5 mM KCl, 147 mM NaCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 
10 mM glucose, and 10 mM HEPES/NaOH, pH 7.4) prior to imaging. Gap junctional 
communication was inhibited by carbenoxolone (CBX) (50 µM; Sigma) in Krebs solution 
at least 30 min before imaging. Imaging was performed by automated epifluorescence 
microscopy (BD Pathway 855, BD Biosciences; 37°C, 5% CO2) using excitation at 340/26 
nm and 387/11 nm and emission detection at 435LP nm with a 1.75s sampling interval. 
Ratiometric 340/380 analysis was performed using Attovision software 1.6/855 (BD 
Bioscience) and post-processed for spatiotemporal mapping using Fiji. For visualization 
of calcium waves, the cell fraction was masked in the 380 nm channel (thresholding 
followed by median filtering, radius 2.0 pixels) to define the cell regions for 340/380 
ratiometric analysis. Cell boundaries were manually defined. 
Transient and stable downregulation of protein expression
Transient downregulation of adherens junction proteins and adhesion receptors was 
obtained for monolayer cultures on growth factor-reduced rBMusing specific or matched 
non-targeting smart-pool RNAi (Dharmacon) or 4 individual RNA probes (Sigma). For 
stable downregulation of p120 with lentiviral particles pLKO.1 (MISSION shRNA, Sigma), 
the following sequences were used:
Specificity / product code Sequence
Non-target shRNA 
Non human or mouse shRNA
CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTC 
ATCTTGTTGTTTTTG
CTNND1 shRNA
TRCN0000122988
CCGGCTCCCAATGTTGCCAACAATACTCGAGTATTGTTGGCAAC 
ATTGGGAGTTTTTG
CTNND1 shRNA
TRCN0000344830
CCGGACTACCCTCCTGATGGTTATACTCGAGTATAACCATCAGG 
AGGGTAGTTTTTTG
CTNND1 shRNA
TRCN0000344770
CCGGGCTTCGAAAGGCTCGTGATATCTCGAGATATCACGAGCC 
TTTCGAAGCTTTTTG
CTNND1 shRNA
TRCN0000333514
CCGGCGCCACTATGAAGATGGTTATCTCGAGATAACCATCTTCAT 
AGTGGCGTTTTTG
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After lentiviral transduction E-98 cells were propagated in neurobasal media using 
flasks coated with growth factor reduced rBM. Stability of p120 downregulation was 
verified monthly by Western blot analysis. For transduction of patient-derived E-468 
xenograft cells, intracranial  tumors from 6 mice were isolated, suspended, cultured (10 
days) in neurobasal media on growth factor reduced rBM-coated flasks and transfected 
with lentiviruses. For in vitro and in vivo assays, cells were used after 8 day-culture after 
transduction in neurobasal media without subculturing. Efficiency of downregulation 
was verified by quantitative PCR, Western blot for total and/or flow cytometry for cell 
surface proteins.
Reverse transcription and real-time quantitative PCR (RT-qPCR)
p120 mRNA levels after shRNA knock-down were analyzed by RT-qPCR. cDNA was 
prepared from 500 ng RNA with the SuperScript Reverse Transcriptase II kit (Invitrogen) 
using random hexamer primers. RNases were inhibited using RNaseOUT (Invitrogen). Pre-
designed KiCqStart primers that were pre-validated according to the Minimal Information 
for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (Sigma) and 
the following three p120 primer pairs were used:
days (E-468) after lentiviral transduction. Total RNA was extracted using the column based 
RNeasy micro kit (Qiagen) and the integrity and quality of obtained RNA was evaluated 
using the Experion RNA HighSens Analysis Kit (Biorad; #7007105) on a 2100 Bioanalyzer 
platform (Agilent). For cDNA synthesis starting from 1-10 ng total RNA, SMARTer Ultra low 
Input RNA kit (Clontech) was used and processed according to the manufacture protocol. 
The transcribed cDNA was sheared into fragments of 200-600 bp using Diagenode Pico 
sonicater. Subsequently the library preparation for Next Generation Sequencing has been 
carried out according to the Illumina standard protocol using the KAPA Hyper prep kit 
(KAPA Biosystems). 
Raw data was aligned to the human genome using GSNAP aligner70 and aligned reads 
annotation and counting was performed using HTSeq-count71. Differential expression 
analysis was performed using the DESeq package in R72. The log2 of fold changes +-1.5,  
p value < 0.05 and FDR < 0.05 are used as criteria to determine the significant deregulated 
genes in p120-knock down samples compared to their matched NT-shRNA samples. Gene 
ontology analysis was performed using DAVID (https://david.ncifcrf.gov) and the KEGG 
database (http://www.genome.jp/kegg/) was used for pathway analysis. Clustering 
analysis of datasets was performed using GENE-E (http://www.broadinstitute.org/cancer/
software/GENE-E/). Gene set enrichment analysis was performed using GSEA73,74. Non-
supervised clustering was performed using normalized read counts table as input and 
the one minus pearson correlation was used as metrics distance. 
Bio-informatic analysis of human samples
Human samples were analyzed using the online platform R2 (r2.amc.nl). For gene ontology 
(GO) analysis, shp120 knockdown experiments in E98 GBM cells resulted in a list of up 
and downregulated genes from which a directional gene signature was generated, taking 
the amount of genes into account (i.e. a directional and weighed signature). Using this 
signature, samples present in the GBM (Verhaak, TCGA 540 tumors, ID2000-01-01)17 
and low- to high-grade glioma (French dataset, 284 samples including normal controls, 
GEO ID: gse16011)46 datasets were scanned for their match to the signature as based 
on the expression values of these genes and displayed as z-value with positive match 
displayed in red and inverse match in blue color. Kaplan-Meier analysis was done using 
p120 expression levels as a determinant of disease outcome, using the significance 
scanner option to identify the most optimal expression cut-off level to provide the highest, 
Bonferroni corrected statistical significance. Reactive and dynamic GO term analysis was 
performed by correlating the E-98 derived p120 signature with 3875 curated gene sets as 
provided by the Broad Institute (www.broadinstitute.org/gsea), using the TCGA 540 GBM 
dataset. Results were top-ranked according to the correlation coefficient.
Glioma growth and invasion in mouse brain
Female athymic Balb/C nu/nu mice (6–8 weeks old), were obtained from Charles River 
Laboratories, maintained under specific pathogen-free conditionsat the central animal 
Primer pair Sequence
P120-1 Forward AGCAATATGGGATCAAACAC
Reverse TAAATCTTCTGCATCAAGGG
P120-2 Forward GGAGCTATGAAGACATGATTG
Reverse CAAGCTTGCTAAACTTCCTC
P120-3 Forward TGTGGAGCTCTCAAGAATATC
Reverse CCGGTAATAACTTCAGTAAGG
RT-qPCR was performed using CFX96 Real-Time PCR Detection System on a C1000 
Thermocycler (Bio-Rad) and analyzed using the Bio-Rad CFX Manager software (version 
2.0). For RT-qPCR, forward and reverse primers were used at a final concentration of 400 
nM in 1x iQ SYBR Green Supermix (BioRad). The thermocycling program was: 10 min 
at 95˚C to denature the cDNA, followed by 40 cycles of 15 s at 95˚C and 50 s at 60˚C, 
and another 95˚C denaturing step for 15 s prior to a melting curve sequence from 65˚C 
to 95˚C at 0.5˚C increments. The threshold cycles (Ct) were normalized on a pool of 5 
reference genes (GAPDH, β-actin, PSMB3, CANX, HMBS). The identity of the amplicon was 
confirmed by melting curve data. Appropriate no-template and no-reverse transcriptase 
negative controls included in each RT-qPCR run confirmed negativity in all cases.
Next-generation RNA sequencing. The RNA expression profile of wild-type and cells 
after stable transfection with p120 or NT shRNA were analyzed by RNA sequencing. Cells 
were maintained in culture with neural basal medium for at least 4 weeks (E-98) or for 8 
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facility, Radboudumc, Nijmegen. E-98-Fluc-mCherry parental cells were cultured as 
spheroids in neurobasal media for 1 month, enzymatically dissociated by accutase 
digestion, and intracranially implanted (5 ´ 105 cells in 20 µL PBS) by guided injection 
into the right parieto-occipital hemisphere of isofluorane-anesthetized mice 2 mm from 
the midline (animal ethics approval number RU-DEC-2013-251).
E-98-Fluc-mCherry and unlabeled E-468 cells with control and p120 shRNA (sequence 
TRCN0000122988) were cultured for more than 4 weeks (E-98) or 8 days (E-468) in 
neurobasal media on growth factor reduced rBM-coated flasks and intracranially 
implanted in 20 µL PBS per mouse - 0.4 or 0.8 ´ 105 of E-98 and 0.4 or 1.0 ´ 105   of 
E-468 cells. The extent to tumor growth and diffuse brain infiltration was quantified 
by whole-brain vibratome sectioning (200 µm thickness) followed by counterstaining 
to detect murine astrocytes by anti-GFAP pAb and glioma cells by human-specific anti-
vimentin pAb. The extent of glioma infiltration was obtained by automated high-content 
microscopy (Leica DMI6000B) from whole-brain vibratome slices (200 µm thickness) 
followed by manual segmentation using the vimentin channel (Fiji). Quantitative image 
analysis from 3D confocal stacks (40x, NA 0.8) was performed to extract the frequency 
of geminin-positive cells, the number of cell-cell contacts per cell and the subcellular 
location of p120 in glioma cells using anti-human p120 mAb.
In vivo bioluminescence imaging
Fluc-E98/NTshRNA and Fluc-E98/p120 shRNA in mouse brain and spinal cord was 
monitored with IVIS Lumina imaging system (Caliber). Luciferine (200 µL; 15 mg/ml in 
PBS) was injected intraperitoneally in isofluorane-anesthetized mice and bioluminescence 
was detected in 10 min. Photon emission was normalized to photons per second per 
centimeter squared per steradian (p/s/cm2/sr). 
Supplementary Figure 1. Identification of glioma cell networks and cohesive perivascular invasion 
zones in patient samples. a-d, Morphological pattern and quantitative cell-cell junction analysis 
of glioma cell networks detected in 100 μm-thick tissue slices. Samples included lower-grade 
astrocytoma, secondary glioblastoma (SGB) originating from low-grade astrocytoma (LGA, grade 
II and III), and primary glioblastoma (PGB). Images represent the peritumor region of the lesions. 
Identification of glioma cells in LGA and SGB via colocalization of IDH1R132H and nestin. In PGB, 
which lacks IDH1R132H, nestin-positive but Myelin Basic Protein-(MBP)- and focally GFAP-negative 
networks represent the glioma cell fraction. e, Tumor-free human brain cortex (1) and adjacent 
white matter region (2) lacking IDH1R132H and interstitial nestin signal, but contain GFAP-positive 
astrocytes in the parenchyma. f, Representative large-field overview used for selecting region 
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for high-resolution imaging. Nestin-positive but myelin basic protein-(MBP-)negative glioma cell 
network in primary glioblastoma (PGB) sample intercalating with astrocyte (GFAP) and myelinated 
axonal (MBP) networks in tumor margin. g, Perivascular cohesive glioma cell layers aligning along 
large vessel, identified by longitudinal lumen (V) in LGA sample. Inset, β-catenin-positive cell-cell 
junctions. h, Cell-cell proximity and number of directly neighboring cells during perivascular invasion 
(3D image analysis of LGA samples). i, Molecular topography of filamentous protrusions connecting 
glioma cells in patient-derived orthotopic E-468 xenograft. Identification of glioma cells using 
human-specific anti-nestin mAb. Arrowhead, nestin- and vimentin-positive filament, also containing 
microtubules. Values display median (black line), 25/75 percentiles (boxes) and maximum/minimum 
values (whiskers) or relative fractions of connected glioma cells interacting with 0 up to 10 connected 
cells (boxes), median (red square), 25/75 percentiles (whiskers). 8 patients (LGA), 1 patient (SGB), 
4 patients (PGB), 1 - 3 samples (25 - 30 cells) per patient, 3 - 5 imaging fields per sample. Detailed 
information in Supplementary Table 1. Bars, 50 μm (a), 100 µm (e, f), 20 μm (i, g).
Supplementary Figure 2. Subtype analysis and differential gene expression of E-98 and E-468 
glioma cells. a, Gene set enrichment analysis on two non-targeting shRNA samples of E-98 and E-468 
datasets using 4 glioblastoma subtype gene sets14. b, Hierarchical clustering and heatmap of mRNA 
expression of genes found to be deregulated after p120 knock-down (compare Supplementary 
Figure 7). Data represent the gene expression in cells after transfection with non-targeting shRNA. 
c, Hierarchical clustering and heatmap of cadherin and protocadherin genes detected in at least one 
of the replicates. The Euclidean distance was used as metrics and the normalized expression level of 
genes used as input values. 
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Supplementary Figure 3. Variability of cell-cell interactions and signaling in human glioma cells 
during invasion in organotypic culture. a, 3D organization of scaffold formed by transformed 
astrocytes, shown by horizontal and orthogonal projections. (1) Random (top section) versus aligned 
(bottom section) orientation of astrocyte cell bodies. (2) Organization of laminin and collagen-IV 
between astrocytes, with intercellular pattern (inset). b, Cell pattern of E-98 glioma invasion from 
spheroids (Sph) into 3D astrocyte scaffolds. c, Quantification of next-neighbor proximity, migration 
speed and cell-cell interactions in glioma cell invasion in reconstituted basement membrane (rBM) 
assays. Values display median (black line), 25/75 percentiles (boxes) and maximum/minimum values 
(whiskers) or relative fractions of connected glioma cells interacting with 0 up to 10 connected 
cells (boxes), median (red square), 25/75 percentiles (whiskers). 5 - 10 spheroids, 94 - 272 cells 
per parameter; data show two representative out of three independent experiments. d, Inhibition 
of multicellular calcium transients in E-98 cells in the presence of carbenoxolone (CBX). Dots, cells 
assessed for calcium transients displayed in the graphs. e, Lack of calcium transients in the presence 
of CBX (left panel) and quantification for multiple cells (right panel). Values display median (black 
line) and values (dots); P values, Mann Whitney test. Bars, 50 µm.
Supplementary Figure 4. Expression and subcellular distribution of p120 and other cell-cell 
adhesion molecules in human glioma cells. a, Surface expression of receptors implicated in cell-cell 
interactions in E-98 cells (FACS data). b, Increased expression of p120 catenin in human gliomas of 
different grade. Data are derived from the 284 sample cohort from French et al. (MAS5.0-u133p2) 
comprising grade I-IV gliomas. Expression reflects log level. c, p120 (brown label in large panels) and 
IDH1R132H (insets) immunohistochemistry in primary/ secondary human glioblastoma and low grade 
glioma samples. P120 positivity in both tumor core and diffuse brain infiltration region. IDH1R132H 
positivity in grade III glioma sample was used to confirm glioma origin. Bars, 500 µm (overviews) 
and 20 µm (details).
P1
2
0
-C
A
TEN
IN
 D
EPEN
D
EN
T C
O
LLEC
TIV
E B
R
A
IN
 IN
FILTR
A
TIO
N
 B
Y
 G
LIO
M
A
-C
ELL N
ETW
O
R
K
S
P1
2
0
-C
A
TEN
IN
 D
EPEN
D
EN
T C
O
LLEC
TIV
E B
R
A
IN
 IN
FILTR
A
TIO
N
 B
Y
 G
LIO
M
A
-C
ELL N
ETW
O
R
K
S
96 97
44
Supplementary Figure 5. Molecular targeting of cell-cell interaction and collective invasion in 
vitro. a, Transient downregulation of candidate proteins involved in cell-cell junction stability of E-98 
cells. (1) Relative protein levels detected by Western blot (total proteins) or flow cytometry (surface 
receptors) after transient downregulation using SMARTpool siRNA. (2) Numbers in the table express 
the ratio between p120 and non-targeting (NT) siRNA. (3) Morphology and (4) quantification of 
single-cell fraction during radial migration of E-98 glioma cells from spheroids on rBM-coated surface 
after single- or triple interference with cell-cell junction proteins. Color code denotes fold-change 
compared with non-targeting baseline. Data represent three independent siRNA transfections, with 
10 to 20 cell spheroids analyzed per condition. b-f, Quality control and functional consequences 
of stable downregulation of p120 in glioma cells. b, Extent of downregulation of p120 protein (1) 
and mRNA (2) and persistence of vimentin expression in E-468 cells (3). Immunostaining of vimentin 
was used for the detection of glioma cells in the mouse brain. c, Effect of four independent shRNA 
sequences on p120 catenin protein levels detected by immunofluorescence (1), the number of cell-
contacts between neighboring cells (2) and cell density as measure for growth (3). Data represent 
three independent shRNA lentiviral transductions with 209 to 2353 cells analyzed from 2 wells per 
shRNA sequence. Based on efficacy of p120 downregulation and representativity, sequence 988 
was used for further in vitro and in vivo experiments. d, Cells in S/G2/M phase detected by geminin 
staining >30 (E-98) or 8 days (E-468) after transduction. In contrast to E-98 cells which grew well in 
liquid culture before p120 downregulation, E-468 cells were derived directly from mouse brains and 
failed to grow in vitro. Therefore, all functional experiments with E-468 cells were performed 8 days 
after transduction, including molecular profiling and implantation into mouse brains. e Reduced 
growth of E-98 cells in neurobasal spheroids. f, Unperturbed migration speed on 3D astrocyte 
scaffolds after p120 downregulation, obtained by single cell tracking. g, h, Myosin light-chain 
phosporylation (ROCK target) after p120-catenin downregulation in E-468 cells in the absence or 
presence of ROCK inhibitor Y-27632 (10 µM) detected by cell-based immunofluorescence. Values 
display the median (black line), 25/75 percentiles (boxes) and maximum/minimum values (whiskers); 
P values, Mann Whitney test (b -  h). Bars, 50 µm (a3, d), 200 µm (e), 100 µm (g). 
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Supplementary Figure 6. Inhibition of multicellular networks and diffuse infiltration into mouse 
brain after p120 downregulation. a, Impaired tumor growth, loss of network formation and diffuse 
brain infiltration of E-98 cells after p120 downregulation. Overviews (1) and zoom images (2) from 
200 µm thick brain slices. Arrowheads, filaments in multicellular networks of vimentin-positive 
E-98 cells diffusely infiltrating the brain. Data represent 19 independent mice from 2 independent 
experimental series; mean values ± SEM (a1) or median (black line), 25/75 percentiles (boxes) and 
maximum/minimum values (whiskers) (a2); P values, Mann Whitney test.  b, Persistent deficiency 
of p120 signal in vivo in E-98 p120 shRNA knock-down cells in 4 weeks after intracranial tumor 
implantation. c, Sustained glioma growth deficit in vivo after p120 downregulation. Frequency of 
geminin-positive glioma cells after the indicated time of post-implantation in mouse brain. Data 
represent two mice per condition. Values display the median (black line), 25/75 percentiles (boxes) 
and maximum/minimum values (whiskers); P values, Mann Whitney test. Bars, 2 mm (a1), 50 μm 
(a2, b, c).
Supplementary Figure 7. Gene expression regulation in glioma cells in response to downregulation 
of p120. a, Proportional Venn diagrams of total number of down- or up-regulated genes in E-98 and 
E-468 cells after p120 downregulation (p values are obtained using hypergeometric test). b, Ranked 
list heatmap of all relevant GO term biological functions resulting from gene ontology analysis of 
deregulated genes in each p120 knock-down cell lines. Log2 of Benjamini values was used as input. 
The annotation was carried out using the DAVID server and GO database and the Benjamini -3 was 
determined as cut off for selecting the relevance of the GO terms. To determine the significance 
of deregulation, log2-fold change of /-1.5 and p value < 0.05 and FDR < 0.05 were used as cut 
offs. c, Gene enrichment analysis of the p120 signature in human glioma. Expression levels of p120 
correlate to migration/ECM. Ranked expression panels of p120 RNA expression as determined by 
MAS5.0 normalized u133a or u133p2 RNA expression arrays (Verhaak, TCGA 540 tumors, ID2000-
01-01) and low- to high-grade glioma (French 284 samples including normal controls, GEO ID: 
gse16011), correlated to z-values of a migration signature75 (http://www.broadinstitute.org/gsea/
msigdb/cards/WU_CELL_MIGRATION.html) and an ECM signature (Segal Stanford cancer modules, 
http://ai.stanford.edu/~erans/cancer/modules/module_47.html).
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ABSTRACT
Malignant gliomas represent a heterogeneous group of primary brain tumors which 
diffusely invade the brain parenchyma and render complete surgical resection ineffective. 
For their dissemination glioma cells preferentially migrate along anatomical vascular and 
neuronal brain structures, however the mechanotransduction underlying each invasion 
route remains poorly defined. To identify matrix molecules and adhesion receptor systems 
supporting glioma cell invasion into brain-like environments we used 2D and 3D invasion 
assays recapitulating different organotypic cell-cell and cell-matrix conditions and 
combined antibody-, small molecule- and RNA-based molecular interference. Migration of 
U-251 and E-98 glioma cells on reconstituted basement membrane was readily abolished 
by interference with β1 and αV integrins, however perivascular invasion into primary brain 
slices, infiltration of 3D astrocyte-based scaffolds or migration on astrocyte-deposited 
matrix was only partly affected and residual migration persisted with 30-50% efficacy. 
Laminin 511 was identified as a central mediator securing integrin-dependent glioma 
cell migration along astrocyte-derived matrix, however, multi-targeted interference with 
all integrin systems expressed by U-251 and E-98 cells, including laminin-binding β1, αV 
and α6 integrins, reduced glioma cell migration into astrocyte scaffolds and on laminin 
511 by 50-80%, but failed to induce complete migration arrest. These data implicate 
integrin/laminin 511 interactions as important adhesion system in glioma cell invasion, in 
cooperation with additional, yet unidentified mechanocoupling strategies.  
INTRODUCTION
Gliomas originate from transformed brain cell progenitors replicating abnormal brain 
development programs with local growth and diffuse infiltration into the brain stroma as 
fatal outcomes1–4. Glioblastoma multiforme is the most detrimental form of gliomas in 
humans due to rapidly progressing diffuse infiltration into any brain region, which renders 
curative surgery impossible5. 
Glioma invasion into the healthy brain occurs along structures of the brain parenchyma, 
including white matter tracks comprising myelinated axons, astrocyte processes and/or 
the basement membranes of blood vessels and the meninges5,6. Astrocytes, as the most 
abundant cell population in the brain, are ubiquitously present in the neuropil and, 
together with myelinated fibers, form complex cellular networks filled with relatively soft 
extracellular matrix (ECM), including hyaluronan, the main ECM component in brain6,7. 
Glioma cell invasion along brain blood vessels follows a particularly permissive niche, 
where brain stroma and vascular basement membranes interface to support molecularly 
and physically complex types of invasion along confined space5,6,8. Brain blood vessels 
are ensheathed with basement membranes jointly formed by endothelium, pericytes 
and astrocytes, and are tightly enveloped with glia limitans formed by astrocytic 
endfeet from the parenchymal side9–13. Glioma cells in the perivascular niche either 
migrate along basement membrane of glia limitans, by displacing astrocytes, or along 
basement membrane underlying the endothelium in perivascular space8,14,15. Glioma cell 
migration along basement membrane proteins including laminin isoforms and type IV 
collagen has been reported16,17, yet the molecular guidance mechanisms of glioma cell 
invasion in the neuropil, along astrocytic and axonal networks, are likely distinct and 
remain unexplored.
The interaction of moving cells, including glioma cells, to basement membranes 
predominantly depends upon integrin adhesion receptors18,17. Laminin-binding integrins 
include α3β1, α6β1, α6β4, and α7β1; type-IV collagen is bound by α1β1, α2β1 
integrins19,20.  αVβ3 and αVβ5 integrins mediate adhesion to both laminin and type-IV 
collagen21–23. Invading glioma cells upregulate multiple integrins in human gliomas, 
including α3β1 and αVβ3 integrins24–26, and engage with a range of basement membrane 
and other stromal proteins in in vitro assays16,17,27–32. 
To address glioma invasion functionally, diverse in vitro assays have been developed to 
model brain stroma33. 3D collagen scaffolds, broadly used in cancer research, are effectively 
invaded by glioma cells34–36, however the relevance of fibrillar collagen for largely collagen-
free brain parenchyma remains disputed33. Reconstituted basement membranes (rBM) or 
cross-linked hyaluronan partially mimic brain ECM were used for probing glioma cell 
migration37,38, but these substrates lack cellular and structural components of the brain 
tissue, such as astrocytes and myelinated axons, which provide additional ligands and 
guidance5,6. Astrocytes cultured as 2D monolayers provide gap-junction communication 
and paracrine secretion of migration-enhancing molecules to glioma cells39–41. As most 
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complex system, brain slice assays provide in vivo-like substrate topologies to reproduce 
glioma cell invasion including radial migration along blood vessels42,43. 
The role of integrin subsets in glioma cell migration was demonstrated for 2D 
surfaces coated with matrix molecules related to basement membranes, including 
α3β1, α6β1, α1β1 integrins binding to laminins, type IV collagen16,17,27–32 and fibrillar 
collagen44, however the role of integrins in mediating invasion into organotypic brain-like 
3D environments remains unclear. We applied complementary 2D and 3D organotypic 
migration assays representing defined both ECM and cell-derived structures for in vitro 
modelling of glioma cell invasion in the brain tissue. With a focus on astrocyte-derived 
matrix and basement membrane of blood vessels, we tested which ECM molecules and 
integrin subunits mediate glioma cell invasion, and identify β1 integrin/laminin 511 
interactions as dominant interaction system driving glioma cell invasion. However, using 
multi-inhibitor integrin targeting strategies, we further identify residual invasion activity 
implicating alternative, yet unexplored compensatory mechanisms maintaining this 
pathological process.
MATERIALS AND METHODS
Antibodies and reagents
The following antibodies and concentrations were used: adhesion-perturbing anti-human 
β1 integrin (mouse monoclonal, clone 4B4, human-specific; 15 µg/ml, BD Biosciences); 
adhesion-perturbing anti-mouse α6-integrin (rat monoclonal, clone GOH3, 10 µg/ml, BD 
Biosciences); adhesion-perturbing anti-human αV-integrin (mouse monoclonal, human-
specific, clone 17E6, 10 µg/ml, Abcam); anti human α3-integrin (mouse monoclonal, 
clone 17C6, 10 µg/ml, AbD Serotec); anti human β3-integrin (mouse monoclonal, clone 
Y2/51, 10 µg/ml, AbD Serotec); anti-human β4-integrin (mouse monoclonal, clone 
ASC-3, 10 µg/ml, Abcam); anti human α1-integrin (mouse monoclonal, FITC labelled, 
clone TS2/7, 1:10, Abcam), human α2-integrin (mouse monoclonal, FITC labelled, clone 
AK-7, 1:10, BD Biosciences); anti-mouse laminin (rabbit polyclonal, 1:100, Sigma); anti-
human collagen-IV (mouse, clone Col-94, 1:300, Sigma); anti-human vimentin (rabbit, 
SP20 clone, human specific,1:300, Thermo Scientific).
Cyclic cRGDFV and control cRADFV peptides (Biochem) were used to interfere with αV/
α5 integrins in migration assays. Growth factor reduced rBM (matrigel; BD Biosciences) 
was used in migration assays as undiluted solution (» 9.8 mg/ml) or for coating culture 
plastic (30 µg/ml in PBS). Recombinant human laminin 511 and laminin 211 (BioLamina) 
and human placenta-derived type IV collagen (Advanced Bio Matrix) were used for coating 
culture plastic (10 µg/ml in PBS).
Cell lines and culture
Human glioblastoma U-251MG cells (kind gift from Dr. J. Schalkwijk, Nijmegen) 
and E-98 cells45 were propagated in vitro in flasks for up to passage 35. H2B/eGFP-
expressing U-251 and E-98 cells were generated by lentiviral transduction with pLenti6.2/
V5-DEST™ Gateway (Invitrogen) containing histone2B/eGFP. Primary mouse astrocytes 
were immortalized with SV40 large T-antigen and additionally transformed with retrovirus 
pBabe puro H-Ras V12, as described46 (kindly provided by Prof. Amparo Acker-Palmer, 
Frankfurt). Primary human astrocytes were immortalized with SV40 large T-antigen only 
(ABM). 
Glioma cells and astrocytes were cultured in complete Dulbecco’s Modified Eagle’s 
Medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (Sigma-
Aldrich), penicillin (100 U/ml) and streptomycin (100 μg/ml; both PAA), L-glutamine (2 
mM, Invitrogen) and sodium pyruvate (1 mM; Invitrogen).
Generation of glioma cell spheroids
U-251 and E-98 cell spheroids were generated using the hanging drop method. Cells 
were cultured in DMEM until subconfluency, detached with 1 mM EDTA/0.075% trypsin, 
washed with PBS, and maintained for 24h in complete DMEM /methylcellulose (2.4%; 
Sigma) as hanging droplets (25 μL) containing 1000 (U-251) or 2000 cells (E-98). 
Interference with integrin function
Integrin function was perturbed by subunit-specific mouse-anti-human mAb targeting β1 
(4B4; 15 µg/mlL, α6 (GOH3; 10 µg/mL), αV (17E6; 10 µg/ml), and cyclic peptide cRGDFV 
(50 µM) targeting RGD-binding αV and α5 integrins. As negative controls, isotypic IgG1 
(10-15 µg/ml) or not-functional cRADFV peptide (50 µM) were used. Antibodies and 
peptides were added to the culture medium 2 - 4 h after seeding to secure initial spheroid 
engagement with the substrate. 
Reconstituted basement membrane migration assays
Glioma cell spheroids were placed on 96-well-plates coated with growth factor reduced 
rBM (30 µg/ml) and overlaid with medium. 3D Matrigel-hyaluronan interface cultures 
were generated by polymerizing Matrigel on a culture dish (30 min, 37°C), addition of 
glioma spheroids (2h, 37°C), followed by addition of complete DMEM supplemented 
with hyaluronan (10 mg/ml; Sigma) as described47. For analysis of migration efficacy after 
24h, samples were fixed (4% PFA) and analysed by bright-field or confocal microscopy.
Invasion into murine brain-slices
Glioma cell invasion from multicellular spheroids was probed using 3D murine brain slice 
culture, as described47. In brief, brains were dissected from female mice (5-6 weeks old, 
from Charles River or Jackson laboratories) C57BL/6-Tg(TcraTcrb)1100Mjb/Crl   (OT1) 
crossed with B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J (dsRed) in our laboratory. 400 µm-thick 
tissue slices were freshly sectioned using a vibratome (Leica, VT100s) and maintained 
on transwell insert membranes (Costar, 12-well plate; 8 µm pore diameter) in complete 
M
U
LTIPLE A
D
H
ESIO
N
 STR
A
TEG
IES M
ED
IA
TE G
LIO
M
A
 C
ELL IN
V
A
SIO
N
M
U
LTIPLE A
D
H
ESIO
N
 STR
A
TEG
IES M
ED
IA
TE G
LIO
M
A
 C
ELL IN
V
A
SIO
N
112 113
55
DMEM (37°C, 5% CO2) for 1h. Glioma cell spheroids expressing H2B/eGFP were added 
(8-10 spheroids per slice), allowed to initially adhere to the substrate (3h), and antibodies 
and peptides were added. During culture, medium and inhibitors were refreshed after 
24h and migration efficacy was assessed after 48 h. Brain slices were fixed (4% PFA, 
1h, RT), washed and stained with human-specific anti-vimentin antibody to discriminate 
glioma cells from DsRed-expressing blood vessels. 
3D astrocyte scaffold invasion assay
3D astrocyte-derived scaffolds were generated by immortalized murine astrocytes 
maintained at high cell density in 96-well plates (20,000 cells/well, coated with growth 
factor-reduced rBM) for 2 days resulting in consolidated scaffolds of up to 3 cell layers 
in thickness (~50 µm), as described47. Glioma cell spheroids expressing H2B/eGFP were 
cultured on top of astrocyte scaffolds for 2 d, fixed (30 min, 4%PFA), stained to visualize 
glioma cells, astrocytes and ECM proteins. Primary antibodies were visualized with 
secondary AlexaFluor-conjugated goat-anti-mouse or goat-anti-rabbit polyclonal antibody 
to (Invitrogen; 5 µg/ml). Cell nuclei were stained with 4’,6-diamidino-2-phenylindole 
(DAPI; 2.5 µg/ml).
Confocal microscopy and quantification of glioma cell migration
Confocal microscopy (Olympus FV1000) was performed using long working distance 20× 
NA 0.50 and 40× NA 0.80 objectives at a step size of 2-3 µm. Imaris V.6.1.5 software 
(Bitplane) was used for 3D reconstruction of Z-stacks.
For quantitative image analysis, operator-assisted image segmentation of bright-field 
or confocal 3D stacks was performed (Fiji software, V.1.49g48). The average cell migration 
distance representing radial migration of glioma cells from spheroids was calculated 
according to the following formula:
Mass-spectrometry
To identify proteins deposited by the astrocytes on culture plastic dishes murine and 
human astrocytes were cultured for 3 and 7 days, respectively, detached (2 mM EDTA/
PBS), remnants of cells solubilized (0.25% Triton X100/0.25% sodium deoxycholate/
PBS), and adsorbed proteins were harvested by scraping (disposable cell scraper, Greiner 
bio-one). The resulting protein fraction was centrifuged (4,250 x G, 45 min), the sediment 
dissolved (8 M urea, 3% SDS, 5% β-mercaptoethanol), cleaned and trypsin digested 
in a 12% polyacrylamide gel (TGX, BioRad), concentrated and desalted using STAGE 
tips (Thermo Scientific). The protein digest was separated on a nanoLC system using 
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Mass-spectrometry. To identify proteins deposited by the astrocytes on culture 
plastic dishes murine and human astrocytes were cultured for 3 and 7 days, 
respectively, detached (2 mM EDTA/PBS), remnants of cells solubilized (0.25% 
a reversed phase C18 column coupled to a LTQ FT Ultra mass spectrometer (Thermo Fisher 
Scientific; Radboud Proteomics Centre, Radboudumc, Nijmegen). Peptide analysis was 
performed using a customized database consisting of the RefSeq protein database with 
Mus musculus, together with Bos taurus taxonomies to identify possible contaminating 
proteins originating from fetal bovine serum used for culture. Validation of peptide and 
protein identifications was carried out by applying score thresholds to minimize false 
positive identification of emPAI values and number of peptides identified per protein. 
emPAI values were calculated as follows emPAI = 10N observed/N observable –1, where Nobserved is 
the number of experimentally observed peptides and Nobservable is the calculated number of 
observable peptides for each protein49. 
Transient down-regulation of β1 integrin expression
Glioma cells were incubated with β1 integrin- or non-targeting smart-pool siRNA 
(Dharmacon; 50 nM) in the presence of Lipofectamine-2000 (1:1000, Dharmacon) for 
20h, washed with growth media, cultured for 24h, aggregated for glioma cell spheroid 
generation (hanging drop assay) and monitored in migration assays for additional 24-28h. 
Efficiency of β1 integrin downregulaton was assessed by flow cytometry of single cells 
after detachment with EDTA (2 mM) 3 and 4d after transfection.  
RESULTS
U-251 and E-98 glioma cell lines abundantly expressed α3 and β1 integrin subunits, 
moderate levels of α6, αV, β3, and negligible levels of α1, α2 and β4 integrins 
(Suppl. Fig. 1). Based on known subunit combinations, both cell lines thus predominantly 
expressed α3β1 and α6β1 integrin heterodimers, with predicted combined ligand 
preference for laminins50,51. Compared to E-98 cells, U-251 expressed higher levels of 
αVβ3, a RGD dependent integrin with broad substrate specificity52,53. 
As reference to published work54, the role of integrins for emigration from U-251 
and E-98 spheroids on reconstituted basement membrane (rBM) was tested. Combined, 
but not individual interference with antibody and peptide targeting β1 and αV integrins 
abrogated migration of U-251 cells in this assay, confirming a role of both integrin 
subsets for U-251 cells (Fig. 1a, b). E-98 cells migrating on rBM were more sensitive to 
mono-targeted β1 integrin interference than U-251 cells (Fig. 1a, b), indicating more 
limited substrate repertoire based on comparably low αVβ3 integrin surface levels (Suppl. 
Fig. 1). Similarly, a prominent pro-migratory function of b1 integrins in both cell types 
was confirmed using a 3D rBM/hyaluronan interface assay (Suppl. Fig. 2a, b), confirming 
the importance of b1 integrins for a 3D model. 
When cultured on 3D organotypic brain slices, U-251 and E-98 cells invaded 
preferentially along blood vessels (Fig. 2a, d), and combined interference with β1 and 
αV integrin subunits decreased their distance migrated by 50 % (Fig. 2a, b). Despite 
abundant presence of adhesion-perturbing antibody 4B4 at the cell surface, detected 
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by post-fixation confocal microscopy using secondary antibody only, glioma cells 
effectively interacted with capillary basement membranes and developed elongation 
and front-rear polarity during persistent migration (Fig. 2c, arrowheads). Moreover, 
the fraction of migrating glioma cells associated with blood vessels increased significantly 
in response to integrin inhibition, whereas interstitial movement was strongly reduced 
(Fig. 2d). This indicates differential adhesion requirements in perivascular versus interstitial 
tissue invasion. 
To address the role of interstitial astrocyte-rich stroma in glioma cell invasion directly, 
an astrocyte-generated 3D scaffold was developed and used as migration substrate47. 
After 3-day culture, immortalized murine astrocytes formed multicellular networks in 
locally varying random or aligned order, with extracellular deposition of laminin and 
type IV collagen along cell-cell junctions (Suppl. Fig. 3a). After addition of glioma cell 
spheroids, glioma cells invaded into the astrocyte scaffolds along the boundaries between 
astrocytes (Fig. 3a). Similarly, to the brain slice assay U-251 and E-98 cell invasion into 
Figure 1. Migration of glioma cells on rBM coated surface is dependent on β1, αV and α6 integrin 
subunits. a. Radial migration of U-251 and E-98 cells from spheroids on plastic surface coated 
with rBM molecules (Matrigel) in media with control isotype IgG1, IgG2, adhesion-perturbing anti-
integrin mAbs - anti β1 (4B4), anti aV (17E6), anti a6 (GOH3), and anti aV integrin cRGDFV peptide. 
b. Average migration distance of U-251 and E-98 cell on rBM. Values display median (black line), 
25/75 percentiles (boxes) and maximum/minimum (whiskers). P values, Mann Whitney test.
Figure 2. Glioma cells effectively invade along blood vessels in mouse brain slices in the presence 
of β1 and αV integrin inhibitors. a. Invasion of U-251 and E-98 cells from spheroids (for 2 days) in 
media with control isotype IgG1 + cRADFV peptide or with adhesion-perturbing anti β1 integrin 4B4 
mAb + anti aV integrin cRGDFV peptide. Red signal originates from the DsRed mouse background, 
as contrast of vessels (bright signals) and stromal cells (dim signal).  b. Average invasion distance 
of glioma cells in mouse brain slices. Values display median (black line), 25/75 percentiles (boxes) 
and maximum/minimum (whiskers) from 3 independent experiments. P values, Mann Whitney test. 
c. Glioma cells invasion along capillaries in the presence of anti β1 and aV integrin inhibitors. 
Anti β1 integrin 4B4 mAb was visualized with secondary AlexaFluor-conjugated goat-anti-mouse 
polyclonal antibody. Basement membranes were stained with anti-laminin or collagen IV antibodies. 
Arrowheads point to elongated glioma cells and their protrusions interacting to basement membrane 
of capillaries. d. Glioma cell distribution in the brain slices. % of blood vessels associated cells with 
or without β1+aV integrin interference. Data represent 3 independent experiments. P values, Mann 
Whitney test. Scale bars, 100 μm (a), 20 μm (c). 
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astrocyte scaffolds was reduced by 50% to 60% after interference with β1 and αV 
integrins (Fig. 3a, b). To discern the matrix components which supported glioma cell 
invasion in this assay, astrocyte-deposited matrix was decellularized and used as migration 
substrate (Suppl. Fig. 3b). Interference with β1 and αV integrin subunits inhibited glioma 
migration on astrocyte-derived matrix by up to 95% and 60% for U-251 and E-98 cells, 
respectively (Fig. 4a-c). Similar inhibition was obtained by interference with β1 and αV 
integrins when matrix deposited by human astrocytes after 3 and 7 days of culture was 
Figure 3. Glioma cells effectively invade in 3D astrocyte scaffolds in the presence of β1 and αV 
integrin inhibitors. a. Invasion of U-251 and E-98 cells from spheroids in 3D astrocyte scaffolds 
in media with control isotype IgG1 + cRADFV peptide or adhesion-perturbing anti β1 integrin 
4B4 mAb + anti aV integrin cRGDFV peptide. b. Average invasion distance of U-251 and E-98 
in 3D astrocytes scaffolds. Values display median (black line), 25/75 percentiles (boxes) and 
maximum/minimum (whiskers) from 3 independent experiments. P values, Mann Whitney test. 
Scale bar, 50 μm. 
Figure 4. β1 and αV integrin interference abolishes migration of glioma cells on rBM but not on 
astrocyte-deposited matrix.  a, b. Average migration distance of U-251 and E-98 cells from spheroids 
on mouse (Ms) astrocyte-deposited matrix or rBM (matrigel coated surface) in media with control 
isotype IgG, IgG2, adhesion-perturbing anti-integrin mAbs - anti β1 (4B4), anti aV (17E6), anti a6 
(GOH3), and anti aV cRGDFV peptide and control cRADFV peptide. Mouse astrocytes were removed 
from culture surface with 0.002 M EDTA only (a), or (b) the culture surface was additionally treated 
0.25% Triton X100 + 0.25% sodium deoxycholate/PBS. c, d. Overviews and average migration 
distance of E-98 cells from spheroids on mouse (Ms) or human (Hu) astrocyte deposited matrix. 
Astrocytes were cultured for 3 (3d) or 7 (7d) days and removed with 0.002 M EDTA followed by 
treatment of culture surface with 0.25% Triton X100 + 0.25% sodium deoxycholate/PBS. Values 
display median (black line), 25/75 percentiles (boxes) and maximum/minimum (whiskers) from 3 
independent experiments. P values, Mann Whitney test. 
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used as migration substrate for E-98 cells (Fig. 4d; minus 95 and 69%, respectively). Thus, 
in contrast to glioma cell migration along rBM, invasion into complex brain stroma, 3D 
astrocyte scaffolds or astrocyte-deposited matrix was incompletely inhibited by antibody 
and small molecule based interference with integrins. 
To identify their protein repertoire, astrocyte-deposited matrices were analyzed by 
mass-spectrometry analysis. 9 and 22 ECM proteins were identified in mouse and human 
astrocyte-derived matrix, respectively (Fig. 5b, c; Suppl. Tables 1 and 2). Laminin α5 
was present in both murine- and human-derived samples, but largely absent in rBM, 
where laminin 111 dominates55. Laminin α5 contributes to laminin 511, the predominant 
isoform in basement membranes of brain blood vessels12,13. 
To test whether laminin 511 accounts for integrin-dependent or integrin-independent 
glioma cell-matrix interactions, human recombinant laminin 511 coated on the culture 
surface was used as migration substrate. Combined β1/αV integrin interference decreased 
U-251 cell migration on laminin 511 by 28%, while E-98 cell migration was not affected 
(Fig. 6a, b). Conversely, migration of U-251 and E-98 cells on laminin 211, type IV collagen 
and rBM (containing predominantly laminin 11155) was ablated by dual-integrin targeting 
(Fig. 6a, b). This verifies the technical stringency of the interference strategy and reveals 
particular pro-migratory properties of laminin 511 beyond β1 and αV integrins. 
The main cell receptors for adhesion to laminin 511 are α3β1, α6β1 and α6β4 
integrins50,51. To address whether glioma cells moving on laminin 511 after dual-integrin 
targeting still develop focal substrate interactions, samples were stained for paxillin, 
a structural protein central to integrin-dependent focal adhesions56. E-98 and U-251 
cells with and without β1/αV integrin inhibitors formed string-like focalized enrichments 
corresponding to focal adhesions (Fig. 6c). This finding indicates the presence of either 
residual adhesion by β1/αV integrins or alternative laminin 511 binding integrin subsets. 
To address the role of residual β1 integrin subunits in glioma cell migration on laminin 
511 and in astrocyte scaffolds, siRNA knock-down was combined with antibody and 
peptide-based β1/αV integrin interference. Transient down-regulation of β1 integrin 
reached 73 - 88% reduction of cell surface levels in the majority of cells detected by flow 
cytometry (Fig. 7a1) or confocal microscopy (Fig. 7a2). This triple-interference caused 
additional reduction of migration efficiency of U-251 and E-98 cells on laminin 511 by 
respective 34% and 59%, compared to non-targeting siRNA (Fig. 7b, c). Likewise, triple-
interference was effective for U-251 and E-98 cell invasion in 3D astrocyte scaffolds 
resulting in additionally reduction of migration distance by ~30% (Fig. 7b, c). Despite 
significant further reduction of migration ability after combinatorial integrin targeting, 
residual activity indicated the engagement of additional adhesion mechanisms, such as 
via α6β4, which is expressed in U-251 but not E-98 cells (Suppl. Fig. 1). To address 
whether α6β4 integrin supports U-251 cell migration, adhesion-perturbing anti-α6 
integrin GoH3 monoclonal antibody57 was combined with anti-β1 antibody, cRGDFV 
peptide and transient  β1 integrin RNA interference reaching downregulation of 93% 
(Suppl. Fig. 4a). No additional inhibition was achieved by GoH3 antibody for U-251 
Figure 5. Differences in ECM composition of astrocyte-deposited matrix and Matrigel. a. PAAG 
electrophoresis of Matrigel (MT), mouse (Ms) and human (Hu) astrocyte deposited matrixes (silver 
staining). b. Matrix proteins identified both in mouse and human astrocyte matrixes and which are 
minor in growth factor reduced Matrigel based on published mass-spectrometry data55. c. Proteins 
identified by mass-spectrometry in mouse deposited matrix.  
cell invasion in 3D astrocyte scaffolds or migration on laminin 511 coated surface 
(Suppl. Fig. 4b-d). 
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Figure 6. Glioma cells effectively migrate and form focal adhesions on laminin 511 in the presence 
of β1 and αV integrin inhibitors. a. Migration of U-251 and E-98 cells from spheroids on a plastic 
surface coated with laminin 511, laminin 211 or collagen IV, in media with control isotype IgG1 + 
cRADFV peptide or with adhesion-perturbing anti β1 integrin 4B4 mAb + anti αV integrin cRGDFV 
peptide. b. Average migration distance of U-251 and E-98 cells on the plastic surface coated with 
laminin 511. Values display median (black line), 25/75 percentiles (boxes) and maximum/minimum 
(whiskers) from 3 independent experiments. P values, Mann Whitney test.  c. Paxillin staining in 
E-98 and U-251 cells radially migrated from spheroids on astrocyte deposited matrix or laminin 511 
coated surface. Scale bar, 25 μm.
Figure 7. β1 integrin subunits mediate glioma cell migration on laminin 511 and invasion in 3D 
astrocyte scaffolds. a. Expression of β1 integrin subunit in U-251 and E-98 cells in 3 days after their 
transfection with either NT siRNA or anti β1 integrin siRNA based on flow cytometry (1) or confocal 
microscopy (2). b. Migration of U-251 and E-98 cells transfected with NT siRNA or anti β1 integrin 
siRNA from spheroids on laminin 511 coated culture surface and the cell invasion in 3D astrocyte 
scaffolds, in media with adhesion-perturbing anti β1 integrin 4B4 mAb + anti αV integrin cRGDFV 
peptide. c. Average migration distance of U-251 and E-98 cells on the plastic surface coated with 
laminin 511 and the cell invasion in 3D astrocyte scaffolds. Values display median (black line), 25/75 
percentiles (boxes) and maximum/minimum (whiskers) from 3 independent experiments. P values, 
Mann Whitney test. Scale bars, 100 μm.
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In aggregate, these data suggest that in complex brain-like environments β1 
integrin represent the primary adhesion system for glioma cell migration, with laminin 
511 present in basement membrane and interstitial astrocyte-derived stroma as key 
ligand. The differential interference efficacy across migration models further indicates 
that adhesion requirements are strongly assay dependent, whereby compensation by 
integrin-dependent and, likely, integrin-independent interaction strategies increases with 
the dimensionality and topologic complexity of the substrate. 
Discussion
By using brain-like culture models to quantify glioma cell invasion, we identified β1 
integrins as the central adhesion system driving glioma cell invasion, predominantly 
through interaction with laminin 511. By comparing 2D and 3D models which represent 
the heterogeneity of cell-matrix and cell-cell interfaces present in the neuropil, the data 
reveal significant resilience of glioma cell migration in complex environments despite 
stringent molecular interference. Thus, adhesion targeting may delay but not abrogate 
invasive progression of gliomas in vivo. 
Major constituents of brain basement membranes include type IV collagen and 
predominant laminin isoforms 511, 211, 411, 332, 11118,20,58. rBM (Matrigel) is broadly 
used in cell invasion assays as an extracellular matrix to reproduce aspects of basement 
membranes in vitro, based on its content of laminin 111 and type IV collagen55. However, 
rBM lacks most other brain-related laminin isoforms, and thus lacks the ligand heterogeneity 
of brain ECM deposited by astrocytes, endothelium and pericytes12,13,17. Accordingly 
glioma cell migration on rBM was abolished with β1 and αV integrin interference, 
while invasion along basement membranes in brain slices and in 3D astrocyte scaffolds 
was reduced by only half, suggesting alternative integrin-ECM interactions available in 
a complex brain-like models. 
By mass-spectrometry analysis of the astrocyte deposited matrixes we identified 
laminin 511 as a molecule guiding glioma cell migration and focalized adhesion 
formation in control cells and cells after β1 and αV integrin interference. Laminin 511 
is a multifunctional adhesion protein ubiquitously expressed in basement membranes 
of different tissue structures including brain blood vessels12,59,60. Integrins α3β1, α6β1, 
α6β4 and α7β1 are the major receptors ensuring cell adhesion and migration on laminin 
51150,51, and αVβ3 integrin can additionally provide interactions to laminin 51121. Notably, 
laminin 511 contains two binding sites for α3β1 (in the LG1-3 and LN domains) and one 
further site for αVβ3 integrins (in the L4a domain)21,61–63, and thereby can act as multi-
domain interaction scaffold to engage multiple integrin subtypes simultaneously and in 
a non-competitive manner. Accordingly, multi-targeted interference with β1 integrin, 
the predominant subunit expressed by U-251 and E-98 cells and other glioma models17, 
revealed its dominant role in mediating migration along laminin 511. 
Several mechanisms may mediate residual migration retained in both cell types despite 
interference with adhesion-perturbing anti-b1 integrin antibody 4B4 and anti αV-integrin 
cRGD peptide. β1 integrins interact with laminin 511 with high affinity50,51; moreover, 
clustering of integrin molecules in the plasma membrane additionally increases the avidity 
of cell-matrix interactions64,65. Therefore the natural integrin-ligand interaction may 
outcompete the used competitive (cRGD) and allosteric (mAb 4B4) integrin inhibitors66–68. 
Laminin 511 may further provide binding sites for non-integrin receptors, including 
Lu/B-CAM, a-dystroglycan and syndecan-462,69–71. 
Laminin 511 is present in quiescent and reactive brain stroma, including basement 
membranes along capillaries and larger brain vessels, and diffusely in tumor associated 
stroma released by astrocytes12,13,41,72–76. Moving glioma cells themselves may secrete 
laminins, including laminin 51117, in an autocrine manner and thereby support migration 
in laminin deficient environments or when integrin functions are antagonized. 
Our and other data17 suggest β1 integrin – laminin 511 interactions as a major 
driver of glioma cell invasion along blood vessels and possibly in astrocyte reach stroma. 
Consequently, integrins may be considered as a therapeutic target to combat glioma cell 
dissemination in the brain tissue. Clinically relevant integrin targeting in glioma patients 
using the αVβ3/αVβ5 integrin inhibitor cilengitide, a RGD mimicking cyclic peptide66, 
significantly reduced diffuse glioma cell invasion in mouse brain77,78. However, recent 
phase II clinical trials in late-stage glioblastoma patients did not confirm efficiency of 
cilengitide to improve overall survival79–82. In a pilot study, humanized anti β1-integrin 
neutralizing antibody OS2966 was injected intracranially for 28 days in mouse brain, and 
this treatment significantly inhibited the invasion of human glioma xenografts28. Beyond 
a direct antiinvasive effect, targeting β1 integrins may further reduce tumor growth and 
sensitize glioma cells to radio-, chemo, anti-angiogenesis therapies28,83. Yet, the benefit 
of the combination of anti-β1 to further integrin-targeting strategies or other adhesion 
systems will require exploration. Thus, in line with these limited preclinical and clinical 
data, our findings suggest that overlapping integrin-dependent and, possibly, integrin-
independent adhesion systems support glioma cell invasion. Targeted approaches to 
interfere with glioma cell invasion will thus require combinatorial strategies designed to 
prevent adhesion plasticity of glioma cell dissemination and/or escape to alternative ECM 
systems and invasion routes in the brain tissue.     
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SUPPLEMENTARY INFORMATION
Supplementary Figure 1. Expression of integrin subunits in U-251 and E-98 cells measured with 
flow cytometry. 
Supplementary Figure 2. Migration of glioma cells along hyaluronan-rBM interface is dependent 
on β1 and α6 integrin subunits. a. Migration of U-251 and E-98 cells from spheroids along 
hyaluronan-rBM interface in media with control isotype IgG1 or with adhesion-perturbing anti β1 
integrin 4B4 mAb or anti α6 GOH3 mAb. b. Average migration distance of U-251 and E-98 cells 
along hyaluronan-rBM interface. Values display median (black line), 25/75 percentiles (boxes) and 
maximum/minimum (whiskers). P value, Mann Whitney test.
M
U
LTIPLE A
D
H
ESIO
N
 STR
A
TEG
IES M
ED
IA
TE G
LIO
M
A
 C
ELL IN
V
A
SIO
N
M
U
LTIPLE A
D
H
ESIO
N
 STR
A
TEG
IES M
ED
IA
TE G
LIO
M
A
 C
ELL IN
V
A
SIO
N
130 131
55
Supplementary Figure 4. Residual migration of U-251 cells after β1, αV and α6 integrin 
interference. a. Surface levels of β1 integrin in U-251 cells 3 days after transfection with either NT 
or β1 integrin siRNA detected by flow cytometry. b. Binding of anti-α6 integrin mAb GoH3 but not 
isotypic IgG by migrating U-251 cells in spheroid culture on laminin 511. c. Migration of U-251 cells 
from spheroids on laminin 511 or in 3D astrocyte scaffold culture after multi-targeted interference, 
as indicated. Glioma cells invading astrocyte scaffolds were identified by human-specific vimentin 
staining and nuclear H2BeGFP. c. Migration distance of U-251 and E-98 cells on laminin 511 or into 
3D astrocyte scaffolds. Values display median (black line), 25/75 percentiles (boxes) and maximum/
minimum (whiskers) from 3 independent experiments. P values, Mann Whitney test. Scale bars, 
50 μm (b) and 100 μm (c).
Supplementary Figure 3. Mouse astrocytes deposit matrix molecules related to basement 
membrane. a. Confocal images of  mouse astrocytes cultured for 3 days and stained for laminin, 
collagen IV and fibronectin. b. Confocal images of mouse astrocyte deposited matrix. Astrocytes 
were cultured for 3 days and removed with 0.002M EDTA/PBS followed by treatment of culture 
surface with 0.25% Triton X100 + 0.25% sodium deoxycholate/PBS. c. Mean grey values in confocal 
images (Z-stack) of astrocyte deposited matrix and plastic surface coated with Matrigel. Scale bars, 
50 μm.
CHAPTER 6
GENERAL DISCUSSION, 
FUTURE DIRECTIONS AND 
CLINICALLY RELEVANT IMPLICATIONS
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Gliomas are malignant tumours of the central nervous system originating from 
transformed brain cells as a result of serial mutations and selections of the cancer cells 
with the highest resistance and proliferative potential1–6. In this thesis, using innovative 
3D models for glioma cell invasion (Chapter 3) and in vivo strategies, new mechanisms 
of glioma cell dissemination in the brain parenchyma have been established: diffuse 
multicellular network invasion ensured by p120 catenin (Chapter 4) and perivascular 
glioma cell invasion driven by β1 integrin - laminin 511 interactions (Chapter 5). The data 
support the concept that glioma cells reproduce abnormal brain development programs, 
diffusely invade brain parenchyma along different anatomical structures, proliferate and 
ultimately disintegrate the brain. 
HYPOTHESES OF GLIOMA CELL DISSEMINATION IN THE BRAIN 
TISSUE 
Recent data demonstrated that diffuse astrocytomas, comprise extensive multicellular 
networks structurally and functionally resembling astrocytic or neuronal syncytium7 
(Chapter 4). These findings challenged the single-cell dissemination concept, which 
predicts that glioma cells invade the brain tissue individually similarly to the migration of 
normal glial and neuronal progenitors8–10. However, both views can come to an agreement 
when considered in the context of normal brain development where non-migratory neural 
stem cells produce neuronal and glial cell progenitors migrating individually throughout 
the brain parenchyma, differentiate into neurons, astrocytes and oligodendrocytes which 
finally form multicellular networks11–14. Similarly, tumor-initiating stem-like glioma cells 
can undergo neuronal and astrocytic differentiation-like transitions4,15,16, and multicellular 
glioma networks possibly are pathological counterparts of normal brain cell networks17. 
Both in vitro and in vivo, single glioma cells with uni- or bi-polar morphology are 
consistently present at the invasion front of glioma networks17,18 (Fig. 1a and Chapter 4). 
These individual “forerunner” cells resemble transformed glial cell progenitors migrating 
and proliferating en route in rodent brain tissue18,19. Single glioma cells can divide and 
undergo differentiation-like transitions establishing intercellular filamentous connections 
(Fig. 1a, b). Such individual glioma cells could create a pool of tumor cells possibly 
ensuring glioma network growth at the invasion front. Due to their deregulated cell cycle, 
glioma cells also proliferate within multicellular networks, and the cell proliferation likely 
contributes to network expansion in the brain tissue (Fig. 1b). 
Glioma networks, unlike quiescent astrocytic or neuronal syncytia, are not static but 
enable glioma cell migration through the surrounding environment by disconnecting 
and reconnecting filamentous junctions, a unique invasion mode in the brain, which 
contributes to glioma network expansion in addition to the cell proliferation (Chapter 4). 
This graded network topology indicates that glioma cell dissemination leads to 
the formation of glioma networks based on a gradient of cell density, with regions of high 
density and high connectivity near the tumor core and loosely connected or individualized 
cells located at the invasion front (Fig. 2).  
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CELL-CELL AND CELL-MATRIX INTERACTIONS IN GLIOMA CELL 
INVASION
There are two major routes of glioma cell dissemination in the brain tissue, (1)  along 
the extravascular interface of blood vessels and (2) through neuronal and astrocytic 
networks guided by myelinated axons and astrocyte processes9,20. During migration along 
blood vessels glioma cells interact with, and are guided by, the basement membrane with 
β1 integrin/laminin 511 interactions as important force-generating cell-matrix adhesion 
(Chapter 5). In the confined perivascular space glioma cells invade cohesively, by forming 
epithelial-like adherens junctions in contrast to diffuse glioma cell networks infiltrating 
the neuropil (Chapter 4), indicating that glioma cell-cell junctions are very plastic and 
modulated by geometry of the brain tissue. The mechanical and molecular adhesion 
mechanisms of single-cell and multicellular glioma invasion through the brain interstitium 
Figure 1. Different modes of glioma cell dissemination and growth in the brain. a. Multicellular 
glioma networks invade in the brain parenchyma forming and resolving intercellular filamentous 
connections during their migration (1) as described in Chapter 4, and possibly via incorporation of 
individual glioma cells at the invasion front (2). b. Single glioma cells migrate in the brain tissue and 
divide en route creating a pool of tumor cells, which potentially can be incorporated in the glioma 
network. Glioma cells also divide within the network ensuring glioma network expansion. 
Arrowheads point to mitotic events. Glioma cells in low grade diffuse astrocytoma (LGA) sample are 
visualized with monoclonal antibody (clone H09) that recognizes IDH1 R132H mutant protein and 
does not cross-react with wild type IDH1; glioma cells in glioblastoma multiforme (GBM) sample 
or in xenograft mouse brain tissue are stained with human specific anti-nestin polyclonal antibody. 
Non-neoplastic astrocytes are visualized with anti GFAP antibody. Scale bars: 100 μm (overview), 
50 μm (details).
Figure 2. Gradient of cell density from glioma tumor core toward invasion front. At the invasion 
front, unipolar glioma cells invade either individually or form filamentous connections with adjacent 
glioma cells (1). Closer to tumor core multipolar glioma cells establish multiple filament connections 
similar to astrocytic networks (2). Glioma cells in low grade diffuse astrocytoma (LGA) are visualized 
with a monoclonal antibody (clone H09) that recognizes IDH1 R132H mutant protein and does not 
cross-react with wild type IDH1. Filamentous connections between glioma cells are underrepresented 
in thin (5 μm) histological sections. Scale bars: 500 μm (overview), 25 μm (details). 
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are still largely obscure. It is not known which cell receptors and matrix molecules are 
involved in the generation of traction forces to ensure cell body movement in confined 
microchannels formed by myelinated axons and astrocytic processes20. Our data suggest 
that astrocytes secrete laminin 511, which is engaged by β1 integrins on glioma cells 
(Chapter 5). In addition to laminin 511, β1 and other integrin subunits expressed by 
glioma cells potentially could interact with various multivalent extracellular matrix 
molecules present in normal brain tissue (tenascin R) or de-novo synthetized by glioma 
and stromal cells (tenascin C, fibronectin, vitronectin, various isoforms of laminins and 
collagens). These molecules may decorate the surface of astrocytic filaments or myelinated 
axons and could provide a permissive multi-ligand substrate for glioma cell invasion20. 
Beyond integrins, additional adhesion systems may be involved in mediating glioma cell 
migration. Hyaluronan is the major extracellular matrix molecule in the brain tissue and its 
receptor CD44 is highly expressed in glioma cells21, however, the role of CD44-hyaluronan 
interactions for glioma invasion in astrocytic/neuronal networks was not addressed in 
vivo. Recent data implicated connexin 43 mediated heterotypic interactions between 
glioma cells and astrocytes in the brain tissue independent of channel function of gap-
junctions22, a cell adhesion mechanism which may generate traction force and migration, 
similar to neuroblast migration along radial glial cells during brain development23,24. 
Another molecule which can potentially be involved in heterotypic glioma-astrocyte 
interactions is N-cadherin, which is the main cadherin receptor in glioma cells25. 
Whether glioma cells establish connections to non-neoplastic astrocytes and generate 
force via cadherin -cytoskeleton linkages, similar to moving cells in morphogenesis26,27, 
awaits further investigations. Additionally, glioma cell invasion in extremely confided 
microchannels formed by myelinated axons or perivascular space with (sub)micrometer 
pore dimension, may be supported by non-adhesive, physical mechanisms, e.g. ensured 
by tubulin polymerization, myosin II contraction and ion channel mediated alterations of 
cytoplasmic volume28–33. 
P120 CATENIN IS INDISPENSABLE FOR GLIOMA NETWORK 
INVASION AND TUMOR GROWTH 
P120 catenin (CTNND1) is a multifunctional protein, which directly or indirectly 
regulates activity of various molecular targets in different cell compartments34,35 (Fig. 3). 
At the plasma membrane p120 catenin stabilizes classical cadherins, preventing their 
endocytosis36. P120 catenin modulates activity of Rho GTPases in cadherin associated 
or unbound states34,35,37. Diminishing RhoA and engaging Rac1 activities p120 promotes 
extension of filaments in neuronal and glioma cells38,39. Moreover, p120 catenin can 
translocate to the nucleus and inhibit activity of transcriptional repressors REST, GLIS2 
and Kaiso, which modulate transcription of genes implicated in neuronal differentiation 
and Wnt signalling pathways40,41. Figure 3. Up- and down- stream targets regulated by p120 catenin. Positive regulation is indicated 
with arrows, negative regulation - by a transverse bar at the end of the line.
The dynamics of multicellular glioma networks is a unique, specialized mode of 
collective cell invasion within discontinuous environments. We identified p120 catenin 
as a key molecule, which involved not only in the stabilization of cadherin cell-cell 
interactions but also in the formation of dendritic-like filaments connecting glioma 
cells within the networks, modulating RhoA/ROCK activity and axonogenesis pathways 
(Chapter 4). Stabilizing adherens junctions p120 catenin promotes also gap-junction 
commutation between glioma cells (Chapter 4), which increases resistance of glioma 
cells after radiotherapy7. Moreover, p120 catenin regulates proliferation of glioma cells 
and down-regulation of this protein induces dramatic growth deficit in vitro and in vivo 
via de-regulation of cellular pathways related to mitosis (Chapter 4). The crucial role of 
p120 catenin in glioma cell invasion and proliferation suggests it as a promising target for 
the future combinatory therapies of glioma patients. 
P120 CATENIN AS A TARGET FOR ANTI-GLIOMA THERAPIES
Different amino acid sequences in p120 catenin molecule are involved in the binding 
and regulation of cadherins, RhoA and transcriptional repressors. To discern up- and 
down- stream pathways mediating p120 functions in glioma cells, different molecular 
approaches can be used. Established genetical constructs encoding p120 proteins 
with mutations or deletions in p120 functional domains will be useful to distinguish 
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the contribution of cadherin junctions, RhoA/ROCK activity and transcriptional repressors 
in (i) formation and elongation of glioma cell filaments, (ii) multicellular network dynamics, 
and (iii) cell proliferation and tumor growth. The identification of functionally important 
sites in the p120 molecule will provide information for the design of low-molecular 
compounds inhibiting glioma cell invasion and proliferation. So far, p120 catenin was 
not considered as a target for anti-glioma therapies. Interestingly, another member of 
p120 protein family – delta catenin (CTNND2) is often down-regulated or inactivated in 
glioblastoma patients because of gene deletions or point mutations, and patients with 
reduced delta catenin levels have poor clinical outcome especially with mesenchymal 
gene expression signature of the tumors42. It is not clear why glioma cells prefer p120 but 
not delta catenin. The functions of p120 and delta catenins are partially overlapping; both 
stabilize cadherins at the plasma membrane, binding to the same site in juxtamembrane 
cadherin domain, inhibit RhoA activities and promote dendritic formation in neurons43–47. 
However the mechanisms of regulation of Rho GTP-ases by delta catenin are likely cell 
type/cell compartment specific, and may not be universal compared to p120 catenin43. 
Moreover, in contrast to p120, delta-catenin contains a carboxyl-terminal motif, which 
binds to PDZ-domain containing proteins46,48, and after cleavage with caspase-3 can 
regulate the activity of ZIFCAT, a transcriptional repressor with unknown gene regulatory 
effects49. Delta-catenin plays a critical role in neuronal development and in the brain 
tissue of adults it is expressed primarily in neurons. Since classical cadherins are crucial 
for synaptic activity44,50 in the brain, it can be expected that anti p120 therapies would 
cause neurotoxicity as a side effect. In addition, whether delta catenin could compensate 
the loss of p120 function in neurons requires further analysis.  
RHOA/ROCK AS POSSIBLE ANTI-GLIOMA TARGETS   
Beyond p120 catenin, its down-stream effectors may be suitable for anti-glioma targeting. 
We demonstrated that elevated RhoA/ROCK signalling, as a consequence of p120 catenin 
down-regulation, restricts filament formation in glioma cells and inhibits multicellular 
glioma network invasion (Chapter 4). Moreover, constitutively active RhoA inhibits 
proliferation by retarding G1 to S phase cell cycle progression51. Thus, the activation 
of RhoA/ROCK signalling in glioma cells, for instance via inhibition of Ras or Rac1, 
could be a promising strategy to inhibit both glioma invasion and cell proliferation52. 
In vivo experiments using xenograft patient derived glioma cells are required to test 
this hypothesis. 
NUCLEAR TARGETS OF P120 CATENIN
Besides regulating adherens junctions stability and Rho GTP-ase activity, p120 catenin 
after translocating to the nucleus, can regulate gene transcription, including genes 
involved in neuronal differentiation40,53, some of which are replicated/ reproduced in 
glioma cells (RNA seq data, Chapter 4). In the nucleus p120 catenin can bind to and inhibit 
function of transcriptional repressors REST, GLIS2 and Kaiso40,54, however the nuclear role 
of p120 catenin in gliomagenesis is not known. The nuclear activity of p120 is tightly 
regulated: at low Wnt signalling and high cadherin expression levels catenins typically do 
not enter the nucleus40. As a particular interest, REST (RE1 silencing transcription factor), 
an established repressor of neuronal differentiation, recently was shown as an important 
regulator of self-renewal of glioblastoma stem-like cells55–57. 
P120 CATENIN REGULATES STEMNESS OF GLIOMA CELLS
Of note, after p120 catenin knock-down in patient-derived glioblastoma cells established 
markers of glioma stem-like cells (GSC)4 were down-regulated at the mRNA level in our 
datasets (Fig. 4a). Moreover, out of 30 gene signature highly over-expressed in GSC 
and positively correlated with poor clinical outcome58, 26 genes are significantly down-
regulated in p120 knock-down cells (Fig. 4b). Thus, p120 catenin regulated signalling 
may support stemness programs in glioma, including stemness-associated chemo- and 
radiation resistance. Moreover, we found significant down-regulation of β-catenin at 
the protein level in glioma cells with p120 knock-down. Since Wnt/β-catenin signalling 
is implicated in the proliferation and therapy resistance of GSC59,60, the interconnection 
between p120 catenin and Wnt signalling warrants further investigation.
INTEGRIN-LAMININ INTERACTIONS AS A TARGET FOR ANTI-
GLIOMA THERAPIES
It has been suggested that GSC reside in the perivascular niche where they interact with 
basement membranes61–63. β1 integrin-laminin 511 adhesions drive glioma cell invasion 
along basement membranes surrounding blood vessel (Chapter 5). α3β1/α6β1 integrins 
are overexpressed in GSC and the role of integrin-laminin 511 interactions in proliferation 
of GSC and their chemo- and radio-resistance remains subjects to future investigation62,63. 
Consequently targeting of β1 integrins could be a promising strategy to retard glioma 
invasion and proliferation64. However, high avidity interactions between β1 integrins 
and laminin 511, which cannot be abolished completely even by adhesion-perturbing 
monoclonal antibodies (Chapter 5), might still suffice to mediate glioma cell invasion in 
complex brain parenchyma and limit the efficiency of anti-integrin therapies in patients. 
Moreover, compensation by non-integrin glioma cell adhesions systems may compromise 
therapeutic strategies against invasion, proliferation, chemo- and  radio-resistance of 
glioma cells in the brain.  
CONCLUSION
In conclusion, the data presented in this thesis provide a novel view on glioma cell invasion 
mechanisms: (1) glioma cells occupy the peritumoral brain tissue as multicellular networks 
(2) within the networks glioma cells are connected with filamentous junctions, which 
are formed and resolved over time during glioma network migration; (3) p120 catenin 
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plays a crucial role in glioma network expansion, promoting formation of filamentous cell 
protrusions, intercellular cadherin junctions and proliferation of glioma cells; and (4) β1 
integrin - laminin 511 interactions drive glioma cell invasion along basement membranes 
of brain blood vessels.
Whether targeting of p120 catenin and β1-integrin pathways can improve the efficacy 
of chemotherapy and irradiation of gliomas requires further investigation.
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Gliomas are a heterogeneous group of primary brain tumors originating from transformed 
brain cell progenitors which abnormally reproduce brain development programs1–3. 
The high lethality of glioma patients results from diffuse glioma cell dissemination in 
the brain parenchyma4. After surgical resection of the primary lesion, residual glioma 
cells which have invaded into surrounding tissue beyond the resecting margin give rise 
to recurrent tumor formation often followed by fatal outcome5,6. Glioma cells invade 
in the brain stroma along the intertwining networks formed by astrocytes, neurons, 
oligodendrocytes and blood vessels4,7. However, due to the anatomic and molecular 
complexity of these invasion routes, molecular mechanisms of glioma cell invasion in 
the brain have neither been resolved nor therapeutically exploited. 
The aims of this thesis were: (1) to design three-dimensional (3D) invasion assays 
recapitulating glioma cell dissemination in different anatomical environments of 
the brain – along blood vessels and in neuronal/astrocytic networks; (2) to perform 3D 
reconstruction of glioma lesions and characterize glioma invasion patterns in patient brain 
samples; (3) to identify cell-cell and cell-matrix adhesion strategies involved in glioma cell 
invasion in the brain.
Chapter 2 describes the brain tissue architecture at cellular and molecular levels and 
recapitulates the main anatomical structures which guide glioma cell invasion in the brain. 
Myelinated axons, astrocyte processes and blood vessels create a complex system of 
microchannels utilized by glioma cells for their disseminations. The extracellular space 
in the brain parenchyma is filled primarily with a soft matrix composed by hyaluronan-
lectican-tenascin molecular complexes, unlike connective tissue where collagen bundles 
are predominant in extracellular matrix. While integrins are the main adhesion receptors 
mediating glioma cell migration along basement membranes in perivascular space, 
the mechanisms of cell-cell and cell-matrix interactions during glioma cell invasion along 
myelinated axons and astrocyte processes are still not elucidated.
In Chapter 3 we introduce set of novel 3D in vitro assays reproducing the major routes 
of glioma cell invasion in the brain parenchyma identified in mouse xenograft and glioma 
patient brain samples: cohesive cell migration along blood vessels and multicellular glioma 
networks invading in astrocyte enriched peritumoral stroma. In reconstituted basement 
membrane (rBM) interface assays (1) glioma cells retained N-cadherin cell-cell junctions 
and invaded collectively in the interfaces representing in vivo perivascular microchannels 
formed by basement membranes and brain parenchyma. Similarly, glioma cells invaded 
cohesively along capillaries and bigger vessels in mouse brain slice organotypic assay 
(2). In 3D astrocyte scaffolds (3) glioma cells invaded as multicellular networks being 
interconnected with dendritic-like filaments, a major glioma cell invasion mode identified 
in patient brain samples8 (Chapter 4). Each assay thus recapitulates aspects of glioma 
invasion in distinct brain compartments in vivo and is suitable for high-throughput 
screening of clinically relevant treatments to inhibit glioma cell invasion and proliferation. 
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In Chapter 4 using 3D reconstruction of glioma lesions from mouse brain xenografts 
and patient samples multicellular glioma networks were identified as a major invasion 
pattern in different histological subtypes of gliomas. Glioma network invasion in 3D 
astrocyte scaffolds was enabled by cyclic formation and resolution of dendritic-like 
interactions  between moving glioma cells, which were stabilized by focal adherens 
junctions. Down-regulation of p120 catenin in glioma cells induced disintegration of 
the multicellular networks and profound glioma growth deficiency in vitro and in vivo. 
RNA seq analysis identified significant deregulation of axonogenesis and cell proliferation 
pathways after p120 catenin shRNA knock-down in patient derived glioma cells, 
implicating p120 dependent pathways on morphogenesis-like programs. 
Chapter 5 describes the role of integrins in engaging with brain-derived matrix 
molecules to drive glioma cell invasion. Using assays described in Chapter 3, we identified 
β1 integrin-laminin 511 interactions as a major interaction accounting for glioma cell 
invasion along blood vessels and in astrocyte enriched stroma. However, these interactions 
were relatively resistant to adhesion-perturbing anti β1 integrin antibodies combined with 
cRGD peptide targeting aV and a5 integrins, indicating potential limitations of antibody 
based therapies targeting glioma cell invasion. 
In Chapter 6 we summarize data presented in the thesis and integrate them with 
existing concepts, which describe the mechanisms of glioma cell invasion in the brain. We 
also discuss p120 catenin regulated pathways and β1 integrin-laminin 511 interactions as 
possible molecular targets to improve anti-glioma therapies.
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Gliomas vormen een heterogene groep van primaire breintumoren en zijn afkomstig 
van getransformeerde voorlopers van hersencellen die op abnormale wijze 
breinontwikkelingsprogramma’s doorlopen1–3. De hoge lethaliteit van gliomas wordt 
veroorzaakt door de diffuse verspreiding van gliomacellen in het parenchym van het 
brein4. Gliomacellen die het omringende weefsel hebben binnengedrongen voorbij 
de resectiemarges kunnen na chirurgische verwijdering van de primaire tumor zorgen 
voor terugkeer van de ziekte, vaak met dodelijke afloop5,6. Gliomacellen verplaatsen zich 
door het stroma van het brein via netwerken van astrocyten, neuronen, oligodendrocyten 
en bloedvaten4,7. Echter, vanwege de anatomische en moleculaire complexiteit van deze 
verspreidingsroutes zijn de moleculaire mechanismen van gliomacelinvasie in het brein 
nog niet volledig opgehelderd, en zijn er nog geen therapieën die hierin ingrijpen.
De doelen van deze scriptie zijn: (1) het ontwerpen van driedimensionale (3D) 
kweekmodellen die nabootsen hoe gliomacellen zich verspreiden in verschillende 
anatomische gebieden van het brein – langs bloedvaten en in neuronale/astrocytische 
netwerken; (2) het reconstrueren van gliomalaesies in 3D en het karakteriseren van 
het invasiepatroon van glioma in hersenmateriaal van patiënten; (3) het identificeren 
van cel-cel en cel-matrix adhesiestrategieën die betrokken zijn bij de verspreiding van 
gliomacellen in het brein.
Hoofdstuk 2 beschrijft de weefselstructuur van het brein op cellulair en moleculair 
niveau met betrekking tot de verspreidingsroutes van gliomacellen. Gemyelineerde axonen, 
uitlopers van astrocyten en bloedvaten vormen een complex systeem van microkanalen 
waarlangs gliomacellen het brein infiltreren. De extracellulaire ruimte in het parenchym 
van het brein is voornamelijk gevuld met een zachte matrix van moleculaire complexen 
van hyaluronan-lectican-tenascin, in tegenstelling tot bindweefsels die voornamelijk uit 
stijve collageenbundels bestaan. Hoewel bekend is dat gliomacellen tijdens migratie over 
basale lamina in perivasculaire ruimtes voornamelijk afhankelijk zijn van de integrines 
voor cel-matrix adhesie, zijn de mechanismen van cel-cel en cel-matrix interactie tijdens 
gliomacelinvasie langs gemyelineerde axonen en de uitlopers van astrocyten nog 
niet opgehelderd.
In Hoofdstuk 3 introduceren we een set van nieuwe 3D kweekmodellen.  Deze 
bootsen de belangrijkste invasiepatronen van gliomacellen na die zijn geïdentificeerd in 
xenotransplantaatmodellen uit de muis en in humaan patiëntenmateriaal; i.e. collectieve 
celmigratie langs bloedvaten, en multicellulaire gliomanetwerken die astrocyt-verrijkte 
peritumorale stroma binnendringen. Perivasculaire microkanalen tussen basale lamina en 
het breinparenchym uit het eerste invasiepatroon werden gesimuleerd met behulp van 
grensvlakmodellen met gereconstitueerde basale lamina (1). In deze modellen behielden 
gliomacellen cel-cel contacten op basis van N-cadherine en migreerden collectief. 
Gliomacellen migreerden op vergelijkbare wijze langs haarvaten en grotere vaten in een 
organotypisch breinmodel uit de muis (2). In 3D matrices geproduceerd door astrocyten 
(3) migreerden gliomacellen als multicellulaire netwerken verbonden met dendrietachtige 
filamenten. Dit is een belangrijke invasiemodus van gliomacellen die geïdentificeerd is 
in breinmateriaal van patiënten (Hoofdstuk 4). Elk kweekmodel simuleert dus aspecten 
van gliomacelinvasie in verschillende breincompartimenten in vivo en is geschikt voor 
screening met hoge verwerkingscapaciteit van klinisch relevante behandelingsmethoden 
om gliomacelinvasie en -proliferatie te remmen.
In Hoofdstuk 4 werden multicellulaire gliomanetwerken geïdentificeerd als 
belangrijk invasiepatroon in verschillende histologische subtypes van glioma. Hiertoe 
werden gliomalaesies in xentransplantaten in muisbreinen en patiëntenmateriaal 
gereconstrueerd in 3D. Het binnendringen van gliomanetwerken in 3D matrices van 
astrocyten werd gefaciliteerd door cyclische formatie en opheffing van dendrietachtige 
interacties tussen gliomacellen, die werden gestabiliseerde door focale adherens 
junctions. Vermindering van expressie van p120 catenine in gliomacellen induceerde 
desintegratie van de multicellulaire newerken en uitgesproken groeideficiëntie in vitro 
en in vivo. RNA seq analyse identificeerde significante ontregeling van signaalroutes van 
axonogenese en celproliferatie na shRNA knock-down van p120 catenine in gliomacellen 
van patiënten, hetgeen impliceert dat er p120-afhankelijke signaalroutes bestaan in 
morfogeneseachtige programma’s.
Hoofdstuk 5 beschrijft de functie van interacties tussen integrines en matrixmoleculen 
afkomstig uit het brein in gliomacelinvasie. Met behulp van de kweekmodellen uit 
Hoofdstuk 3 identificeren we interacties tussen β1 integrine en laminine 511 als 
belangrijke factor in gliomacelinvasie langs bloedvaten en in astrocyt-verrijkte stroma. 
Deze interacties waren echter relatief bestendig tegen verstoring met behulp van 
anti-β1 integrine antilichamen gecombineerd met cRGD peptiden die gericht zijn tegen 
αV en α5 integrines. Dit geeft de eventuele beperkingen weer van therapieën tegen 
gliomacelinvasie die zijn gebaseerd op antilichamen.
In Hoofdstuk 6 vatten we de data samen die gepresenteerd zijn in de thesis en 
integreren we ze in bestaande concepten die de mechanismen van gliomacelinvasie in het 
brein beschrijven. Daarnaast bespreken we signaalroutes van p120 catenine en interacties 
tussen β1 integrine en laminine 511 als mogelijke moleculaire doelwitten om therapieën 
tegen glioma te verbeteren.
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